{"meta":{"query_hash":"1dadcfb68954","filters":{"venue":"European Journal of Clinical Pharmacology"},"cohort_total":114,"direct_labels_cover":0,"predictions_cover":114,"exported":114,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1dadcfb68954","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Journal+of+Clinical+Pharmacology"},"results":[{"id":"W1607337468","doi":"10.1007/s00228-002-0553-3","title":"Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial","year":2003,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Digoxin; Atrial fibrillation; Digitalis; Medicine; Internal medicine; Pharmacokinetics; Pharmacodynamics; Heart rate; Placebo; Cardiology; Population; Anesthesia; Heart failure; Blood pressure","score_opus":0.057055738695292915,"score_gpt":0.38996754928953725,"score_spread":0.33291181059424435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607337468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99137706,0.000042120722,0.00041717282,0.0030642664,0.0025499873,0.0016486167,0.000027323553,0.000023564444,0.0008499139],"genre_scores_gemma":[0.9932294,0.00010229046,0.0003562385,0.0006731386,0.0053319763,5.9893966e-7,0.00014404199,0.000051241946,0.00011108714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99183136,0.0035300332,0.0030277357,0.00043838195,0.0007821651,0.00039034826],"domain_scores_gemma":[0.99555624,0.0018406756,0.0018459008,0.0002575923,0.00025170913,0.00024791618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038559341,0.0003560878,0.0013115298,0.00092351576,0.000090071044,0.000068005465,0.00022807694,0.00010818638,0.0006241661],"category_scores_gemma":[0.00087840407,0.00024354899,0.001287601,0.0014232188,0.00011554894,0.00028160267,0.000046230012,0.0006580128,0.000022741491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22537167,0.00008035886,0.6930792,0.000012968471,0.0034073652,0.0003972083,0.000064607724,0.06768938,0.000025084772,0.000035985737,0.0003470311,0.009489152],"study_design_scores_gemma":[0.2156019,0.0065764682,0.74601215,0.000059383,0.007289637,0.000012900103,0.000014103546,0.014815705,0.00002378984,0.000026135443,0.00923165,0.00033614816],"about_ca_topic_score_codex":0.0000045468523,"about_ca_topic_score_gemma":0.0000057132456,"teacher_disagreement_score":0.052932996,"about_ca_system_score_codex":0.00015690971,"about_ca_system_score_gemma":0.00021306257,"threshold_uncertainty_score":0.99316394},"labels":[],"label_agreement":null},{"id":"W1966621515","doi":"10.1007/s00228-008-0606-3","title":"CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Connaught Fund","keywords":"Tacrolimus; Transplantation; Subclinical infection; Medicine; CYP3A5; Dosing; Kidney transplantation; Trough level; Gastroenterology; Chronic allograft nephropathy; Internal medicine; Trough Concentration; Genotype; Immunosuppression; Urology; Biology","score_opus":0.06302590369775925,"score_gpt":0.3991620833413752,"score_spread":0.336136179643616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966621515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938217,0.00010537202,0.00036613352,0.0033670978,0.000954566,0.00040883638,0.0000398711,0.00003468905,0.0009017535],"genre_scores_gemma":[0.991266,0.0023443438,0.00052118796,0.004207253,0.00086592534,0.0000029207447,0.000086313055,0.00003355689,0.00067251263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99465996,0.0017194052,0.0023683524,0.0003569382,0.00044189484,0.00045346256],"domain_scores_gemma":[0.997342,0.00084023573,0.0009642948,0.00015013215,0.00025574194,0.00044760128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019161724,0.0002815862,0.0010483173,0.0001686686,0.00009058144,0.000022099368,0.00021782225,0.00013450968,0.00028981554],"category_scores_gemma":[0.00020794802,0.00018165298,0.00041903052,0.00031209158,0.00020119284,0.00019633047,0.000010176207,0.0012030008,0.000033521137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27526402,0.02228872,0.35944676,0.00010605199,0.0121078845,0.23643282,0.0035194121,0.0024921447,0.052310925,0.000043665535,0.00748912,0.028498473],"study_design_scores_gemma":[0.05794303,0.02344694,0.9089206,0.0005759208,0.002261656,0.0029923944,0.00003725655,0.00032643095,0.000899252,0.000006552822,0.0023209709,0.00026900976],"about_ca_topic_score_codex":0.0000056240015,"about_ca_topic_score_gemma":0.000032516025,"teacher_disagreement_score":0.5494738,"about_ca_system_score_codex":0.00014964186,"about_ca_system_score_gemma":0.00039427594,"threshold_uncertainty_score":0.7407594},"labels":[],"label_agreement":null},{"id":"W1968497968","doi":"10.1007/s00228-005-0927-4","title":"Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Mycophenolic acid; Pharmacokinetics; Population; Transplantation; NONMEM; Urology; Creatinine; Renal function; Medicine; Volume of distribution; Population pharmacokinetics; Kidney transplantation; Tacrolimus; Internal medicine; Pharmacology","score_opus":0.04378147236536111,"score_gpt":0.37847592594470636,"score_spread":0.33469445357934524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968497968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949256,0.0003463754,0.00031200636,0.0026336822,0.00071404455,0.00016881451,0.0000131981615,0.000009398135,0.00087685225],"genre_scores_gemma":[0.99361145,0.0020435478,0.00095430866,0.0016059126,0.0016163489,0.0000016166106,0.000008092443,0.00002282287,0.00013589473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975419,0.00044517094,0.0014697028,0.00012411279,0.00026306283,0.00015604391],"domain_scores_gemma":[0.99869555,0.00023993691,0.0006859867,0.00008972327,0.00014377902,0.00014501924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083480385,0.00013052716,0.00041700614,0.000099657824,0.000054556436,0.0000067103597,0.00013419065,0.000034702018,0.0005018753],"category_scores_gemma":[0.000030175896,0.000081761726,0.00031707576,0.00010578682,0.00009153289,0.00010642487,0.000011094468,0.00040468198,0.00003919174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05965728,0.004637669,0.7919278,0.0014332951,0.0039995937,0.007693765,0.0027386341,0.005564005,0.057196554,0.000031337648,0.002073743,0.06304633],"study_design_scores_gemma":[0.013184257,0.00086425856,0.96836543,0.00017087841,0.0010625445,0.0007512864,0.000007948979,0.00008973716,0.008841726,0.000004736087,0.00658284,0.000074345895],"about_ca_topic_score_codex":0.0000013332433,"about_ca_topic_score_gemma":0.000002095437,"teacher_disagreement_score":0.17643765,"about_ca_system_score_codex":0.000023764067,"about_ca_system_score_gemma":0.0000316041,"threshold_uncertainty_score":0.5495182},"labels":[],"label_agreement":null},{"id":"W1968595695","doi":"10.1007/s002280100298","title":"Study of the drug-drug interaction between simvastatin and cisapride in man","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Dalton Pharma Services (Canada); Université Laval; Université de Montréal","funders":"Medical Research Council; Heart And Stroke Foundation Of Quebec","keywords":"Simvastatin; Cisapride; Pharmacology; Drug interaction; Medicine; Concomitant; Pharmacokinetics; Drug; Internal medicine","score_opus":0.27510572726083704,"score_gpt":0.5407515798846579,"score_spread":0.2656458526238209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968595695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876442,0.00056634675,0.000016348691,0.0021929112,0.0058893366,0.00042119715,0.000010495645,0.000010423866,0.0032487735],"genre_scores_gemma":[0.9937473,0.0014151136,0.00006680844,0.002565996,0.0018530214,0.0000028741854,9.0106994e-7,0.00003528503,0.00031272534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9863673,0.010079216,0.002604368,0.00030144193,0.00027346463,0.0003742357],"domain_scores_gemma":[0.99532104,0.0023225842,0.0016119112,0.00017743779,0.00021320111,0.00035382115],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008804705,0.00024970606,0.00083311094,0.00022971253,0.00012128041,0.000013564325,0.0007370143,0.00007704139,0.0005043389],"category_scores_gemma":[0.00038460584,0.00018440608,0.00024327823,0.00032067669,0.00035695027,0.00014316695,0.00035417007,0.0024523258,0.000028574426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023596382,0.0033449465,0.84809303,0.000030583706,0.0007260819,0.0011413897,0.003922201,0.0020079804,0.008879135,0.000014413477,0.01592831,0.11355227],"study_design_scores_gemma":[0.02084374,0.0008376875,0.7778576,0.000043427815,0.0010885076,0.00020087165,0.0017987235,0.0003779387,0.0059592472,0.00020592399,0.19046621,0.00032014205],"about_ca_topic_score_codex":0.000008597834,"about_ca_topic_score_gemma":0.000014633325,"teacher_disagreement_score":0.17453791,"about_ca_system_score_codex":0.000025252719,"about_ca_system_score_gemma":0.00009481174,"threshold_uncertainty_score":0.9998491},"labels":[],"label_agreement":null},{"id":"W1970389466","doi":"10.1007/s00228-012-1407-2","title":"The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Tacrolimus; Sirolimus; Pharmacokinetics; Pharmacology; Medicine; Dosing; Crossover study; Drug interaction; Antibacterial agent; Urology; Internal medicine; Chemistry; Antibiotics; Transplantation","score_opus":0.14739553808766365,"score_gpt":0.49724640948616666,"score_spread":0.349850871398503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970389466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939892,0.0011630808,0.00012991454,0.0017464436,0.002072201,0.00021586691,0.0000029057458,0.0000030194344,0.00067731773],"genre_scores_gemma":[0.9961255,0.001910157,0.0001271524,0.0005597745,0.0012430177,0.0000010709248,0.0000030726687,0.000012610335,0.00001761243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961826,0.0019513889,0.0012738248,0.00008589858,0.0003214068,0.00018484768],"domain_scores_gemma":[0.9982404,0.00066412013,0.000601905,0.000056373647,0.00022124872,0.00021594613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058377883,0.00008951616,0.00036621292,0.00010549963,0.0000387943,0.000005228,0.000075011514,0.000028799097,0.000080401056],"category_scores_gemma":[0.00017400285,0.00005678503,0.00014108939,0.000082766295,0.000110854715,0.00011100925,0.000017416793,0.00043797397,0.000010999172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011226293,0.00091361045,0.6647556,0.000116841235,0.000996475,0.00017757731,0.00046055962,0.00042367436,0.0030497527,0.000005993679,0.00056735537,0.31730628],"study_design_scores_gemma":[0.016609129,0.0015448409,0.9764143,0.000067308385,0.001274035,0.00023777656,0.000057268866,0.0007872353,0.00027256118,0.000009238599,0.0026803515,0.000045903584],"about_ca_topic_score_codex":0.0000030167384,"about_ca_topic_score_gemma":4.8471844e-7,"teacher_disagreement_score":0.31726035,"about_ca_system_score_codex":0.00003551691,"about_ca_system_score_gemma":0.0000735892,"threshold_uncertainty_score":0.23156263},"labels":[],"label_agreement":null},{"id":"W1974326801","doi":"10.1007/s00228-011-1172-7","title":"Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allografts","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Samsung; Università di Bologna; Ludwig-Maximilians-Universität München; Feinberg School of Medicine; University of Alberta; Clínica Las Condes; University of Minnesota; University of South Carolina; Ohio State University; University of Florida; Saint Louis University; University of Rochester; Cleveland Clinic; Pfizer; Northwestern University; London Health Sciences Centre; Queen Mary University of London; Eli Lilly and Company","keywords":"Cmin; Pharmacokinetics; Medicine; Cmax; Sirolimus; Area under the curve; Gastroenterology; Internal medicine; Pharmacology","score_opus":0.05717057857147966,"score_gpt":0.36585632981161836,"score_spread":0.3086857512401387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974326801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957843,0.00013563437,0.000100174984,0.00019333525,0.0010662674,0.0002801169,0.000007096278,0.000012611467,0.0024204555],"genre_scores_gemma":[0.99379724,0.0011826799,0.0024939452,0.0021426526,0.0002308033,0.0000011296528,0.000007926728,0.00003790432,0.000105715146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972359,0.00069903967,0.0013656968,0.00021510979,0.00024248706,0.00024174449],"domain_scores_gemma":[0.99845326,0.00024009014,0.0006155382,0.00009705097,0.0002041365,0.00038995157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979313,0.00019474691,0.00062068447,0.0001835649,0.000027749598,0.0000065476597,0.00013122239,0.000038690596,0.00021421544],"category_scores_gemma":[0.000053952674,0.00013248516,0.00015064397,0.0001383233,0.00017744394,0.00010737848,0.000031731324,0.0005958072,0.000015397922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009861599,0.0020140745,0.9712013,0.000087814,0.00062664895,0.004367566,0.00021447787,0.00001791801,0.00017516842,0.000003177867,0.00018298757,0.011247244],"study_design_scores_gemma":[0.039197493,0.004165257,0.9538045,0.00013048871,0.00092077715,0.00018585769,0.000008913488,0.00014387316,0.00015004542,0.000008624602,0.0011629013,0.000121282836],"about_ca_topic_score_codex":0.0000025411452,"about_ca_topic_score_gemma":8.2151644e-7,"teacher_disagreement_score":0.029335896,"about_ca_system_score_codex":0.000021037702,"about_ca_system_score_gemma":0.000061908344,"threshold_uncertainty_score":0.5402588},"labels":[],"label_agreement":null},{"id":"W1976578775","doi":"10.1007/s00228-015-1841-z","title":"Association between hypnotics use and increased mortality: causation or confounding?","year":2015,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Confounding; Medicine; Demography; Norwegian; Cause of death; Cohort study; Population; Prospective cohort study; Internal medicine; Environmental health; Disease","score_opus":0.24596144725003816,"score_gpt":0.4785673799028033,"score_spread":0.23260593265276513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976578775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866791,0.00015830516,0.00029393626,0.0010589124,0.0063621495,0.000112729955,0.000006623064,0.000022401588,0.0053058537],"genre_scores_gemma":[0.9942208,0.00019689556,0.00019048351,0.0022544703,0.0023584294,4.5154135e-7,0.000006053517,0.0000267814,0.0007456596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938741,0.0040827445,0.0013934153,0.000172707,0.00024818737,0.00022887158],"domain_scores_gemma":[0.9952051,0.0025295762,0.0013576656,0.00009965692,0.00037873673,0.000429247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007259395,0.00012518094,0.000452991,0.00011630536,0.000049190083,0.000038276015,0.00016704327,0.00015533227,0.00039474398],"category_scores_gemma":[0.0032543603,0.0000955966,0.00011718321,0.00012564611,0.00013490734,0.00018136302,0.00004690732,0.0008095776,0.00015900498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089157344,0.00041934196,0.86395717,0.0000040711034,0.0035443392,0.0006414727,0.0005974265,0.000015343972,0.0000408844,0.000052163396,0.121884786,0.00795141],"study_design_scores_gemma":[0.017937051,0.0015587471,0.8675003,0.000015897365,0.002546698,0.00007078967,0.00032949995,0.000040668438,0.000016924632,0.00013577593,0.10967231,0.00017532194],"about_ca_topic_score_codex":0.000020120318,"about_ca_topic_score_gemma":0.000003338608,"teacher_disagreement_score":0.017045477,"about_ca_system_score_codex":0.00005159254,"about_ca_system_score_gemma":0.00012105617,"threshold_uncertainty_score":0.43221697},"labels":[],"label_agreement":null},{"id":"W1977559592","doi":"10.1007/s00228-008-0575-6","title":"The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery","year":2008,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Pharmacokinetics; Erythropoietin; Medicine; Cardiac surgery; Recombinant DNA; Pharmacology; Surgery; Internal medicine; Chemistry; Biochemistry","score_opus":0.08095988494717514,"score_gpt":0.3804681069292526,"score_spread":0.29950822198207744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977559592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870771,0.00088823325,0.0000031635975,0.004779018,0.004417001,0.00033224066,0.000004141541,0.000011162361,0.0024879302],"genre_scores_gemma":[0.9895826,0.007403151,0.0002167558,0.0011018445,0.0009339603,0.0000026182963,0.0000069884168,0.000042805168,0.000709266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943052,0.002355484,0.0023510002,0.00022843386,0.00040255836,0.00035731273],"domain_scores_gemma":[0.99594134,0.00199103,0.0012745174,0.0001899821,0.00034896744,0.00025413703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039098463,0.00020200471,0.0010480513,0.00015311663,0.000157622,0.0000052289683,0.0002103126,0.000058574424,0.0004525545],"category_scores_gemma":[0.00051003735,0.000131188,0.0006416191,0.00021741279,0.0005446521,0.000053188163,0.000092539856,0.0008015655,0.000050087252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018372312,0.0025426382,0.6049661,0.00009359088,0.00055221946,0.0012126375,0.00037720677,0.0000029006958,0.0013008016,0.000003739425,0.36820725,0.018903717],"study_design_scores_gemma":[0.016521838,0.0054727895,0.9145013,0.0003982605,0.0005191511,0.00013453382,0.0001587907,0.000011844178,0.0061021387,0.000020859063,0.05592976,0.00022871312],"about_ca_topic_score_codex":0.0000037449472,"about_ca_topic_score_gemma":6.8936356e-7,"teacher_disagreement_score":0.31227747,"about_ca_system_score_codex":0.000068867914,"about_ca_system_score_gemma":0.0002806509,"threshold_uncertainty_score":0.53496915},"labels":[],"label_agreement":null},{"id":"W1981177404","doi":"10.1007/s00228-001-0400-y","title":"Heavy metals in traditional Indian remedies","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Heavy metals; Harm; Popularity; Cadmium; Mercury (programming language); Toxicology; Traditional medicine; Medicine; Political science; Environmental chemistry; Law; Chemistry; Computer science; Biology","score_opus":0.3021332740000091,"score_gpt":0.48550926581434023,"score_spread":0.18337599181433112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981177404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97011757,0.0006681345,0.000093486466,0.012727829,0.003068101,0.00011560976,0.0000033741194,0.000007577231,0.0131983],"genre_scores_gemma":[0.9850871,0.0017327941,0.00044905487,0.005422724,0.006998248,8.5305135e-7,0.0000038400294,0.000012865949,0.00029254542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996841,0.0010322169,0.0015167911,0.00014325125,0.00026150438,0.00020519774],"domain_scores_gemma":[0.998211,0.0009063434,0.00043964473,0.0000636466,0.00014447293,0.00023483988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033922843,0.0001179391,0.000674309,0.00021238858,0.000040781648,0.0000033005208,0.00015343395,0.0000092640985,0.0020136666],"category_scores_gemma":[0.0007343986,0.000085507294,0.00023667542,0.00014978723,0.0002874622,0.00008220294,0.00005099081,0.0007486418,0.00004614017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007696804,0.0030350361,0.6566755,0.00006493312,0.0019330768,0.060514465,0.0010921385,0.000033749697,0.0022968468,0.00015189804,0.14075452,0.125751],"study_design_scores_gemma":[0.010933019,0.0044046124,0.736418,0.000115446295,0.00021373587,0.0014528314,0.000329059,0.000013310576,0.00020378194,0.00018488662,0.24564339,0.000087900764],"about_ca_topic_score_codex":0.0000014426076,"about_ca_topic_score_gemma":0.0000034662894,"teacher_disagreement_score":0.1256631,"about_ca_system_score_codex":0.000025208314,"about_ca_system_score_gemma":0.00007847767,"threshold_uncertainty_score":0.9988986},"labels":[],"label_agreement":null},{"id":"W1982275656","doi":"10.1007/s00228-004-0731-6","title":"Patterns of antihypertensive drug utilization in primary care","year":2004,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Primary care; Drug; Antihypertensive drug; Intensive care medicine; Pharmacology; Internal medicine; Family medicine; Blood pressure","score_opus":0.11364996999884724,"score_gpt":0.40176952171841085,"score_spread":0.2881195517195636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982275656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858998,0.006357401,0.00008355391,0.0029755067,0.0013651641,0.00012749618,0.0000042826223,0.000007469426,0.0031793113],"genre_scores_gemma":[0.98444176,0.0027210973,0.00038711537,0.011536754,0.0008457697,2.4889638e-7,0.0000037408652,0.000017719733,0.00004578874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769187,0.00053916476,0.0013068349,0.00013355931,0.00019288476,0.00013570543],"domain_scores_gemma":[0.99831074,0.00023840024,0.0005513076,0.00009249652,0.0006880425,0.00011898167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009623025,0.000100219586,0.00088776014,0.00013588244,0.000020747899,0.0000021784174,0.00011235139,0.000036683206,0.00005162522],"category_scores_gemma":[0.00017298927,0.000073867246,0.00021426448,0.00009642975,0.00008912136,0.00005699199,0.000071136696,0.0005058818,0.000012373906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009097708,0.0063319784,0.7048911,0.0013630061,0.0035172577,0.030305654,0.006988163,0.0005418825,0.037860822,0.00005738856,0.07109206,0.12795301],"study_design_scores_gemma":[0.019124117,0.0015938113,0.93302333,0.00048784865,0.0012993746,0.00042879497,0.000727077,0.000003573938,0.004420524,0.000015809974,0.038762413,0.000113305505],"about_ca_topic_score_codex":0.000003674843,"about_ca_topic_score_gemma":0.0000019576144,"teacher_disagreement_score":0.22813228,"about_ca_system_score_codex":0.000012225566,"about_ca_system_score_gemma":0.00015894845,"threshold_uncertainty_score":0.3012219},"labels":[],"label_agreement":null},{"id":"W1982738196","doi":"10.1007/s00228-014-1711-0","title":"Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone","year":2014,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Boceprevir; Pharmacodynamics; Pharmacokinetics; Protease inhibitor (pharmacology); Medicine; Pharmacology; Virology; Hepatitis C virus; Human immunodeficiency virus (HIV); Virus; Antiretroviral therapy; Viral load; Ribavirin","score_opus":0.06975994241826408,"score_gpt":0.4341093469362494,"score_spread":0.36434940451798536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982738196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680232,0.0010857335,0.001014437,0.02479339,0.0014126278,0.0010992722,0.000024099716,0.00002735173,0.002519915],"genre_scores_gemma":[0.98078805,0.007900138,0.00038722454,0.006674383,0.003971963,0.000014728211,0.0000035927433,0.000056581386,0.00020335814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9860647,0.010839591,0.0018429147,0.00034487294,0.00049689814,0.00041105904],"domain_scores_gemma":[0.991903,0.005947342,0.000900349,0.0002243952,0.00036541026,0.0006594991],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0129457,0.00027957014,0.0010318152,0.00014136132,0.0002882637,0.00006677156,0.00041432958,0.000077008044,0.0005183545],"category_scores_gemma":[0.0027865262,0.00015692526,0.00029467122,0.00018272617,0.0024097047,0.00021970454,0.00024361016,0.0039449083,0.00005486264],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009105757,0.0006670064,0.12798151,0.00016493378,0.00262015,0.0013675088,0.0017839964,0.000033548782,0.016460858,0.00012189445,0.03623772,0.8034551],"study_design_scores_gemma":[0.07448831,0.005720463,0.42096454,0.00041765522,0.0046778847,0.0019434245,0.00012207487,0.0161254,0.0029536951,0.00047372206,0.47150707,0.00060576067],"about_ca_topic_score_codex":0.00007888104,"about_ca_topic_score_gemma":0.000013398314,"teacher_disagreement_score":0.80284935,"about_ca_system_score_codex":0.000045144167,"about_ca_system_score_gemma":0.0001813598,"threshold_uncertainty_score":0.998353},"labels":[],"label_agreement":null},{"id":"W1984784837","doi":"10.1007/s00228-008-0611-6","title":"Health care providers’ requests to Teratogen Information Services on medication use during pregnancy and lactation","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Health Canada","keywords":"Pregnancy; Teratology; Lactation; Medicine; Drugs in pregnancy; Obstetrics; Family medicine; Gestation","score_opus":0.049004443476388805,"score_gpt":0.42812480650689805,"score_spread":0.3791203630305092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984784837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540347,0.0010258574,0.00042490513,0.041845236,0.00086131593,0.00056941714,0.000005455613,0.000037575002,0.0011955402],"genre_scores_gemma":[0.97296786,0.0012139187,0.00091439864,0.024268916,0.0005682517,0.0000014914385,0.000017073284,0.000008631372,0.000039433453],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976194,0.0006268789,0.0012059666,0.000122913,0.00025776433,0.00016710856],"domain_scores_gemma":[0.99804306,0.00014858246,0.00088787125,0.00011114185,0.0002602584,0.0005491066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008449997,0.00010519446,0.00033528396,0.00019319101,0.00007129773,0.000025186853,0.00010281694,0.000041693165,0.000021318527],"category_scores_gemma":[0.0005735566,0.00008280937,0.0000681883,0.000098763005,0.00003603268,0.0006576976,0.000016959119,0.0003972321,0.000032139353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031529616,0.0003867675,0.011153368,0.0005581773,0.00013769517,0.0002516685,0.012413899,0.00003429939,0.0020938702,0.000038537702,0.009555059,0.9602237],"study_design_scores_gemma":[0.0071130996,0.005804953,0.95240414,0.0027747774,0.000116940246,0.0003068769,0.00029457285,0.000029468054,0.00090762076,0.00001107277,0.030123966,0.00011251533],"about_ca_topic_score_codex":0.0000019170031,"about_ca_topic_score_gemma":7.835465e-7,"teacher_disagreement_score":0.9601112,"about_ca_system_score_codex":0.000058372083,"about_ca_system_score_gemma":0.00022210546,"threshold_uncertainty_score":0.3376868},"labels":[],"label_agreement":null},{"id":"W1986144795","doi":"10.1007/s00228-002-0515-9","title":"Multivariate cluster analysis of a human hepatic cytochrome P 450 database","year":2002,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; McGill University","funders":"Medical Research Council Canada; University of Delaware","keywords":"Multivariate analysis; Multivariate statistics; Cluster (spacecraft); Cytochrome; Biology; Chemistry; Medicine; Internal medicine; Computer science; Statistics; Mathematics; Biochemistry","score_opus":0.07350740395286898,"score_gpt":0.398613016039456,"score_spread":0.325105612086587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986144795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8667298,0.0059595355,0.003389172,0.10740347,0.0076815095,0.0007611745,0.0008383087,0.000021444626,0.0072155776],"genre_scores_gemma":[0.5464404,0.00801607,0.003195928,0.40703943,0.030272411,0.0000068722425,0.00083811145,0.00023181776,0.0039589414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99228495,0.0033301213,0.0030352597,0.000557484,0.000363627,0.00042855038],"domain_scores_gemma":[0.9950718,0.00038121289,0.0033612447,0.000539123,0.0004716005,0.00017501967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003408138,0.00041762405,0.0021036156,0.0006254407,0.0000779775,0.000017904582,0.0009451058,0.00033720993,0.00082642195],"category_scores_gemma":[0.00067983416,0.00034466776,0.0016026059,0.00037848123,0.00038490986,0.0000073232804,0.00053372415,0.0019951856,0.000024831263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002556208,0.0003197166,0.0008249765,0.00007741292,0.014256204,0.0009835958,0.000024222369,0.000050523293,0.1043269,0.000002160651,0.878484,0.00039463968],"study_design_scores_gemma":[0.0045918953,0.0028270849,0.011387939,0.00004796692,0.012136573,0.00006137525,0.00000775433,0.00017559256,0.0021624274,0.0000101841915,0.9660834,0.00050777633],"about_ca_topic_score_codex":0.0000050360113,"about_ca_topic_score_gemma":0.000002819154,"teacher_disagreement_score":0.32028937,"about_ca_system_score_codex":0.000016520327,"about_ca_system_score_gemma":0.00007696232,"threshold_uncertainty_score":0.9999005},"labels":[],"label_agreement":null},{"id":"W1988144987","doi":"10.1007/s002280000116","title":"Genotype and phenotype of cytochrome P 450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome","year":2000,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Genotype; CYP2D6; Dextromethorphan; Phenotype; Biology; Immunology; Virology; Internal medicine; Medicine; Genetics; Pharmacology; Gene","score_opus":0.05406232218643753,"score_gpt":0.40537479072086907,"score_spread":0.35131246853443154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988144987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914955,0.0030000661,0.000012653352,0.00011875406,0.0010779384,0.00047366155,0.000094636816,0.000013919809,0.003712901],"genre_scores_gemma":[0.9954502,0.0026461792,0.00017800559,0.001391794,0.0001788307,0.000003253175,0.00001551543,0.000056956313,0.00007928231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99318147,0.0030848098,0.002326701,0.00046745554,0.0003575305,0.00058201316],"domain_scores_gemma":[0.9971856,0.0006172619,0.0011762152,0.000176518,0.0004547855,0.00038962488],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031939268,0.00039183735,0.0010981971,0.00030233676,0.00021766443,0.000021153555,0.0005705092,0.0001804648,0.0014999909],"category_scores_gemma":[0.00011452568,0.00032538344,0.00016510797,0.00035104065,0.001059712,0.00025312166,0.00020336107,0.0011495681,0.00003382067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022268357,0.016791206,0.4795557,0.0002157072,0.0019173712,0.0015113631,0.003976025,0.001516549,0.17265053,0.00019739184,0.0012958886,0.29810393],"study_design_scores_gemma":[0.020458927,0.0039675743,0.9651612,0.000051323816,0.00054422667,0.000057716494,0.000026026779,0.00012473343,0.002020997,0.000089568115,0.0071134614,0.0003842506],"about_ca_topic_score_codex":0.000008926985,"about_ca_topic_score_gemma":0.000001301995,"teacher_disagreement_score":0.4856055,"about_ca_system_score_codex":0.000034325876,"about_ca_system_score_gemma":0.00011819714,"threshold_uncertainty_score":0.99991983},"labels":[],"label_agreement":null},{"id":"W1988463445","doi":"10.1007/s00228-002-0487-9","title":"Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression","year":2002,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Medical Research Council Canada","keywords":"CYP3A4; Chemistry; Microsome; Population; Internal medicine; Biology; Molecular biology; Endocrinology; Enzyme; Cytochrome P450; Biochemistry","score_opus":0.17140802209131079,"score_gpt":0.4408356935308331,"score_spread":0.2694276714395223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988463445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891904,0.004932997,0.0023638122,0.000623274,0.0018750282,0.00037357557,0.00010257754,0.00002040432,0.00051794975],"genre_scores_gemma":[0.9928846,0.0033618843,0.0009602997,0.0008599314,0.0017957787,0.0000068031322,0.000044828525,0.00004479324,0.00004111113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9910885,0.004687551,0.0030186283,0.00040371245,0.0003191273,0.00048249203],"domain_scores_gemma":[0.9968587,0.0006203893,0.0015601302,0.00015946469,0.0003032332,0.00049805746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004164154,0.0003275814,0.0009293463,0.00024103612,0.00013837198,0.00001943331,0.0005464738,0.0002663321,0.0011129498],"category_scores_gemma":[0.00046268714,0.00030153323,0.00024171335,0.0002194503,0.00038108998,0.00020996165,0.00024699868,0.0018034212,0.000035517678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000917023,0.0018192203,0.017568508,0.00005540013,0.00027215722,0.00034272124,0.0005584985,0.008721365,0.9490127,0.000028165805,0.0017920315,0.018912185],"study_design_scores_gemma":[0.021732707,0.0017705681,0.031432003,0.00018992153,0.0010631643,0.00008371935,0.00009066975,0.14399412,0.7838001,0.00079544535,0.014299911,0.0007476299],"about_ca_topic_score_codex":0.000010699004,"about_ca_topic_score_gemma":0.0000024818505,"teacher_disagreement_score":0.16521259,"about_ca_system_score_codex":0.000042781372,"about_ca_system_score_gemma":0.000048186153,"threshold_uncertainty_score":0.9999437},"labels":[],"label_agreement":null},{"id":"W1988914230","doi":"10.1007/s00228-012-1396-1","title":"Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Medicine; Bioavailability; Confidence interval; Statistics; Pharmacology; Mathematics; Internal medicine","score_opus":0.7357467910902785,"score_gpt":0.5167654140692793,"score_spread":0.21898137702099918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988914230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9315488,0.004131315,0.047626797,0.004013854,0.0025239594,0.00034898135,0.0006379708,0.000028443408,0.009139914],"genre_scores_gemma":[0.97509044,0.0005940677,0.019075166,0.003227342,0.0018179266,0.0000042965016,0.000015814694,0.00005772579,0.0001172177],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923109,0.002060751,0.004382949,0.00040764126,0.00010829399,0.00072947156],"domain_scores_gemma":[0.9924732,0.0037084748,0.0026346154,0.00024875236,0.00008253952,0.00085246016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012929584,0.00030365254,0.0021964945,0.00030535331,0.00008964313,0.00004276361,0.0008826963,0.000107124695,0.00081744726],"category_scores_gemma":[0.001988958,0.00030210047,0.00032640382,0.00027110276,0.00036322503,0.00026793877,0.00033282302,0.00095412345,0.0004607458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013551111,0.0016338922,0.7103875,0.00021157235,0.001929149,0.00003986219,0.0023464507,0.0010027079,0.002646782,0.009462664,0.21328531,0.055698976],"study_design_scores_gemma":[0.0060839946,0.002606608,0.13799404,0.00006895387,0.00042447686,0.000037137313,0.0002596231,0.0017990528,0.0068160803,0.0044219797,0.838444,0.0010440358],"about_ca_topic_score_codex":0.000012072683,"about_ca_topic_score_gemma":6.452192e-7,"teacher_disagreement_score":0.6251587,"about_ca_system_score_codex":0.000060290655,"about_ca_system_score_gemma":0.00007057386,"threshold_uncertainty_score":0.99994314},"labels":[],"label_agreement":null},{"id":"W1989133590","doi":"10.1007/s00228-005-0980-z","title":"Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Statin; Cohort; Medical prescription; Persistence (discontinuity); Proportional hazards model; Internal medicine; Coronary artery disease; Cohort study; Diabetes mellitus; Disease; Endocrinology; Pharmacology","score_opus":0.09092833399569246,"score_gpt":0.3528317980808257,"score_spread":0.26190346408513326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989133590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171096,0.007056779,0.0000875258,0.00016526469,0.0004429156,0.00030346418,0.000013928891,0.0000045220304,0.0002146158],"genre_scores_gemma":[0.9918673,0.0057983915,0.0009637094,0.0004500638,0.0008668208,9.618194e-7,0.0000011839293,0.000025364981,0.00002621627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564296,0.0018187414,0.0015939113,0.00019942281,0.0005511601,0.00019382499],"domain_scores_gemma":[0.9976772,0.00019833777,0.0008487941,0.000372819,0.0004223429,0.0004805078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004752222,0.00013614412,0.0010677761,0.00009084615,0.000035091256,0.0000034240722,0.00023173414,0.000039858183,0.0000701808],"category_scores_gemma":[0.0006870579,0.00010053216,0.0010537079,0.00008596884,0.00037194375,0.0000930019,0.000081316786,0.0004105683,0.0000023377984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042906892,0.0014502425,0.5472039,0.00034200962,0.0032345287,0.0007597775,0.00041874894,0.00017579172,0.00035787682,8.594826e-7,0.0012982736,0.44046733],"study_design_scores_gemma":[0.01622303,0.0023230065,0.9704521,0.00018031671,0.0010991469,0.00003552567,0.00004542575,0.00009615393,0.0008182609,0.0000040431105,0.008630936,0.000092083035],"about_ca_topic_score_codex":0.0000072185862,"about_ca_topic_score_gemma":7.566405e-7,"teacher_disagreement_score":0.44037524,"about_ca_system_score_codex":0.000015591544,"about_ca_system_score_gemma":0.00015947042,"threshold_uncertainty_score":0.40995824},"labels":[],"label_agreement":null},{"id":"W1989382717","doi":"10.1007/s00228-008-0609-0","title":"Smoking in pregnancy and lactation: a review of risks and cessation strategies","year":2009,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Nicotine replacement therapy; Breastfeeding; Adverse effect; Psychological intervention; Smoking cessation; Obstetrics; Pediatrics; Nicotine; Psychiatry; Internal medicine","score_opus":0.3160672631367449,"score_gpt":0.5434006920424276,"score_spread":0.2273334289056827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989382717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025958102,0.9951901,0.000029601395,0.00019687356,0.00051054097,0.00035040482,0.0000025071008,0.000005044516,0.0011191162],"genre_scores_gemma":[0.01152338,0.9875659,0.00008612348,0.00030278214,0.00047585132,0.0000018285511,0.000009889186,0.000020504303,0.000013740434],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949259,0.0020178158,0.0025512264,0.00018441319,0.00021049721,0.000110152505],"domain_scores_gemma":[0.9966385,0.0005340701,0.0024336476,0.00008657142,0.0001950069,0.0001122378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035201183,0.00017944997,0.0019020917,0.00020873667,0.00001771423,0.000011581973,0.00009930775,0.00011300583,0.000074607815],"category_scores_gemma":[0.00041848834,0.00013352209,0.00025226065,0.00017313089,0.000120855126,0.00012827873,0.000029205974,0.0010197092,5.3454727e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004382349,0.00012192521,0.0015932439,0.027312567,0.00009433608,0.00032582745,0.000036994443,2.1482447e-7,7.937044e-7,0.000013713541,0.00039433248,0.97006226],"study_design_scores_gemma":[0.0047774217,0.00205304,0.113040656,0.47614872,0.008395914,0.001055979,0.00004524704,0.0000019367633,0.0000016051397,0.000066531575,0.39416853,0.00024441362],"about_ca_topic_score_codex":8.125024e-7,"about_ca_topic_score_gemma":1.5089347e-7,"teacher_disagreement_score":0.9698178,"about_ca_system_score_codex":0.000025994952,"about_ca_system_score_gemma":0.000294747,"threshold_uncertainty_score":0.5444873},"labels":[],"label_agreement":null},{"id":"W1992426204","doi":"10.1007/s00228-009-0744-2","title":"Perception of risk regarding the use of medications and other exposures during pregnancy","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Pregnancy; Medicine; Risk perception; Anxiety; Family medicine; Pharmacist; Perception; Psychiatry; Pharmacy; Psychology","score_opus":0.13229200385250559,"score_gpt":0.4324849511113704,"score_spread":0.3001929472588648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992426204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933839,0.0013639276,0.00075893797,0.0030495694,0.00040118233,0.00013579741,0.0000053672743,0.000009099023,0.00089223625],"genre_scores_gemma":[0.99289244,0.004590407,0.0010110678,0.0008788928,0.0005513322,3.7310716e-7,4.609872e-7,0.000009164075,0.00006586409],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972322,0.0011400876,0.0012305257,0.000094572846,0.00019770734,0.00010488265],"domain_scores_gemma":[0.99741954,0.00078972464,0.0012907702,0.00014881048,0.00018102909,0.00017013296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016112473,0.000072966664,0.00036865877,0.00008956051,0.00004751812,0.0000031690083,0.00013061473,0.000037275244,0.00013304163],"category_scores_gemma":[0.0022350557,0.00004403501,0.00016219147,0.0000855907,0.0002962128,0.000095287716,0.000022456,0.00047120466,0.000002685051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037746457,0.0018259978,0.37546852,0.00022488812,0.0012615017,0.00030123486,0.006014185,0.00011832389,0.11052594,0.00012525517,0.02404625,0.47631323],"study_design_scores_gemma":[0.004257847,0.0010005467,0.9854861,0.00085790135,0.00061522867,0.0003274877,0.0001433541,0.000049722916,0.0010259089,0.000029873117,0.0061608288,0.000045220426],"about_ca_topic_score_codex":0.0000011055913,"about_ca_topic_score_gemma":1.295879e-7,"teacher_disagreement_score":0.61001754,"about_ca_system_score_codex":0.0000075857533,"about_ca_system_score_gemma":0.00007448125,"threshold_uncertainty_score":0.26757318},"labels":[],"label_agreement":null},{"id":"W1996085123","doi":"10.1007/s00228-011-1208-z","title":"CYP2A6 genetic variation and dexmedetomidine disposition","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institute on Aging; Canadian Institutes of Health Research","keywords":"Dexmedetomidine; Disposition; Genetic variation; CYP2A6; Anesthesia; Pharmacology; Medicine; Biology; Metabolism; Psychology; Genetics; Sedation; Internal medicine","score_opus":0.0811628957762019,"score_gpt":0.41967740816788646,"score_spread":0.33851451239168456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996085123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930658,0.00048886257,0.0023904382,0.0017948585,0.0009975726,0.0000868909,4.7332452e-7,0.000006931118,0.0011682123],"genre_scores_gemma":[0.99007994,0.00048130052,0.0020338641,0.0037945793,0.0034546612,3.1063368e-7,0.0000016699227,0.000015155087,0.00013853495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784434,0.0010435538,0.00075385044,0.00008102717,0.00012575283,0.00015146776],"domain_scores_gemma":[0.9988165,0.00026061817,0.00041780414,0.00005209287,0.000114432565,0.00033856166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019825853,0.00007805926,0.00030970975,0.00006005566,0.000034900007,0.0000047146455,0.000057633086,0.000031969754,0.00030947817],"category_scores_gemma":[0.00022362212,0.00005772437,0.0001043238,0.000050543746,0.00008778691,0.00011120974,0.000024669564,0.00030592736,0.00007609158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003752634,0.0017681025,0.80229914,0.000060806444,0.0006330165,0.0017201047,0.0010284721,0.00001200721,0.07789947,0.00008356196,0.023816474,0.086926214],"study_design_scores_gemma":[0.0022730022,0.0010803657,0.9734241,0.000018596671,0.00039873514,0.00089515204,0.000013603314,0.00007257663,0.0005459066,0.000012387128,0.021212732,0.000052880077],"about_ca_topic_score_codex":3.0624136e-7,"about_ca_topic_score_gemma":2.0230562e-8,"teacher_disagreement_score":0.17112494,"about_ca_system_score_codex":0.000012444153,"about_ca_system_score_gemma":0.000031218555,"threshold_uncertainty_score":0.3388569},"labels":[],"label_agreement":null},{"id":"W1996546862","doi":"10.1007/s00228-009-0713-9","title":"Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Montelukast; Medicine; Pregnancy; Prospective cohort study; Obstetrics; Pediatrics; Intensive care medicine; Asthma; Internal medicine","score_opus":0.14099225731700213,"score_gpt":0.4697847156997751,"score_spread":0.32879245838277293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996546862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954967,0.00048307097,0.00006992526,0.00078408216,0.00085710414,0.0007534109,0.000003270492,0.00002057966,0.001531881],"genre_scores_gemma":[0.99793565,0.00033910986,0.0004292716,0.00061439665,0.0003715028,0.0000015909787,6.6017907e-7,0.000014119855,0.00029370785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581856,0.0013072272,0.0020779977,0.00021005089,0.00035063535,0.00023554677],"domain_scores_gemma":[0.99684584,0.00061079446,0.0014798443,0.00020495665,0.00044607188,0.0004125152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009499264,0.00017685698,0.0011242571,0.00016436093,0.000048788777,0.000007833732,0.00022376458,0.00003952431,0.00011886132],"category_scores_gemma":[0.001369534,0.00012292585,0.00028713487,0.00015975673,0.00014578746,0.00022218062,0.000048169928,0.0008411826,0.000016833941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066902214,0.012841357,0.9564589,0.0000504188,0.0013900968,0.00305672,0.005934175,0.00007579742,0.0043545733,0.000008161336,0.0024671277,0.0066724513],"study_design_scores_gemma":[0.026253384,0.0068316488,0.96356136,0.00048757586,0.0005556568,0.00017953143,0.0004936713,0.000039411912,0.0010549253,0.0000042305005,0.0004431397,0.00009548027],"about_ca_topic_score_codex":0.0000017272421,"about_ca_topic_score_gemma":0.0000012267008,"teacher_disagreement_score":0.019563163,"about_ca_system_score_codex":0.000031378557,"about_ca_system_score_gemma":0.00013556353,"threshold_uncertainty_score":0.5012771},"labels":[],"label_agreement":null},{"id":"W1999169026","doi":"10.1007/s00228-012-1225-6","title":"Comparative adherence to oxybutynin or tolterodine among older patients","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Tolterodine; Oxybutynin; Discontinuation; Medicine; Tolerability; Persistence (discontinuity); Retrospective cohort study; Cohort; Internal medicine; Adverse effect; Overactive bladder","score_opus":0.24511334555718958,"score_gpt":0.4767996316286377,"score_spread":0.23168628607144812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999169026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98754525,0.00077687966,0.00009356013,0.0013453161,0.0038615726,0.00023516078,0.000003340179,0.000014139316,0.0061248015],"genre_scores_gemma":[0.97683173,0.00010905793,0.0008061778,0.017850038,0.003310602,0.0000014331919,0.0000011867164,0.000018118855,0.0010716358],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99701416,0.0010167619,0.0012714113,0.0001497693,0.00024916834,0.000298737],"domain_scores_gemma":[0.9975229,0.0006021301,0.00053012825,0.00010339997,0.00058701105,0.0006544638],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018483885,0.00015142444,0.0010568439,0.00008911857,0.000057219822,0.000006875611,0.00016865562,0.00003889073,0.001051913],"category_scores_gemma":[0.00043112834,0.00009249559,0.00020306089,0.00012100409,0.00015623278,0.00013536237,0.000146082,0.00062278635,0.00032255764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026567054,0.0015939953,0.2725905,0.000017544235,0.0008449493,0.00034753725,0.00091259845,0.0000028233621,0.0006826576,0.000001673454,0.713186,0.0071629896],"study_design_scores_gemma":[0.006152936,0.0043804883,0.7938964,0.00008318274,0.0009464829,0.00007454045,0.000088425055,0.000004439476,0.00083460455,6.426356e-7,0.19343415,0.00010375428],"about_ca_topic_score_codex":8.337689e-7,"about_ca_topic_score_gemma":7.5584956e-7,"teacher_disagreement_score":0.52130586,"about_ca_system_score_codex":0.0000060700245,"about_ca_system_score_gemma":0.000045960445,"threshold_uncertainty_score":0.99986124},"labels":[],"label_agreement":null},{"id":"W2001451405","doi":"10.1007/s00228-009-0663-2","title":"The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Everolimus; Medicine; Mycophenolate; Pharmacokinetics; Pharmacology; Heart transplantation; Whole blood; Ciclosporin; Toxicity; Sirolimus; Calcineurin; Lymphocyte; Mycophenolic acid; Therapeutic drug monitoring; Transplantation; Internal medicine; Gastroenterology","score_opus":0.07139606124691972,"score_gpt":0.45428246080107626,"score_spread":0.38288639955415654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001451405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954354,0.0008965165,0.000020070953,0.0013847366,0.0013827326,0.00012595556,0.000006759775,0.0000062358795,0.00074159575],"genre_scores_gemma":[0.9912179,0.00662766,0.00086489326,0.00062974053,0.0006158398,2.1522682e-7,0.0000013020956,0.000013691635,0.000028734383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968396,0.0012551898,0.0013371952,0.00014976483,0.00019877791,0.0002194635],"domain_scores_gemma":[0.99744123,0.001644293,0.00046580672,0.000117355296,0.00009869073,0.00023259538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030606769,0.0001444209,0.00062289444,0.00010126781,0.000042481777,0.0000064941446,0.00014406927,0.00004829235,0.00004260605],"category_scores_gemma":[0.00021910486,0.00008345032,0.00029894218,0.00011594289,0.000113031565,0.000051237086,0.000009731418,0.0005750164,0.0000051364154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16723265,0.0023158616,0.6373968,0.00004559221,0.0015106577,0.0064891824,0.0008369953,0.0006050878,0.026916197,0.00004741146,0.0011484503,0.15545511],"study_design_scores_gemma":[0.03155304,0.014962484,0.9510909,0.00012758064,0.00036807178,0.0003859469,0.000010680267,0.000019541674,0.00076174084,0.0000374745,0.00061186054,0.000070732014],"about_ca_topic_score_codex":0.000003487567,"about_ca_topic_score_gemma":8.306133e-7,"teacher_disagreement_score":0.31369403,"about_ca_system_score_codex":0.000024206814,"about_ca_system_score_gemma":0.00011960952,"threshold_uncertainty_score":0.34030053},"labels":[],"label_agreement":null},{"id":"W2002239118","doi":"10.1007/s00228-007-0317-1","title":"About the appetite-related effects of topiramate","year":2007,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Topiramate; Appetite; Medicine; Anticonvulsant; Pharmacology; Internal medicine; Psychology; Epilepsy; Psychiatry","score_opus":0.039368170796032644,"score_gpt":0.4270460686626478,"score_spread":0.38767789786661516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002239118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791754,0.002115657,0.00022765498,0.002871535,0.0046002422,0.00025602174,6.581817e-7,0.00001542851,0.010737437],"genre_scores_gemma":[0.9896101,0.0010402787,0.00028314735,0.007080144,0.0013112291,4.8047957e-7,0.0000010754626,0.000018844252,0.00065473974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963198,0.0014167799,0.0016676333,0.0001339835,0.0001994844,0.00026234097],"domain_scores_gemma":[0.9960208,0.0023291986,0.0009485661,0.00013535592,0.00021427259,0.0003518083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005447916,0.00013557181,0.0006257024,0.00009804807,0.000060784547,0.000002965588,0.0002658879,0.00007727484,0.00036129486],"category_scores_gemma":[0.0006624956,0.00007962768,0.00042914358,0.00013979786,0.0004395305,0.00004244317,0.0000714282,0.0009939375,0.00012250469],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030339286,0.013061312,0.2152203,0.0009818025,0.011377576,0.059741713,0.0030847585,0.00010914683,0.20011774,0.00082705694,0.16665787,0.29848143],"study_design_scores_gemma":[0.030497745,0.00918983,0.7111961,0.00033406663,0.0025333136,0.0014335002,0.00008008697,0.000034677254,0.060822293,0.00012994256,0.18356653,0.0001818976],"about_ca_topic_score_codex":4.1766998e-7,"about_ca_topic_score_gemma":1.4164806e-7,"teacher_disagreement_score":0.49597582,"about_ca_system_score_codex":0.000022920203,"about_ca_system_score_gemma":0.00012427682,"threshold_uncertainty_score":0.4318219},"labels":[],"label_agreement":null},{"id":"W2003756898","doi":"10.1007/s00228-008-0462-1","title":"Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia","year":2008,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Vitamin C and Antioxidants Research","field":"Nursing","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Placebo; Pharmacokinetics; Dyslipidemia; Chemistry; Pharmacology; Medicine; Internal medicine; Endocrinology; Adverse effect","score_opus":0.061555073411973416,"score_gpt":0.3922688526170878,"score_spread":0.3307137792051144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003756898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265957,0.0008706424,0.00017160372,0.002528632,0.000544315,0.00018499652,0.000004381558,0.000009412522,0.0030264345],"genre_scores_gemma":[0.99633235,0.001867728,0.0005057249,0.0005374886,0.0005971103,4.5828537e-7,7.511269e-7,0.000033873122,0.00012453661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955103,0.0020364115,0.0016034555,0.00023093724,0.0002842105,0.00033469233],"domain_scores_gemma":[0.9973711,0.0013703713,0.0007074925,0.00011108389,0.00019443361,0.0002455499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030556575,0.00016102381,0.00075493107,0.000107916945,0.00008534153,0.000009935505,0.0002979605,0.00005156209,0.00011154789],"category_scores_gemma":[0.00045166936,0.000115697134,0.000113407776,0.00019694834,0.00061378395,0.00018294578,0.00008760645,0.0011632587,0.000014043566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18452978,0.0050378065,0.43249768,0.00033047836,0.0010911779,0.0090232985,0.0030320736,0.0031386628,0.07470035,0.000043402833,0.059437145,0.22713815],"study_design_scores_gemma":[0.037641592,0.0062228017,0.9207767,0.00046759105,0.00015191585,0.00042100393,0.00012992174,0.0015953585,0.021692004,0.000041515174,0.010541534,0.00031802693],"about_ca_topic_score_codex":0.0000026071955,"about_ca_topic_score_gemma":0.000001168231,"teacher_disagreement_score":0.48827907,"about_ca_system_score_codex":0.000020801204,"about_ca_system_score_gemma":0.00008336202,"threshold_uncertainty_score":0.50538445},"labels":[],"label_agreement":null},{"id":"W2004002197","doi":"10.1007/s00228-010-0845-y","title":"Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000–2009 period","year":2010,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicine; Epidemiology; Asthma; Confidence interval; Pharmacoepidemiology; Pediatrics; Proxy (statistics); Population; Demography; MEDLINE; Family medicine; Environmental health; Internal medicine; Pharmacology","score_opus":0.05994383642191356,"score_gpt":0.4379739008060609,"score_spread":0.3780300643841473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004002197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007525931,0.9924937,0.00002792374,0.0008090045,0.002480929,0.0032581352,0.00008233957,0.0000124606295,0.00008289747],"genre_scores_gemma":[0.0008468291,0.9954414,0.000115888,0.0011229786,0.0020480999,0.000068666304,0.000016914037,0.00006622521,0.00027304853],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98738056,0.0050306334,0.006667572,0.00029768728,0.00033811928,0.00028539676],"domain_scores_gemma":[0.9915594,0.001645678,0.005321624,0.00045572277,0.0007804189,0.0002371761],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00868735,0.00038434894,0.005683845,0.0003457432,0.00011521062,0.000028428205,0.0007283119,0.00011551997,0.00017675872],"category_scores_gemma":[0.0096442895,0.00020077462,0.001777472,0.00037921558,0.00035562462,0.00015293887,0.00015769362,0.0019487217,0.00002051251],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058612524,0.0008130084,0.0002104718,0.96524644,0.002125898,0.00020408531,0.00013606297,9.753965e-7,0.000002637439,0.000007156491,0.018658468,0.012536202],"study_design_scores_gemma":[0.002746074,0.0004707022,0.0036424506,0.7125129,0.018227285,0.0010250349,0.000070186026,0.0000041214957,3.0028443e-7,0.000004559352,0.26106134,0.00023506665],"about_ca_topic_score_codex":3.1772436e-7,"about_ca_topic_score_gemma":8.3618613e-7,"teacher_disagreement_score":0.25273353,"about_ca_system_score_codex":0.000077405304,"about_ca_system_score_gemma":0.0010074048,"threshold_uncertainty_score":0.9986979},"labels":[],"label_agreement":null},{"id":"W2007225730","doi":"10.1007/s00228-012-1213-x","title":"The adverse event profile of pregabalin across different disorders: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Eisai; American Academy of Neurology","keywords":"Pregabalin; Medicine; Ataxia; Epilepsy; Blurred vision; Placebo; Neuropathic pain; Adverse effect; Fibromyalgia; Internal medicine; Anesthesia; Psychiatry; Pathology","score_opus":0.3072327464922621,"score_gpt":0.5326128832583301,"score_spread":0.225380136766068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007225730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031537723,0.9960159,0.0003000901,0.00034887972,0.0016512655,0.0008489112,0.00008391906,0.000008875158,0.0004267499],"genre_scores_gemma":[0.007020264,0.9899459,0.000300325,0.00020302656,0.0011062465,0.000022016764,0.00002458148,0.00006659368,0.0013110819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866435,0.0074818763,0.0045859907,0.0003196539,0.0005044503,0.00046452938],"domain_scores_gemma":[0.9910004,0.0023838377,0.0054185046,0.00045886284,0.00024090422,0.0004974932],"candidate_categories":["metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00874483,0.00048207204,0.0068569104,0.00015754625,0.000105469255,0.000009757653,0.0005995985,0.00014936556,0.0011962876],"category_scores_gemma":[0.00041208207,0.00021299871,0.012690822,0.0003279955,0.0002692429,0.00005236732,0.00023592789,0.0013516939,0.000099147335],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035654986,0.0021646838,0.00011835297,0.001219149,0.42744195,0.00030661802,0.000054631924,0.0000028342251,0.0000010842865,0.000010582443,0.0015721411,0.5667514],"study_design_scores_gemma":[0.0013904262,0.00082865014,0.00037520877,0.00014854793,0.45317185,0.000047842583,0.00001297631,0.000003961839,0.00000209263,0.000006316555,0.5439147,0.00009748854],"about_ca_topic_score_codex":0.0000011417341,"about_ca_topic_score_gemma":0.0000027543758,"teacher_disagreement_score":0.5666539,"about_ca_system_score_codex":0.000051413575,"about_ca_system_score_gemma":0.00020940485,"threshold_uncertainty_score":0.99971676},"labels":[],"label_agreement":null},{"id":"W2008571420","doi":"10.1007/s00228-006-0201-4","title":"Pamidronate distribution in pediatric renal and rheumatologic patients","year":2006,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Bone resorption; Creatinine; Renal function; Resorption; Internal medicine; Urinary system; Urinary calcium; Bone disease; Endocrinology; Urology; Excretion; Population; N-terminal telopeptide; Osteoporosis; Alkaline phosphatase; Chemistry; Osteocalcin","score_opus":0.0368934800574312,"score_gpt":0.38215002598698,"score_spread":0.3452565459295488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008571420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961755,0.0005439032,0.000034475004,0.0012018216,0.0008151675,0.00012441234,0.0000059517556,0.0000075678777,0.0010911861],"genre_scores_gemma":[0.997494,0.0012292033,0.00013366646,0.00066011754,0.00039087972,5.756125e-7,0.000019792686,0.000009870836,0.00006192629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974739,0.00076062913,0.0012966527,0.00013405937,0.00013110059,0.00020367748],"domain_scores_gemma":[0.99880916,0.00025503905,0.00055119814,0.000047052807,0.00011667177,0.00022087045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013104622,0.00009298313,0.00042138802,0.00007993082,0.00002989016,0.000003898404,0.000054070748,0.000045903136,0.00004460402],"category_scores_gemma":[0.00022506222,0.00006802792,0.00009094673,0.000103895705,0.00007618493,0.000052799005,0.000030565618,0.00048699568,0.000026973254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010805841,0.00096840545,0.9744108,0.000020562054,0.00002208285,0.0010553991,0.0000052171104,0.000004308663,0.000007313232,0.000010732231,0.011395099,0.0110195],"study_design_scores_gemma":[0.013451771,0.0015701198,0.9766869,0.000018714649,0.00012688883,0.00014026072,0.0000010049856,0.000024764146,0.000011389535,0.0000626711,0.007857639,0.000047900798],"about_ca_topic_score_codex":0.000005745811,"about_ca_topic_score_gemma":0.0000016861335,"teacher_disagreement_score":0.012371187,"about_ca_system_score_codex":0.000030786836,"about_ca_system_score_gemma":0.000082437204,"threshold_uncertainty_score":0.27740982},"labels":[],"label_agreement":null},{"id":"W2010099631","doi":"10.1007/s00228-010-0985-0","title":"Ciprofloxacin-induced theophylline toxicity: a population-based study","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences","keywords":"Theophylline; Medicine; Toxicity; Population; Odds ratio; Internal medicine; Drug interaction; Pharmacokinetics","score_opus":0.1756239777568172,"score_gpt":0.43889066714029284,"score_spread":0.26326668938347564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010099631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903053,0.000047087684,0.0005827816,0.00087264716,0.0028031955,0.00038492586,0.0000020331222,0.000029611803,0.004972404],"genre_scores_gemma":[0.99094385,0.00002866613,0.0014851663,0.0046307547,0.002729169,4.0363895e-7,0.0000025701452,0.000052956097,0.00012645741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554956,0.0015464838,0.0020354,0.0002596189,0.00033149333,0.00027746725],"domain_scores_gemma":[0.99752784,0.0003875428,0.0009607495,0.00021822294,0.00041068002,0.0004949729],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0040755,0.00020387696,0.0007972932,0.00020193662,0.000065003005,0.000009675976,0.00031243722,0.000055436532,0.001339735],"category_scores_gemma":[0.00048809327,0.00015291199,0.00040651453,0.0001996493,0.00006863075,0.000053379674,0.00007271718,0.0009955583,0.00012931068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013938016,0.023581406,0.8522469,0.00008154823,0.0018697164,0.011449131,0.0008208435,0.00011338177,0.04257518,0.00006703325,0.009771126,0.043485712],"study_design_scores_gemma":[0.0155001655,0.010976782,0.9650061,0.0000435735,0.0010391125,0.000059584734,0.00007703742,0.0005089637,0.0040723337,0.000026209253,0.0025031797,0.00018694269],"about_ca_topic_score_codex":0.000003595879,"about_ca_topic_score_gemma":5.135739e-7,"teacher_disagreement_score":0.11275921,"about_ca_system_score_codex":0.000020546226,"about_ca_system_score_gemma":0.0001605297,"threshold_uncertainty_score":0.9995732},"labels":[],"label_agreement":null},{"id":"W2011852042","doi":"10.1007/s00228-013-1628-z","title":"Hemodialysis effects on phenytoin pharmacokinetics","year":2014,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pharmacokinetics; Phenytoin; Hemodialysis; Pharmacology; Medicine; Metabolic clearance rate; Anticonvulsant; Intensive care medicine; Internal medicine; Epilepsy","score_opus":0.09014708943512653,"score_gpt":0.42012231607153677,"score_spread":0.3299752266364102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011852042","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03425996,0.0010030101,0.00034074602,0.91885227,0.022108631,0.00090150605,0.000014119127,0.000107773354,0.022411989],"genre_scores_gemma":[0.078829184,0.0016862132,0.00042910528,0.82168347,0.09591956,0.0000054772718,0.00002034673,0.00014809088,0.0012785789],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98582095,0.008514996,0.0032020616,0.0006951907,0.0009662992,0.0008004924],"domain_scores_gemma":[0.98658013,0.009095306,0.0027315577,0.0003600029,0.0005828905,0.0006501006],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005856581,0.0007806397,0.0036521587,0.0004502997,0.00012921664,0.000032737633,0.0007914143,0.0005531303,0.00092887285],"category_scores_gemma":[0.0023885684,0.0005390278,0.0021607701,0.00026878214,0.0005304541,0.000054997563,0.00024543426,0.010570627,0.00077505136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001959017,0.00062770594,0.00017908402,0.0005009211,0.0028269065,0.039390318,0.000018754803,0.000027642633,0.0025435374,0.0000010349557,0.9149452,0.03697991],"study_design_scores_gemma":[0.014386067,0.010736313,0.0012713451,0.00034373725,0.0058796513,0.0005431068,0.0000014400782,0.00010486541,0.003571841,0.000027256472,0.96268433,0.0004500292],"about_ca_topic_score_codex":3.8470228e-7,"about_ca_topic_score_gemma":2.8139857e-8,"teacher_disagreement_score":0.09716882,"about_ca_system_score_codex":0.00009667151,"about_ca_system_score_gemma":0.0001890349,"threshold_uncertainty_score":0.99998444},"labels":[],"label_agreement":null},{"id":"W2013091814","doi":"10.1007/s00228-012-1343-1","title":"Prescription drug dispensing profiles for one million children: a population-based analysis","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; St. Paul's Hospital; Providence Health Care; BC Children's Hospital; Child and Family Research Institute; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medical prescription; Medicine; Epidemiology; Population; Drug; Pharmacoepidemiology; Pediatrics; Prescription drug; Environmental health; Internal medicine; Pharmacology","score_opus":0.15488162418023566,"score_gpt":0.47297957415175457,"score_spread":0.3180979499715189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013091814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851968,0.0010726465,0.0039703045,0.007039087,0.0017375408,0.00039595176,0.000010456938,0.000018169023,0.0005590115],"genre_scores_gemma":[0.98611087,0.00031376316,0.0047692526,0.0044195037,0.0042676674,0.0000019614536,0.000028174974,0.000022485201,0.00006630509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996674,0.00133486,0.0012943983,0.00015671467,0.00024248756,0.00029752424],"domain_scores_gemma":[0.9968804,0.0013656128,0.0009977964,0.00009222367,0.0002595907,0.0004043781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048928554,0.00013186964,0.00069105224,0.00016143282,0.00012226272,0.000014816187,0.00010958791,0.00003725574,0.00035520643],"category_scores_gemma":[0.0010882869,0.000099673314,0.0006106078,0.0002505716,0.000078197794,0.0002125793,0.0000376961,0.0005245937,0.000020744541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045485212,0.0015448375,0.9508021,0.00005341012,0.0035338376,0.000021814414,0.00006925063,0.00020034781,0.0015501159,0.000016537457,0.01287984,0.024779385],"study_design_scores_gemma":[0.0046693105,0.0005789943,0.9524275,0.000032794167,0.007852082,0.000021742273,0.000013710253,0.0012334314,0.00052106456,0.000008727765,0.032533176,0.000107457265],"about_ca_topic_score_codex":0.0000061962687,"about_ca_topic_score_gemma":0.0000014844377,"teacher_disagreement_score":0.024671927,"about_ca_system_score_codex":0.000032524833,"about_ca_system_score_gemma":0.000038283524,"threshold_uncertainty_score":0.406456},"labels":[],"label_agreement":null},{"id":"W2020245539","doi":"10.1007/s00228-004-0843-z","title":"Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Silymarin and Mushroom Poisoning","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; Health Canada; Women's College Hospital; University of Toronto; McMaster University","funders":"Ontario HIV Treatment Network","keywords":"Indinavir; Milk Thistle; Dosing; Medicine; Pharmacokinetics; Silybum marianum; Crossover study; Randomized controlled trial; Pharmacology; Internal medicine; Placebo; Human immunodeficiency virus (HIV); Sida; Traditional medicine; Immunology","score_opus":0.1316122100948178,"score_gpt":0.46259562364358237,"score_spread":0.3309834135487646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020245539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758065,0.009179426,0.00024633485,0.008409409,0.000571351,0.0012085943,0.0000024527558,0.000020619009,0.004555331],"genre_scores_gemma":[0.9865479,0.0021020353,0.0015725706,0.007334179,0.001186172,0.000008222571,7.625925e-7,0.00002672498,0.0012214506],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99123037,0.0052780244,0.0026785822,0.0002793562,0.00030954965,0.00022412046],"domain_scores_gemma":[0.994648,0.0032005806,0.0013025523,0.00013300372,0.0002534206,0.00046246182],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014059633,0.00023703142,0.005422155,0.00034370983,0.000069790745,0.000028293076,0.00014786684,0.000048534544,0.0015838372],"category_scores_gemma":[0.0013633674,0.00014152867,0.0019440363,0.00019927515,0.00036013726,0.00008017096,0.000115938165,0.00083201483,0.000015044082],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34072044,0.0027360308,0.00909376,0.00003334698,0.6234208,0.0022905055,0.001255763,0.0000967399,0.0010343924,0.000016200276,0.010352792,0.008949244],"study_design_scores_gemma":[0.44766864,0.0010679134,0.00667546,0.0000021286737,0.5325462,0.00019308602,0.00007729994,0.00084551156,0.000052482872,0.000003830289,0.010761542,0.000105870735],"about_ca_topic_score_codex":0.000002112672,"about_ca_topic_score_gemma":0.0000015723427,"teacher_disagreement_score":0.10694821,"about_ca_system_score_codex":0.000012512794,"about_ca_system_score_gemma":0.000059938437,"threshold_uncertainty_score":0.99932885},"labels":[],"label_agreement":null},{"id":"W2025086223","doi":"10.1007/s00228-015-1807-1","title":"Treatment of clozapine-associated weight gain: a systematic review","year":2015,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Mental Health & Substance Use Services; University of British Columbia","funders":"","keywords":"Clozapine; Medicine; Weight gain; Pharmacology; Intensive care medicine; Internal medicine; Body weight; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.2659441573859407,"score_gpt":0.5294422474198315,"score_spread":0.2634980900338908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025086223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021102063,0.9942715,0.0000051521374,0.00057393755,0.001437932,0.0026390105,0.000041420783,0.000017057257,0.0009928965],"genre_scores_gemma":[0.000038293914,0.9968064,0.0002505767,0.0003950265,0.0016775641,0.00003121045,0.000051626586,0.00009538259,0.0006539624],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9801652,0.011644138,0.006697908,0.0003421333,0.00075301813,0.00039760806],"domain_scores_gemma":[0.9892847,0.0020302027,0.006118609,0.00046167328,0.0010373285,0.0010674692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0070015923,0.0005502754,0.011806743,0.00031622266,0.000030374387,0.000008257755,0.0004769532,0.00016983134,0.00037561508],"category_scores_gemma":[0.002956577,0.00029461455,0.0035627556,0.00038888707,0.00021181208,0.000041834686,0.00008751852,0.00095983024,0.00041729413],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020901032,0.0038003544,0.000008847521,0.5509942,0.013402954,0.014586223,0.000016033036,9.3412126e-8,2.489957e-7,0.000007809122,0.037767228,0.3773259],"study_design_scores_gemma":[0.011979005,0.010733565,0.0000089060595,0.31680155,0.042050872,0.002061322,0.0000020752827,0.0000017878937,6.781237e-7,0.0000055866108,0.61619693,0.00015772243],"about_ca_topic_score_codex":8.1398025e-7,"about_ca_topic_score_gemma":3.340208e-7,"teacher_disagreement_score":0.5784297,"about_ca_system_score_codex":0.0004371424,"about_ca_system_score_gemma":0.0026504428,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W2025696894","doi":"10.1007/s00228-011-1015-6","title":"Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Osteoarthritis; Medicine; Cohort; Cohort study; Physical therapy; Internal medicine; Alternative medicine","score_opus":0.10759170090027316,"score_gpt":0.3198673932116619,"score_spread":0.21227569231138876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025696894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863401,0.0002930226,0.00013021949,0.00085337734,0.0032964381,0.0004562477,0.000060866387,0.000030183654,0.008539526],"genre_scores_gemma":[0.9899848,0.0001065685,0.0006981348,0.0022077765,0.0067287544,0.000005407558,0.0000184265,0.000048514034,0.00020161702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99446124,0.0025303564,0.0018216749,0.00033163672,0.0005203792,0.0003347383],"domain_scores_gemma":[0.9955103,0.0014951157,0.001817188,0.00023661474,0.00040828847,0.0005325356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00480255,0.00024192432,0.000808431,0.00007336083,0.00011462633,0.000017756829,0.00037856906,0.000114035305,0.0006824498],"category_scores_gemma":[0.0011682507,0.00014100895,0.00032236075,0.00012673317,0.00064822735,0.00015561188,0.00005003944,0.0017339368,0.00009579083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02544757,0.0016259261,0.68981177,0.00004335741,0.0022205568,0.031076398,0.0017141404,0.000014414062,0.001169653,0.000018276161,0.21429664,0.03256132],"study_design_scores_gemma":[0.01734705,0.0057707867,0.96229494,0.00022099438,0.00078356493,0.00039937397,0.00008747519,0.000025799907,0.0008892386,0.000032245,0.01198185,0.00016666166],"about_ca_topic_score_codex":0.00002169041,"about_ca_topic_score_gemma":0.00001189631,"teacher_disagreement_score":0.2724832,"about_ca_system_score_codex":0.000024061757,"about_ca_system_score_gemma":0.0002167838,"threshold_uncertainty_score":0.7533189},"labels":[],"label_agreement":null},{"id":"W2029228714","doi":"10.1007/s00228-013-1512-x","title":"Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study","year":2013,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Spironolactone; Eplerenone; Medicine; Propensity score matching; Internal medicine; Heart failure; Mineralocorticoid receptor; Ejection fraction; Cardiology; Aldosterone","score_opus":0.05893678542085342,"score_gpt":0.3464912320211201,"score_spread":0.2875544466002667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029228714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98685986,0.000010137439,0.00002576491,0.011731326,0.0002293296,0.0010779304,0.000001347766,0.000011605617,0.000052690673],"genre_scores_gemma":[0.9981963,0.000014276707,0.00049141556,0.000716019,0.00050559605,0.000003510552,0.0000071867235,0.000018733468,0.000046980796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970625,0.001254092,0.00090973574,0.00024071954,0.0003759296,0.00015702422],"domain_scores_gemma":[0.9981871,0.00027020706,0.00055325805,0.00007078777,0.000601823,0.000316799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026320987,0.00013163088,0.00071431295,0.00015928794,0.00006392298,0.000024989455,0.00003242847,0.00007052872,0.000078852296],"category_scores_gemma":[0.00041133023,0.00009714777,0.000052760748,0.00014539337,0.000049537597,0.00023484952,0.00004590037,0.0006203415,0.00002035886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013091781,0.00051002164,0.9878536,0.000006908832,0.00023595657,0.00003496888,0.00008214019,0.000004035926,0.0031082153,9.776084e-8,0.004849662,0.0020052018],"study_design_scores_gemma":[0.009145588,0.0036757872,0.984327,0.000052492647,0.000392226,0.000017682029,0.00012612683,0.000017161381,0.0002411507,0.0000018377871,0.0019086174,0.000094294584],"about_ca_topic_score_codex":0.000018860306,"about_ca_topic_score_gemma":0.000012760754,"teacher_disagreement_score":0.011336413,"about_ca_system_score_codex":0.00010157807,"about_ca_system_score_gemma":0.000059064852,"threshold_uncertainty_score":0.39615712},"labels":[],"label_agreement":null},{"id":"W2031575997","doi":"10.1007/s00228-013-1592-7","title":"Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates","year":2013,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Beef Cattle Research Council; GlaxoSmithKline","keywords":"Omeprazole; Pharmacology; CYP2C19; Pharmacokinetics; CYP3A4; Rosuvastatin; Chemistry; Pioglitazone; Oral administration; In vivo; Medicine; Cytochrome P450; Endocrinology; Enzyme; Type 2 diabetes; Biology; Biochemistry; Diabetes mellitus","score_opus":0.1660924149876682,"score_gpt":0.4554010342335258,"score_spread":0.2893086192458576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031575997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133134,0.004647267,0.00007481047,0.0011750705,0.0018015081,0.00052425737,0.000015802638,0.000008443431,0.00042150286],"genre_scores_gemma":[0.99037313,0.007159319,0.00020977379,0.0015867117,0.00061204884,0.0000036111712,4.9641164e-7,0.000033280237,0.000021609889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994267,0.0036101262,0.0012829287,0.0002881558,0.00019441966,0.0003574005],"domain_scores_gemma":[0.99429435,0.0038169338,0.0011440126,0.00010950135,0.00020903345,0.00042619556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038661913,0.00028470036,0.00086772843,0.00014180018,0.00012520014,0.000016508662,0.00029960895,0.00015203857,0.00020883341],"category_scores_gemma":[0.00023502692,0.00019873319,0.00018541154,0.00012512544,0.0011852932,0.0001589704,0.00010384429,0.0012761997,0.000004514984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017699355,0.00082547986,0.015261446,0.00029108452,0.0007792502,0.0001635315,0.0006419022,0.000118591386,0.9220406,0.00015682833,0.0012261859,0.056725167],"study_design_scores_gemma":[0.0097114025,0.0017701596,0.32922357,0.0001133074,0.00164599,0.00015505108,0.00008566112,0.0019662832,0.64766216,0.00034756813,0.006996568,0.0003222646],"about_ca_topic_score_codex":0.0000068883396,"about_ca_topic_score_gemma":4.635884e-7,"teacher_disagreement_score":0.31396213,"about_ca_system_score_codex":0.000008700942,"about_ca_system_score_gemma":0.00008798641,"threshold_uncertainty_score":0.81041044},"labels":[],"label_agreement":null},{"id":"W2032926075","doi":"10.1007/s00228-005-0896-7","title":"The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Erythropoietin; Pharmacokinetics; Cerebrospinal fluid; Cmax; Medicine; Internal medicine; Endocrinology; Blood–brain barrier; Albumin; Pharmacology; Central nervous system","score_opus":0.041971735042184474,"score_gpt":0.4026972002829395,"score_spread":0.360725465240755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032926075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657444,0.0013661099,0.000039628554,0.028020008,0.0015915434,0.0003818779,0.0000042579286,0.000007448723,0.002844756],"genre_scores_gemma":[0.99191827,0.0033830905,0.0010853874,0.0014914224,0.0018325854,0.0000040232107,0.000003924855,0.000033999604,0.00024729435],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934771,0.0023042036,0.0031648502,0.00022504726,0.0004863717,0.0003424078],"domain_scores_gemma":[0.99674714,0.0008699201,0.0015511027,0.0002893563,0.0003661153,0.00017639651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057464167,0.00023512595,0.00079016015,0.00010338208,0.00010716183,0.000014450096,0.0004703128,0.000080065016,0.00060078304],"category_scores_gemma":[0.00028935273,0.00013164169,0.00047512577,0.00020504813,0.0010512011,0.000060497267,0.00007778672,0.0010724133,0.000026972395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05622691,0.04228691,0.078642234,0.000949097,0.0029001476,0.011857711,0.007595061,0.00028088325,0.11584733,0.0008680403,0.31867322,0.36387244],"study_design_scores_gemma":[0.03864634,0.044614304,0.51057947,0.00079368014,0.0021140473,0.0035833716,0.0020143527,0.0001614155,0.03935002,0.00019677162,0.35742906,0.000517194],"about_ca_topic_score_codex":0.0000035704488,"about_ca_topic_score_gemma":0.0000072087696,"teacher_disagreement_score":0.43193722,"about_ca_system_score_codex":0.000050181414,"about_ca_system_score_gemma":0.00024444718,"threshold_uncertainty_score":0.6578153},"labels":[],"label_agreement":null},{"id":"W2042978277","doi":"10.1007/s00228-007-0277-5","title":"Characterizing early prescribers of newly marketed drugs in Canada: a population-based study","year":2007,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"Pfizer","keywords":"Medical prescription; Medicine; Celecoxib; Early adopter; Family medicine; Logistic regression; Pharmacovigilance; Specialty; Population; Drug; Pharmacology; Internal medicine; Environmental health; Business","score_opus":0.08873143451036468,"score_gpt":0.36007470077563947,"score_spread":0.2713432662652748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042978277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079597,0.00011545268,0.00008688346,0.0011712367,0.0022091868,0.00018730682,0.000031735846,0.0000038341004,0.005398368],"genre_scores_gemma":[0.9955541,0.000037959664,0.00017406531,0.0035956982,0.0005804349,6.283508e-7,0.0000019409397,0.000027294911,0.000027872244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950728,0.00044885732,0.0038406113,0.00023019382,0.000061739156,0.0003457885],"domain_scores_gemma":[0.99650764,0.00089068623,0.0020948097,0.00013740775,0.00006601278,0.00030342114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008237216,0.00014340907,0.00085408054,0.0003235217,0.000028397804,0.000013121218,0.00042292802,0.00003821101,0.00044315954],"category_scores_gemma":[0.00037643174,0.00015742502,0.0001978767,0.00020087032,0.00004288804,0.0001345561,0.000059490205,0.0006354037,0.000025242689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089264545,0.0004646557,0.9924669,0.000013806228,0.00014883747,0.00016421791,0.00021476374,0.00026517373,0.00006828689,0.00014093245,0.0009551121,0.0042046225],"study_design_scores_gemma":[0.004921731,0.00037182713,0.9850664,0.000012926842,0.000023299022,0.0000025129643,0.000058005036,0.0007849882,0.00004201589,0.000092873954,0.008480856,0.00014252983],"about_ca_topic_score_codex":0.038311288,"about_ca_topic_score_gemma":0.015557366,"teacher_disagreement_score":0.02275392,"about_ca_system_score_codex":0.0002193552,"about_ca_system_score_gemma":0.00032433224,"threshold_uncertainty_score":0.9680927},"labels":[],"label_agreement":null},{"id":"W2043552831","doi":"10.1007/s00228-006-0103-5","title":"Bromide as a marker to measure adherence to drug therapy","year":2006,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal function and acid-base balance","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Bromide; Potassium bromide; Pharmacokinetics; Asymptomatic; Drug; Medicine; Pharmacology; Internal medicine; Chemistry; Inorganic chemistry","score_opus":0.07699422078145428,"score_gpt":0.41758004385571856,"score_spread":0.34058582307426427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043552831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499609,0.00034474258,0.0005770128,0.015433903,0.0032142834,0.00027824577,0.0000021138537,0.000027825185,0.03016098],"genre_scores_gemma":[0.936141,0.00016210196,0.0014553319,0.04973766,0.004704977,0.0000020582759,0.0000010518494,0.00003424886,0.007761545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965705,0.0012064226,0.0013573462,0.0002432933,0.00035874484,0.00026364895],"domain_scores_gemma":[0.99795,0.00041264622,0.00040622798,0.00015734385,0.0004311316,0.0006426514],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0033008459,0.00016356309,0.0005904601,0.00013398351,0.000045768724,0.00001674723,0.0002541179,0.000036460224,0.0020032434],"category_scores_gemma":[0.00071385346,0.000117789015,0.00033211117,0.00023110166,0.00006847939,0.000060647508,0.000047613627,0.0006982262,0.001737147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012398308,0.0006418737,0.017262569,0.0000102510785,0.00016627394,0.0027669203,0.0000551273,0.000118313976,0.10560037,0.000016160087,0.8062977,0.054666117],"study_design_scores_gemma":[0.008320947,0.0051098093,0.20609446,0.00013572654,0.00009144839,0.00058001216,0.000020885236,0.000012360057,0.012186524,0.000033768873,0.76725215,0.00016189477],"about_ca_topic_score_codex":0.0000068498143,"about_ca_topic_score_gemma":0.0000015392864,"teacher_disagreement_score":0.1888319,"about_ca_system_score_codex":0.000030598316,"about_ca_system_score_gemma":0.00018843071,"threshold_uncertainty_score":0.9990401},"labels":[],"label_agreement":null},{"id":"W2048639962","doi":"10.1007/s00228-006-0113-3","title":"Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics","year":2006,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; NIH Clinical Center; National Institutes of Health; National Center for Research Resources; National Institute on Drug Abuse; Canada Research Chairs","keywords":"CYP2A6; Nicotine; Cotinine; Allele; In vivo; Single-nucleotide polymorphism; Biology; Genotype; Genetics; Pharmacology; Metabolism; Medicine; Endocrinology; Internal medicine; Gene","score_opus":0.03606456227835719,"score_gpt":0.35157806293772104,"score_spread":0.31551350065936384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048639962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948356,0.000090442474,0.002231676,0.0004223125,0.0015882845,0.00013548383,0.000011372984,0.0000022887289,0.00068254856],"genre_scores_gemma":[0.99553823,0.00013596211,0.0009364461,0.0005509937,0.0025698412,3.449104e-7,0.0000062457875,0.000031241165,0.00023071218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968286,0.0009776256,0.0016476597,0.0001861298,0.00016333754,0.00019664438],"domain_scores_gemma":[0.99816185,0.00006984191,0.0013105191,0.00017497846,0.00021853186,0.00006427731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017423878,0.00013627984,0.0003706846,0.000051775543,0.000026821024,0.000005757447,0.00045444316,0.0000784177,0.00007792196],"category_scores_gemma":[0.00028473148,0.0001026316,0.00024407114,0.00014264334,0.00017660738,0.0000062163135,0.00023040165,0.0003721341,0.000002385751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020617376,0.0007435354,0.014241663,0.0000061816186,0.00005598728,0.00000252518,0.0000132927635,0.00069716206,0.98155284,0.0000037758489,0.002144393,0.00033244686],"study_design_scores_gemma":[0.0050789434,0.00078520854,0.06182847,0.000027851149,0.00010303242,0.00007448682,0.000012714918,0.00022305473,0.85721153,0.0000034273803,0.07449974,0.00015155636],"about_ca_topic_score_codex":0.0000031019847,"about_ca_topic_score_gemma":0.000005034815,"teacher_disagreement_score":0.12434135,"about_ca_system_score_codex":0.0000135352575,"about_ca_system_score_gemma":0.00010013099,"threshold_uncertainty_score":0.41851953},"labels":[],"label_agreement":null},{"id":"W2048702921","doi":"10.1007/s00228-012-1341-3","title":"Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Science and Engineering Research Board","keywords":"Genotype; Internal medicine; Methotrexate; Medicine; Toxicity; Adverse effect; Pharmacology; Gastroenterology; Biology; Gene; Genetics","score_opus":0.03376443808756524,"score_gpt":0.35925888925498517,"score_spread":0.32549445116741993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048702921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881517,0.0001864755,0.000054852328,0.010202318,0.0005006328,0.00039820536,0.0000077738505,0.0000031332277,0.0004948643],"genre_scores_gemma":[0.99592584,0.00009719424,0.0003726633,0.0024861537,0.0004120595,0.0000012649745,4.6156836e-7,0.000030696523,0.0006736358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98985606,0.007896069,0.0010661015,0.00014663125,0.0007044292,0.00033067566],"domain_scores_gemma":[0.9937093,0.0036635764,0.0016333648,0.00023796556,0.0005708715,0.00018489895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0122997025,0.00014531668,0.00057254004,0.00007815934,0.00007053123,0.000006217645,0.00039210927,0.00007525957,0.00009661776],"category_scores_gemma":[0.0035337112,0.00005894502,0.00014035562,0.00035649582,0.0005033915,0.00008406747,0.00022451277,0.0010807446,0.000005649716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06991823,0.0013313475,0.84751356,0.00007055299,0.0010757871,0.00012977341,0.0017801098,0.00010152213,0.05648084,0.0000095416835,0.016478496,0.0051102587],"study_design_scores_gemma":[0.012191371,0.0022918233,0.9734938,0.00008797754,0.0005158707,0.00008911851,0.00007309753,0.000081237486,0.005499179,0.0000048901134,0.005602134,0.000069508314],"about_ca_topic_score_codex":0.000007950182,"about_ca_topic_score_gemma":0.000008136689,"teacher_disagreement_score":0.12598026,"about_ca_system_score_codex":0.00019428546,"about_ca_system_score_gemma":0.0005639893,"threshold_uncertainty_score":0.46953574},"labels":[],"label_agreement":null},{"id":"W2050544071","doi":"10.1007/s00228-006-0220-1","title":"The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension","year":2007,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Ottawa; Université Laval","funders":"","keywords":"Topiramate; Placebo; Open label; Medicine; Balance (ability); Randomized controlled trial; Double blind; Energy balance; Anesthesia; Internal medicine; Physical therapy; Psychiatry; Epilepsy","score_opus":0.06172501775900885,"score_gpt":0.4388851087607025,"score_spread":0.3771600910016937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050544071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98301786,0.00090624084,0.000080647435,0.0013790769,0.0011265664,0.0035537458,7.8560373e-7,0.0000125046445,0.009922583],"genre_scores_gemma":[0.9965447,0.00052952475,0.00011284187,0.0014795758,0.00056242204,0.000047300382,0.0000014254507,0.000035508765,0.0006866593],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98672634,0.00921355,0.0027917137,0.00037437625,0.0004367154,0.0004573151],"domain_scores_gemma":[0.9867715,0.010585688,0.0017376677,0.00028571088,0.0002648703,0.0003545296],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031676125,0.00033791555,0.0029008216,0.00021551827,0.00013439683,0.000021297108,0.0005697184,0.00008903387,0.000070929644],"category_scores_gemma":[0.0008529881,0.00016207782,0.00033189994,0.00022974524,0.00044122216,0.00010041036,0.00016280873,0.0011074472,0.0000128630545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9633359,0.007413015,0.008389417,0.000018897006,0.0023282778,0.008411941,0.00015822353,0.00011947367,0.00093577645,0.000023539871,0.0020168312,0.006848733],"study_design_scores_gemma":[0.933395,0.048709664,0.011391801,0.0001601604,0.0020528461,0.00015781826,0.00006119761,0.00039817518,0.002556969,0.0000086157615,0.0009746447,0.00013309265],"about_ca_topic_score_codex":0.000012502528,"about_ca_topic_score_gemma":0.000024725838,"teacher_disagreement_score":0.04129665,"about_ca_system_score_codex":0.000077923636,"about_ca_system_score_gemma":0.00018690365,"threshold_uncertainty_score":0.9970932},"labels":[],"label_agreement":null},{"id":"W2051372812","doi":"10.1007/s00228-009-0714-8","title":"Blood−brain barrier transporters and response to CNS-active drugs","year":2009,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Efflux; Blood–brain barrier; Transporter; Abcg2; ATP-binding cassette transporter; Choroid plexus; Pharmacology; Organic anion transporter 1; P-glycoprotein; Organic cation transport proteins; Solute carrier family; Organic anion-transporting polypeptide; Biology; Multidrug Resistance-Associated Proteins; Central nervous system; Multiple drug resistance; Chemistry; Drug resistance; Biochemistry; Endocrinology","score_opus":0.07350030341275973,"score_gpt":0.4395012768909245,"score_spread":0.36600097347816474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051372812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008690103,0.9792696,0.00019745018,0.0046773995,0.003443661,0.0010096479,0.000063143176,0.000038497816,0.002610502],"genre_scores_gemma":[0.0010174355,0.98578423,0.0010862723,0.007235355,0.0026888952,0.0000031405536,0.000011905419,0.00012071321,0.0020520533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914901,0.0036728196,0.0034534743,0.000522612,0.0004115715,0.00044940427],"domain_scores_gemma":[0.9952983,0.0014338592,0.0014333115,0.00025036992,0.00021192622,0.0013722014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007995002,0.00052780384,0.0040146983,0.0004656986,0.00006982155,0.000015453585,0.00041560386,0.00024649827,0.00042188904],"category_scores_gemma":[0.0004037543,0.00037216436,0.0015813888,0.0002788225,0.00025384533,0.00007348959,0.000030134996,0.002280629,0.00006802133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01002731,0.00044804672,0.0000052897144,0.0013021475,0.001404736,0.016014894,0.00035364297,5.4174217e-7,0.00018960296,0.0000044517196,0.0095046265,0.96074474],"study_design_scores_gemma":[0.005412502,0.0040956154,0.0007129438,0.0049503967,0.007740363,0.000978084,0.000048442304,2.1718179e-7,0.000025347204,0.0000072173734,0.9757052,0.0003236742],"about_ca_topic_score_codex":2.0729641e-7,"about_ca_topic_score_gemma":2.479533e-7,"teacher_disagreement_score":0.9662006,"about_ca_system_score_codex":0.000046688518,"about_ca_system_score_gemma":0.00085896556,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W2054862111","doi":"10.1007/s00228-011-1089-1","title":"The status of paediatric medicines initiatives around the world—what has happened and what has not?","year":2011,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Incentive; Globe; European union; Clinical trial; Developing country; Work (physics); Variety (cybernetics); Economic growth; Family medicine; Public relations; Political science; Business; Economic policy","score_opus":0.41578897889663124,"score_gpt":0.527273278655142,"score_spread":0.11148429975851071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054862111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000227099,0.97087955,0.000007385429,0.018106164,0.007481923,0.00064675923,0.000006849567,0.000009694761,0.0026345665],"genre_scores_gemma":[0.0014879417,0.98482114,0.00006983436,0.0065314635,0.0068141622,0.000005817869,0.0000034779107,0.00006587061,0.00020027434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98638785,0.008147697,0.003929325,0.00036325274,0.0004776907,0.0006942017],"domain_scores_gemma":[0.9671995,0.02636484,0.0049277134,0.00029157678,0.00046132447,0.000755029],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010350484,0.00048758113,0.003131533,0.0001900998,0.0004578721,0.0002905734,0.00071703683,0.00012349065,0.00036785725],"category_scores_gemma":[0.004066682,0.00021230977,0.0009960022,0.00042390477,0.0032219372,0.0008669226,0.0004747082,0.0032425264,0.000053193082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016478606,0.00026219152,0.00009622859,0.0013259012,0.0027666115,0.0005209743,0.0002645191,1.651622e-7,0.0000013584239,0.000031537933,0.018840503,0.97424215],"study_design_scores_gemma":[0.0031382474,0.0015901689,0.0009892086,0.0033797272,0.010047049,0.0003811648,0.0006877732,0.0000036589026,0.0000029698365,0.000031451484,0.9795608,0.00018780059],"about_ca_topic_score_codex":0.0000026783978,"about_ca_topic_score_gemma":0.0000054645807,"teacher_disagreement_score":0.97405434,"about_ca_system_score_codex":0.00004706898,"about_ca_system_score_gemma":0.00084282923,"threshold_uncertainty_score":0.99949074},"labels":[],"label_agreement":null},{"id":"W2060608558","doi":"10.1007/s00228-004-0773-9","title":"A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients","year":2004,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Tacrolimus; Pharmacokinetics; Medicine; Trough Concentration; Calcineurin; Ciclosporin; Urology; Trough level; Pharmacology; Dosing; Area under the curve; Internal medicine; Transplantation; Gastroenterology","score_opus":0.07825873593479586,"score_gpt":0.4322813305626776,"score_spread":0.3540225946278817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060608558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969388,0.00070953666,0.00010338218,0.00075033866,0.00091556046,0.00018604226,0.000017310927,0.0000025740237,0.0003764479],"genre_scores_gemma":[0.99605554,0.0025948896,0.00072421064,0.00034710523,0.00024055387,3.9851906e-7,0.0000022234885,0.000014250901,0.000020830605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969936,0.00057987246,0.0019132539,0.00012721028,0.00023529002,0.00015078891],"domain_scores_gemma":[0.9983468,0.00031866878,0.0009788398,0.000085131374,0.00011828785,0.00015228371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010226314,0.00012255444,0.0007243959,0.00013114625,0.000018664115,0.0000021613212,0.00016803108,0.000042072294,0.000034144152],"category_scores_gemma":[0.000057492547,0.00007675926,0.00026512632,0.00019624642,0.000187074,0.00003307219,0.000024166284,0.00053758797,0.0000022538595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045777545,0.0018101477,0.9556041,0.000116329575,0.0004007775,0.0008843146,0.0006545793,0.0009117207,0.02923003,0.000009861589,0.000108462744,0.0056919344],"study_design_scores_gemma":[0.026130127,0.0015176657,0.9475656,0.0003507582,0.00077759736,0.0002799196,0.000020410847,0.000031253476,0.022763422,0.000020197556,0.0004806712,0.000062388775],"about_ca_topic_score_codex":0.0000035283504,"about_ca_topic_score_gemma":0.0000013505313,"teacher_disagreement_score":0.021552373,"about_ca_system_score_codex":0.000018137665,"about_ca_system_score_gemma":0.00009066509,"threshold_uncertainty_score":0.3130152},"labels":[],"label_agreement":null},{"id":"W2061592066","doi":"10.1007/s00228-009-0673-0","title":"Impact of better adherence to statin agents in the primary prevention of coronary artery disease","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Coronary artery disease; Statin; Diabetes mellitus; Cohort; Logistic regression; Surgery; Endocrinology","score_opus":0.10771605853810795,"score_gpt":0.46211172206242085,"score_spread":0.3543956635243129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061592066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672765,0.00029550758,0.00029120015,0.0014809741,0.00027783055,0.00037481973,0.000005751962,0.0000021428605,0.00054411497],"genre_scores_gemma":[0.99322,0.00023206961,0.0004960585,0.005365004,0.0006471783,8.5520645e-7,0.0000030495437,0.000008595533,0.000027210008],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99568427,0.0022942608,0.0014089528,0.0001151846,0.00034595528,0.00015139506],"domain_scores_gemma":[0.9986313,0.00017871431,0.00060527347,0.00018553055,0.00014678594,0.00025237686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047572358,0.00008846583,0.00055987015,0.00008866983,0.000012183195,0.0000024800809,0.00020004106,0.000021918819,0.00017569421],"category_scores_gemma":[0.0002396302,0.00005356063,0.00061449886,0.00012654303,0.00006434545,0.000057337544,0.00002691617,0.0004337966,0.000009048046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012751715,0.0041874624,0.21017437,0.00016458542,0.00072830304,0.004523026,0.0004590655,0.00020424252,0.005019939,0.0000031895584,0.025601642,0.73618245],"study_design_scores_gemma":[0.004706461,0.010333529,0.98360425,0.00014349831,0.00023313268,0.00011352042,0.000013861092,0.000009934158,0.00003600866,0.00004386567,0.0007198496,0.00004206303],"about_ca_topic_score_codex":0.0000020341445,"about_ca_topic_score_gemma":1.9906733e-7,"teacher_disagreement_score":0.77342993,"about_ca_system_score_codex":0.000028363633,"about_ca_system_score_gemma":0.00031097315,"threshold_uncertainty_score":0.21841392},"labels":[],"label_agreement":null},{"id":"W2063776035","doi":"10.1007/s00228-005-0036-4","title":"Inappropriate medication prescribing in community-dwelling elderly people living in Iran","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Medical prescription; Beers Criteria; Drug class; Multivariate analysis; Cohort; Retrospective cohort study; Pediatrics; Drug; Internal medicine; Psychiatry; Pharmacology","score_opus":0.2501810931681696,"score_gpt":0.47911328935772934,"score_spread":0.22893219618955973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063776035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98535895,0.00042709036,0.00027151266,0.0078045535,0.0012018394,0.0002279702,4.871137e-7,0.000014058896,0.004693516],"genre_scores_gemma":[0.9913033,0.0012228764,0.0012082789,0.004783987,0.0013912276,0.0000011586806,0.0000016055764,0.000026397627,0.00006112682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909357,0.0060801683,0.0022402576,0.00015285432,0.00028545724,0.00030556944],"domain_scores_gemma":[0.99455446,0.004017261,0.0008766678,0.00015024442,0.00008962551,0.0003117372],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014594437,0.00014179331,0.00065311894,0.00027323418,0.00006302086,0.000014678403,0.0003212386,0.00007006899,0.00038304194],"category_scores_gemma":[0.0029107311,0.00011921623,0.00018343709,0.00024362947,0.00009806367,0.00033832074,0.00011448055,0.0034704483,0.000066866385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024233684,0.0029282065,0.81101066,0.000118853364,0.00014241514,0.00051424355,0.00452449,0.0011476822,0.0018878081,0.000012532418,0.0014518717,0.17383787],"study_design_scores_gemma":[0.011895889,0.0020232107,0.9158703,0.00058114907,0.00023295116,0.00018036405,0.00057531166,0.009035125,0.00016941839,0.000027400685,0.05922344,0.00018540867],"about_ca_topic_score_codex":0.000015331918,"about_ca_topic_score_gemma":0.00004064391,"teacher_disagreement_score":0.17365246,"about_ca_system_score_codex":0.000068418194,"about_ca_system_score_gemma":0.00009568321,"threshold_uncertainty_score":0.9988286},"labels":[],"label_agreement":null},{"id":"W2067067997","doi":"10.1007/s00228-006-0151-x","title":"Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?","year":2006,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Isotretinoin; Medicine; Acne; Medical prescription; Population; Odds ratio; Family medicine; Pediatrics; Dermatology; Internal medicine; Environmental health; Pharmacology","score_opus":0.11454733585958798,"score_gpt":0.44136342694297226,"score_spread":0.3268160910833843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067067997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98387533,0.0006461034,0.010252449,0.0034220119,0.00085563795,0.00049884856,0.000109793946,0.000005292636,0.0003345092],"genre_scores_gemma":[0.9907456,0.00032128548,0.0023750418,0.0038768817,0.0020438815,0.0000029042342,0.000023494378,0.0000239185,0.00058696605],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986322,0.00021546439,0.0007987005,0.00013764053,0.00008039042,0.00013559965],"domain_scores_gemma":[0.99857396,0.00048337158,0.00044031075,0.000062520514,0.0002931537,0.0001467125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067169237,0.00010097493,0.00048972626,0.000043415257,0.00003541899,0.0000052789314,0.00006749866,0.000044736596,0.00019165094],"category_scores_gemma":[0.0001700595,0.0000679604,0.0001550172,0.000052489115,0.00004665517,0.00003303359,0.000023228058,0.000117120624,0.0000046947544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012952353,0.0016019633,0.24623363,0.00021218637,0.0010980843,0.00026014575,0.0004878669,0.00003356819,0.015757974,0.000046768313,0.629166,0.09214949],"study_design_scores_gemma":[0.04147684,0.01495622,0.581067,0.00031810228,0.0018040185,0.000044727618,0.0001530697,0.0008937395,0.018406682,0.00019200575,0.34047806,0.00020949403],"about_ca_topic_score_codex":0.000011110869,"about_ca_topic_score_gemma":0.0000014803411,"teacher_disagreement_score":0.3348334,"about_ca_system_score_codex":0.00000804269,"about_ca_system_score_gemma":0.000051440005,"threshold_uncertainty_score":0.27713445},"labels":[],"label_agreement":null},{"id":"W2067568957","doi":"10.1007/s00228-011-1110-8","title":"Children’s views on unlicensed/off-label paediatric prescribing and paediatric clinical trials","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Clinical trial; Off-label use; Pediatrics; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.5394283754674166,"score_gpt":0.5419572735086138,"score_spread":0.0025288980411971584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067568957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95211565,0.018056892,0.00007230405,0.005926053,0.008250947,0.0007343619,0.000014062568,0.000045419572,0.014784283],"genre_scores_gemma":[0.87145764,0.08817245,0.0016916052,0.02081418,0.017635394,0.0000027555052,0.000002293648,0.00006500396,0.00015870073],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97748816,0.015537693,0.0055374526,0.0004994058,0.00043028398,0.0005069853],"domain_scores_gemma":[0.98319376,0.01182807,0.003250225,0.00022359863,0.0003073582,0.0011970163],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.046194006,0.0003385749,0.0022350496,0.0002142519,0.00015053985,0.000025064435,0.00036491957,0.0001636503,0.00086782454],"category_scores_gemma":[0.016158296,0.00022567718,0.00086075993,0.00026942397,0.00040724385,0.00019288746,0.00026514166,0.0028686444,0.00026800134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014892775,0.0037008214,0.13906133,0.000052201176,0.0020264846,0.0018540864,0.00019364688,0.0000014164306,0.00015470768,0.000045415436,0.14503258,0.6929845],"study_design_scores_gemma":[0.030682113,0.01228552,0.5458978,0.00007535011,0.0054714833,0.0006604679,0.000050194245,0.00011662087,0.0001119754,0.000078699726,0.4042157,0.00035406885],"about_ca_topic_score_codex":0.0000018048299,"about_ca_topic_score_gemma":3.3354473e-7,"teacher_disagreement_score":0.69263047,"about_ca_system_score_codex":0.000023930097,"about_ca_system_score_gemma":0.00016177633,"threshold_uncertainty_score":0.9994318},"labels":[],"label_agreement":null},{"id":"W2070661820","doi":"10.1007/s002280100327","title":"Functional foods, neutraceuticals, designer foods: innocent fad or counterproductive marketing ploy?","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Marketing; Business; Food science; Advertising; Medicine; Environmental health; Chemistry","score_opus":0.17723200721606966,"score_gpt":0.43690809912783,"score_spread":0.25967609191176033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070661820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93413424,0.0070987265,0.009931051,0.022695143,0.0111562265,0.00061029376,0.000007942346,0.00009472082,0.014271661],"genre_scores_gemma":[0.9788918,0.0022497508,0.0037371314,0.007802008,0.006359528,0.0000018593814,0.0000028837378,0.00006308758,0.00089196383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99460644,0.0020615875,0.0021123542,0.00038053215,0.0004089444,0.00043017245],"domain_scores_gemma":[0.9961953,0.0015763816,0.00078659673,0.00018499723,0.0007455956,0.0005111152],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00797474,0.00024018683,0.0008026068,0.00012793607,0.00011371655,0.000026385324,0.00023809343,0.00008239187,0.002823642],"category_scores_gemma":[0.0021554825,0.00017042508,0.0003765333,0.00026046194,0.00027528612,0.00013939831,0.00012550334,0.0014692268,0.00014121656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11878188,0.005959829,0.0935389,0.00028782277,0.008137093,0.017800996,0.0003276919,0.00031639755,0.02074365,0.000078663055,0.16618617,0.56784093],"study_design_scores_gemma":[0.016608909,0.006498574,0.3908269,0.0004000117,0.0029371507,0.0061662076,0.00016641387,0.0006856205,0.00037885946,0.00002606911,0.5748823,0.00042293544],"about_ca_topic_score_codex":6.037498e-7,"about_ca_topic_score_gemma":0.0000010274978,"teacher_disagreement_score":0.567418,"about_ca_system_score_codex":0.00005849949,"about_ca_system_score_gemma":0.0003698708,"threshold_uncertainty_score":0.9980879},"labels":[],"label_agreement":null},{"id":"W2073747924","doi":"10.1007/s00228-004-0732-5","title":"Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age","year":2004,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Thiopurine methyltransferase; Genotype; Azathioprine; Population; Medicine; Pharmacogenetics; Allele; Methyltransferase; Pharmacology; Internal medicine; Immunology; Biology; Genetics; Gene","score_opus":0.08043065171374629,"score_gpt":0.4553931071206182,"score_spread":0.3749624554068719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073747924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360263,0.0001737919,0.0018035605,0.0031181127,0.00033398595,0.00037295948,0.000009620753,0.000004268602,0.0005810508],"genre_scores_gemma":[0.9964624,0.00017443812,0.0016410929,0.0006317522,0.0010421755,0.0000014227214,0.0000032906125,0.00002174737,0.000021675443],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972008,0.0011620831,0.0009804587,0.000158974,0.00026202048,0.0002356562],"domain_scores_gemma":[0.9977372,0.0013773289,0.00033984194,0.00013874666,0.00019333253,0.00021349202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004487292,0.0001275813,0.0006127011,0.0001405972,0.000037771977,0.000008099759,0.00022470935,0.000058938385,0.000081069054],"category_scores_gemma":[0.0009668593,0.000075730786,0.00029180676,0.00018857728,0.00021065246,0.000078603654,0.000036773486,0.00075127254,0.0000037927543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09261329,0.014275081,0.28643742,0.0013615162,0.006213057,0.036932252,0.009189004,0.00549149,0.21617304,0.00057338,0.024032818,0.30670765],"study_design_scores_gemma":[0.020076694,0.006266847,0.97113204,0.00004985398,0.0002995294,0.00045120332,0.000023688908,0.00012492237,0.0005259319,0.00030746427,0.0006622651,0.000079535224],"about_ca_topic_score_codex":0.00009408321,"about_ca_topic_score_gemma":0.000015555148,"teacher_disagreement_score":0.68469465,"about_ca_system_score_codex":0.00013178913,"about_ca_system_score_gemma":0.000513914,"threshold_uncertainty_score":0.3263947},"labels":[],"label_agreement":null},{"id":"W2077458329","doi":"10.1007/s00228-014-1743-5","title":"Identification of black market products and potential doping agents in Germany 2010–2013","year":2014,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Anabolic-Androgenic Steroids; Chemistry; Anabolic steroid; Human growth hormone; Chromatography; Growth hormone; Anabolism; Hormone; Biochemistry","score_opus":0.07274013532468974,"score_gpt":0.4004350252814011,"score_spread":0.32769488995671137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077458329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875038,0.00041098203,0.000103764716,0.007852228,0.0020250229,0.00015089965,9.5128286e-7,0.0000041181775,0.0019482352],"genre_scores_gemma":[0.9944786,0.0017562099,0.00014550565,0.0003713493,0.0024064337,3.521799e-7,4.3142435e-7,0.000012902638,0.00082822324],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99684685,0.0011772001,0.001446146,0.00021355781,0.00017808398,0.0001381547],"domain_scores_gemma":[0.9984588,0.00015920571,0.0007999402,0.0001058674,0.00036694904,0.00010922416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054336125,0.00009332487,0.00051955716,0.00012452973,0.000026140335,0.0000043230207,0.00010607184,0.000028214203,0.00006939367],"category_scores_gemma":[0.0010109606,0.00006768567,0.00010241969,0.00009808614,0.0003831302,0.00007338547,0.00007036502,0.00042156136,0.000022846549],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084455265,0.002905308,0.12409412,0.00085647055,0.0015006372,0.0013286951,0.0013021795,0.00021809686,0.5472346,0.000038914866,0.2395663,0.07250918],"study_design_scores_gemma":[0.003181911,0.00071001396,0.98143595,0.000061930885,0.00018704426,0.00009765284,0.000043377677,0.00023799928,0.002212834,0.000040829615,0.011726144,0.00006433753],"about_ca_topic_score_codex":9.200215e-7,"about_ca_topic_score_gemma":1.9077076e-7,"teacher_disagreement_score":0.8573418,"about_ca_system_score_codex":0.000008827581,"about_ca_system_score_gemma":0.000038111448,"threshold_uncertainty_score":0.27601415},"labels":[],"label_agreement":null},{"id":"W2079321673","doi":"10.1007/s00228-005-0900-2","title":"A population approach to study the influence of nevirapine administration on lopinavir pharmacokinetics in HIV-1 infected patients","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Nevirapine; Lopinavir; Lopinavir/ritonavir; Pharmacokinetics; Ritonavir; Regimen; Pharmacology; Reverse-transcriptase inhibitor; Medicine; Population; Human immunodeficiency virus (HIV); Internal medicine; Gastroenterology; Viral load; Antiretroviral therapy; Virology","score_opus":0.05791000055017056,"score_gpt":0.40825114173839,"score_spread":0.35034114118821946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079321673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954545,0.000021924774,0.000045587603,0.0027207239,0.0002325083,0.0007201115,0.0000023642137,0.000007550753,0.0007947491],"genre_scores_gemma":[0.99685305,0.000049297352,0.0009558766,0.0015142845,0.00045306992,0.0000044100016,0.000011829971,0.000016958877,0.00014123585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964292,0.0012506023,0.0016781437,0.00017205371,0.00031782966,0.0001521724],"domain_scores_gemma":[0.9985691,0.00025560887,0.0006533471,0.000117594755,0.00024339862,0.00016098526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017260513,0.00014374327,0.000462865,0.00018643447,0.00003206355,0.0000060624643,0.00017149071,0.000028310544,0.00004393586],"category_scores_gemma":[0.00037751455,0.000093027935,0.000105141335,0.0002900709,0.00004838816,0.00007498247,0.000046327164,0.00047296102,0.00003964425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049015908,0.01488879,0.92929524,0.00001880999,0.0003752995,0.00015300175,0.000995057,0.004893638,0.00031433447,0.000008299131,0.0039289235,0.040227026],"study_design_scores_gemma":[0.012570314,0.0038108334,0.9773053,0.00004462049,0.00023690144,0.000014785507,0.000031906253,0.00014036302,0.00029386545,0.0000016531942,0.005474309,0.00007514032],"about_ca_topic_score_codex":6.1930655e-7,"about_ca_topic_score_gemma":8.102293e-7,"teacher_disagreement_score":0.04801008,"about_ca_system_score_codex":0.000050553877,"about_ca_system_score_gemma":0.000074909854,"threshold_uncertainty_score":0.37935692},"labels":[],"label_agreement":null},{"id":"W2079998855","doi":"10.1007/s00228-007-0281-9","title":"British and Canadian views on the ethics of paediatric clinical trials","year":2007,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Children's Hospital of Western Ontario","funders":"","keywords":"Clinical trial; Medicine; Family medicine; Internal medicine","score_opus":0.834679914960894,"score_gpt":0.703939353177783,"score_spread":0.130740561783111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079998855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8367239,0.002487447,0.00032091702,0.118769854,0.007405238,0.00074372516,0.000016081087,0.000012819879,0.03351998],"genre_scores_gemma":[0.9199045,0.02452131,0.0008934032,0.04566521,0.008348725,6.1750836e-7,0.0000011305374,0.000044508277,0.00062063866],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9517999,0.034662325,0.010962631,0.00047152225,0.0014219434,0.0006816491],"domain_scores_gemma":[0.6211032,0.3708601,0.0032698752,0.00043702123,0.0020482747,0.0022815333],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.49261025,0.00016571663,0.0017917606,0.00024571444,0.000115254516,0.000026091653,0.0006653681,0.00056460366,0.0016220323],"category_scores_gemma":[0.4239445,0.00011154224,0.0009633724,0.0003144196,0.0017541026,0.00004517901,0.00017231677,0.015100023,0.000073053656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097803995,0.0022934387,0.11799672,0.00031348146,0.0017839017,0.013731176,0.0004250444,0.0000068388845,0.0004666829,0.0031860345,0.37245202,0.47756425],"study_design_scores_gemma":[0.012995845,0.010997926,0.51270676,0.00054340455,0.0009806429,0.0006320549,0.00019054538,0.000030397781,0.00017440256,0.0028894255,0.45763338,0.00022522923],"about_ca_topic_score_codex":0.00025678947,"about_ca_topic_score_gemma":0.0027774407,"teacher_disagreement_score":0.47733903,"about_ca_system_score_codex":0.000043420783,"about_ca_system_score_gemma":0.0025119067,"threshold_uncertainty_score":0.99929065},"labels":[],"label_agreement":null},{"id":"W2080537274","doi":"10.1007/s00228-006-0186-z","title":"Current and novel approaches to the drug therapy of obesity","year":2006,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Health Canada; Canada Research Chairs","keywords":"Sibutramine; Orlistat; Weight loss; Obesity; Medicine; Drug; Pharmacotherapy; Human obesity; Pharmacology; Bioinformatics; Intensive care medicine; Internal medicine; Biology","score_opus":0.47652054113126546,"score_gpt":0.4974479939294345,"score_spread":0.020927452798169044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080537274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006128576,0.9875746,0.00013817823,0.001598787,0.0029212227,0.0009136019,0.000025344229,0.000009311075,0.0006904092],"genre_scores_gemma":[0.002265965,0.99262136,0.00032793617,0.0010453417,0.0035132784,0.000006125153,0.000009311158,0.000043997177,0.00016669296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99361604,0.0030503685,0.0024939391,0.00032215618,0.0002508767,0.0002666105],"domain_scores_gemma":[0.99593997,0.0014431463,0.001884211,0.00021823206,0.000141295,0.00037311716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053230957,0.00036859556,0.0028043892,0.00018770268,0.00007702393,0.000007672777,0.00048407546,0.000105457264,0.000093477895],"category_scores_gemma":[0.00014939482,0.00019547158,0.0010474594,0.00018630692,0.00037893967,0.00003644881,0.00019238156,0.0018589029,0.000048246908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005369362,0.00318437,0.00038040293,0.0013220808,0.0014538692,0.00030013322,0.00007405299,0.000004363546,0.000004714525,0.000020916055,0.06578799,0.9269302],"study_design_scores_gemma":[0.0042843428,0.0011269132,0.004249513,0.0012514328,0.0033650708,0.0004568875,0.000004966846,0.0000030608926,0.0000131770685,0.0000065301583,0.9850968,0.00014127356],"about_ca_topic_score_codex":9.3389554e-7,"about_ca_topic_score_gemma":4.331088e-7,"teacher_disagreement_score":0.9267889,"about_ca_system_score_codex":0.000041431886,"about_ca_system_score_gemma":0.00042769217,"threshold_uncertainty_score":0.80761117},"labels":[],"label_agreement":null},{"id":"W2080935585","doi":"10.1007/s00228-012-1307-5","title":"The effect of operational stressors on ibuprofen pharmacokinetics","year":2012,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Waterloo; Defence Research and Development Canada","funders":"","keywords":"Ibuprofen; Pharmacokinetics; Supine position; Crossover study; Medicine; Treadmill; Bioavailability; Anesthesia; Sitting; Animal science; Chemistry; Pharmacology; Internal medicine; Biology","score_opus":0.05894296225776641,"score_gpt":0.46159946018841647,"score_spread":0.40265649793065006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080935585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373616,0.00066914933,0.000080744874,0.005587647,0.005737828,0.00023131832,0.000002518367,0.00001364501,0.0039410093],"genre_scores_gemma":[0.98991966,0.0003032848,0.00017165813,0.0018749225,0.0073228558,0.0000011298688,0.0000019651193,0.00003786895,0.0003666535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946605,0.002984764,0.0015456347,0.00009327057,0.00047226937,0.00024356566],"domain_scores_gemma":[0.994798,0.0035580567,0.0008781533,0.000145486,0.00025818145,0.00036212997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008572874,0.00013515528,0.0005340247,0.000076293516,0.000057523233,0.000004441009,0.00025526196,0.00004143044,0.00047841255],"category_scores_gemma":[0.0018274568,0.00007124212,0.0002552002,0.00010113582,0.0003886278,0.000064409,0.000053092852,0.0008577929,0.000060293954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033473108,0.0018890547,0.36302337,0.00017395351,0.0023003041,0.0004954514,0.00044923855,0.0010265635,0.06108584,0.00037857136,0.3329239,0.20278065],"study_design_scores_gemma":[0.01898804,0.012230512,0.6239786,0.0001500191,0.00094341923,0.00028975072,0.000033640736,0.00023939328,0.036959928,0.0000057328416,0.30606404,0.0001169139],"about_ca_topic_score_codex":1.4509072e-7,"about_ca_topic_score_gemma":1.7137989e-8,"teacher_disagreement_score":0.26095527,"about_ca_system_score_codex":0.000021589347,"about_ca_system_score_gemma":0.000066635774,"threshold_uncertainty_score":0.5238282},"labels":[],"label_agreement":null},{"id":"W2081153577","doi":"10.1007/s00228-011-0991-x","title":"Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Diltiazem; Medicine; Transplantation; Regimen; Kidney transplantation; Urology; Prednisolone; Gastroenterology; Internal medicine; Pharmacology","score_opus":0.1598856336846059,"score_gpt":0.42170217606879934,"score_spread":0.26181654238419344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081153577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461037,0.0000731644,0.0018049302,0.0005890486,0.0013814686,0.001090595,0.000063243664,0.000018550849,0.0003686191],"genre_scores_gemma":[0.9906742,0.004198616,0.0027831232,0.0016040097,0.00026042294,0.00001637802,0.00011544601,0.000056019086,0.0002917886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945317,0.001849089,0.0026984995,0.00034843848,0.0002598567,0.00031241644],"domain_scores_gemma":[0.99684334,0.0011734876,0.0012108475,0.0001752955,0.00023336703,0.00036367265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002194807,0.00026332942,0.0010487083,0.00026960342,0.000047400154,0.00001822063,0.00023215824,0.000119987,0.00040655004],"category_scores_gemma":[0.00020591171,0.00017158283,0.00037073647,0.00020028513,0.00017120723,0.00039188357,0.0000129369155,0.00076011335,0.000008569495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21898338,0.0056469375,0.74752045,0.00018981159,0.0013738523,0.010252923,0.0033891387,0.00008284692,0.0005653937,0.000024587527,0.0006128973,0.011357773],"study_design_scores_gemma":[0.11429203,0.010541102,0.8718881,0.00044990392,0.00049056346,0.0003836476,0.000052340096,0.00021432023,0.0006912686,0.000019853005,0.0008111652,0.00016572695],"about_ca_topic_score_codex":0.00004214253,"about_ca_topic_score_gemma":0.000064576394,"teacher_disagreement_score":0.12436762,"about_ca_system_score_codex":0.000053553424,"about_ca_system_score_gemma":0.0003406798,"threshold_uncertainty_score":0.69969445},"labels":[],"label_agreement":null},{"id":"W2102338684","doi":"10.1007/s00228-015-1949-1","title":"The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review","year":2015,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Clopidogrel; P2Y12; Medicine; Odds ratio; Mace; Acute coronary syndrome; Internal medicine; Confidence interval; Cardiology; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.09233038123619429,"score_gpt":0.47012471673754946,"score_spread":0.37779433550135516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102338684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016236522,0.9946195,0.000047611902,0.00009493755,0.0017175993,0.0017246295,0.000008540518,0.000016653325,0.0001469127],"genre_scores_gemma":[0.0015245983,0.9945502,0.000014537181,0.00024471313,0.0034794784,0.000010580399,0.000008708636,0.00010414415,0.0000630016],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9846111,0.009125484,0.005100397,0.00025763284,0.0006215589,0.00028384355],"domain_scores_gemma":[0.9919495,0.0009043257,0.00540513,0.0004764807,0.0008032896,0.00046130456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012241381,0.00044769776,0.0064001516,0.00010491688,0.0000956498,0.000024186515,0.0006363615,0.0001420029,0.0001573366],"category_scores_gemma":[0.0015198251,0.00021441083,0.006317567,0.00034268442,0.00017912309,0.000096524316,0.00009427977,0.0014321584,0.000054480133],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012672333,0.0006629823,0.00011324973,0.48681188,0.023774954,0.0012650342,0.00007130763,0.0000064970245,0.000005893141,0.0000014724213,0.019725615,0.46629387],"study_design_scores_gemma":[0.006311263,0.0026037141,0.0002728844,0.53464717,0.014766836,0.002209382,0.000019628276,0.0000026860498,0.0000022130798,0.0000032321898,0.43882117,0.00033981187],"about_ca_topic_score_codex":5.1040917e-7,"about_ca_topic_score_gemma":1.5672626e-8,"teacher_disagreement_score":0.46595407,"about_ca_system_score_codex":0.00010642339,"about_ca_system_score_gemma":0.001026192,"threshold_uncertainty_score":0.87434196},"labels":[],"label_agreement":null},{"id":"W2103715266","doi":"10.1007/s002280100330","title":"Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine","year":2001,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council Canada","keywords":"CYP1A2; Fluvoxamine; Caffeine; Chemistry; Analysis of variance; Cytochrome P450; Internal medicine; Endocrinology; Biochemistry; Enzyme; Biology; Medicine","score_opus":0.1731870082302075,"score_gpt":0.48344738447724644,"score_spread":0.31026037624703895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103715266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928763,0.0004367901,0.0041536908,0.00014812587,0.001829933,0.00030131225,0.00004094935,0.000013368602,0.00019956076],"genre_scores_gemma":[0.9966631,0.0016843277,0.0003526444,0.00035265472,0.00084483484,0.0000024480123,0.000026544527,0.00004075223,0.000032672182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99166393,0.0054756827,0.002027093,0.00028026346,0.0002675536,0.00028547534],"domain_scores_gemma":[0.9962217,0.0005035018,0.0025301299,0.000116767726,0.0003109946,0.00031686586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026902636,0.0002629342,0.0008541106,0.0002070658,0.00014594516,0.000010677636,0.00022929991,0.00019489476,0.00078006304],"category_scores_gemma":[0.00013982959,0.00024301071,0.00023127419,0.00016108788,0.0004420489,0.00023485787,0.00016593328,0.00086743815,0.0000029555385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002373138,0.0012877964,0.0120539935,0.00005115494,0.00021688067,0.00006243307,0.00031339147,0.00008843477,0.971966,0.0000036215806,0.00023155191,0.011351592],"study_design_scores_gemma":[0.008014388,0.00065231073,0.07605557,0.000049922604,0.00046370344,0.000036695743,0.000024109297,0.002487493,0.910667,0.000018695358,0.0013453277,0.00018477236],"about_ca_topic_score_codex":0.0000029612247,"about_ca_topic_score_gemma":5.509518e-7,"teacher_disagreement_score":0.064001575,"about_ca_system_score_codex":0.000025365804,"about_ca_system_score_gemma":0.00006825859,"threshold_uncertainty_score":0.99096894},"labels":[],"label_agreement":null},{"id":"W2123034125","doi":"10.1007/s00228-011-1083-7","title":"The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; SickKids Foundation; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"National Institute on Aging; Hospital for Sick Children","keywords":"Tacrolimus; Medicine; Dosing; Liver transplantation; CYP3A5; Internal medicine; Liver disease; Transplantation; Kidney; Gastroenterology; Genotype; Biology","score_opus":0.10100674035513141,"score_gpt":0.40846359396760873,"score_spread":0.3074568536124773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123034125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741274,0.00043958574,0.00015952566,0.00039957798,0.00073711097,0.00011746953,0.000019180687,0.0000032256642,0.00071159226],"genre_scores_gemma":[0.9757659,0.022087876,0.00049698114,0.0012864341,0.0002813199,7.7320743e-7,0.0000027003805,0.000009949462,0.00006807071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985916,0.0004469403,0.00065355346,0.000101447964,0.000115525545,0.00009095256],"domain_scores_gemma":[0.99889517,0.00027642125,0.0003237948,0.00005504319,0.000080049176,0.0003695106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000501493,0.0000816707,0.0002056301,0.00005751051,0.000052160056,0.0000070726596,0.000048541762,0.000014791975,0.000067787936],"category_scores_gemma":[0.00006827846,0.00005106362,0.00009899253,0.00003552839,0.00012464174,0.00006150463,0.000011265002,0.0002193706,0.0000047739177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035161756,0.001356944,0.914892,0.00048648877,0.0012458062,0.01703628,0.0013950943,0.0000037096986,0.0005900402,0.000021958665,0.0009630415,0.026846869],"study_design_scores_gemma":[0.004730183,0.0009139909,0.9912892,0.00009292149,0.0017792083,0.00020704255,0.000008432591,0.000022467457,0.00017900314,0.00002859747,0.0007045592,0.000044385135],"about_ca_topic_score_codex":0.0000010135392,"about_ca_topic_score_gemma":4.5980187e-7,"teacher_disagreement_score":0.076397195,"about_ca_system_score_codex":0.0000063731723,"about_ca_system_score_gemma":0.000046037127,"threshold_uncertainty_score":0.2082314},"labels":[],"label_agreement":null},{"id":"W2129509075","doi":"10.1007/s00228-009-0741-5","title":"Ontogeny of midazolam glucuronidation in preterm infants","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Western University","funders":"","keywords":"Midazolam; Urine; Glucuronidation; Bolus (digestion); Medicine; Chemistry; Anesthesia; Endocrinology; Internal medicine; Microsome","score_opus":0.20983649816865482,"score_gpt":0.531550800048629,"score_spread":0.3217143018799742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129509075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746695,0.002230397,0.00012847426,0.0013318919,0.008648529,0.00028067146,0.000017282575,0.000017601544,0.01267565],"genre_scores_gemma":[0.9872889,0.0032640523,0.00056956726,0.0060927435,0.002632231,0.0000012695158,0.000003996439,0.00002878666,0.00011844416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99029785,0.00516792,0.003420693,0.00030989537,0.0002993648,0.0005042492],"domain_scores_gemma":[0.9959268,0.0009295663,0.0019705289,0.000188726,0.0004957912,0.00048858713],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009242642,0.00027784993,0.0009857091,0.00036530007,0.000060432914,0.000010607399,0.000832778,0.00020058312,0.0011642348],"category_scores_gemma":[0.000858364,0.00025267698,0.00042113804,0.00032575498,0.00029058332,0.00020271662,0.000103008046,0.0019112678,0.0000742055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008781544,0.0039519747,0.042935666,0.00005648015,0.00060463673,0.0014534881,0.0010225646,0.0042848256,0.38029227,0.00024575146,0.029008284,0.5273625],"study_design_scores_gemma":[0.025011392,0.0028273957,0.45691842,0.000072955205,0.0007319722,0.00016040866,0.00004842197,0.0021935906,0.100799,0.0007407433,0.4099626,0.0005331014],"about_ca_topic_score_codex":0.0000012755062,"about_ca_topic_score_gemma":0.0000012125067,"teacher_disagreement_score":0.5268294,"about_ca_system_score_codex":0.000032931366,"about_ca_system_score_gemma":0.00023368574,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2133902908","doi":"10.1007/s00228-009-0762-0","title":"Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"CYP2A6; Nicotine; Biology; Epigenetics; Cotinine; DNA methylation; CpG site; Genotype; Allele; Methylation; Endocrinology; Gene expression; Genetics; Internal medicine; Metabolism; Gene; Medicine; Cytochrome P450","score_opus":0.044910138672011,"score_gpt":0.37730833038839495,"score_spread":0.33239819171638396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133902908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497783,0.0040746923,0.00021737287,0.00011077144,0.0003603579,0.000153589,0.00002167296,0.0000038851504,0.00007980555],"genre_scores_gemma":[0.9913235,0.0062352796,0.001166111,0.00036061654,0.00085340586,3.6092212e-7,0.0000052746636,0.000024513636,0.00003099212],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99638784,0.0014422112,0.0014174517,0.00033108753,0.00014826148,0.00027315764],"domain_scores_gemma":[0.9983078,0.00015935431,0.0009702403,0.00018041873,0.00006250986,0.00031964766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001168585,0.0002584267,0.00076262275,0.000058831538,0.000050245468,0.0000098082755,0.00029882306,0.00009826978,0.00014898184],"category_scores_gemma":[0.0003076792,0.00018397282,0.0003480362,0.000047465743,0.00041809375,0.0000069380226,0.00019426344,0.00037329987,0.000004655115],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035662725,0.0006108364,0.077246316,0.000006713669,0.00040864528,0.000008383399,0.000051821986,0.00008765783,0.9080671,8.3990176e-7,0.0015746763,0.011580379],"study_design_scores_gemma":[0.0031392202,0.0062671728,0.9460018,0.00000828635,0.00023778033,0.00006972229,0.000026240157,0.000026482747,0.04186548,0.000020947586,0.002148977,0.00018786403],"about_ca_topic_score_codex":0.0000011186976,"about_ca_topic_score_gemma":1.8452012e-7,"teacher_disagreement_score":0.8687555,"about_ca_system_score_codex":0.000008185172,"about_ca_system_score_gemma":0.000060538452,"threshold_uncertainty_score":0.7502194},"labels":[],"label_agreement":null},{"id":"W2151151850","doi":"10.1007/s00228-004-0774-8","title":"Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients","year":2004,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bioequivalence; Medicine; Ciclosporin; Pharmacokinetics; Renal transplant; Urology; Creatinine; Trough level; Transplantation; Surgery; Pharmacology; Internal medicine; Tacrolimus","score_opus":0.1731343986324838,"score_gpt":0.4976282268952688,"score_spread":0.324493828262785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151151850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16187386,0.8063524,0.016153233,0.00094821997,0.008668583,0.00445422,0.0011717563,0.000031652045,0.0003460758],"genre_scores_gemma":[0.107376084,0.88444746,0.006699334,0.000072454706,0.00086524704,0.000009718453,0.00041213576,0.000055275163,0.00006232762],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9910581,0.00090756227,0.007140573,0.0003594646,0.0002625102,0.0002717668],"domain_scores_gemma":[0.9940396,0.00085709646,0.0040778453,0.0002490637,0.00047135403,0.00030502706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023887428,0.00034715483,0.0033103183,0.00045765704,0.00004202486,0.0000039023284,0.00033032658,0.00022737052,0.000060245882],"category_scores_gemma":[0.00016500929,0.00025472383,0.0022723097,0.00036614735,0.00023193956,0.0000902155,0.000029710323,0.00082515745,0.000009303569],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074637644,0.009653824,0.04900682,0.01834497,0.00446314,0.0015620389,0.0000686689,0.0006345238,0.0002721565,0.00047186462,0.00027817165,0.90778005],"study_design_scores_gemma":[0.061105926,0.010293356,0.48196456,0.039844688,0.028095348,0.0024044383,0.0000041411045,0.00005470657,0.00012667007,0.00033135098,0.37505323,0.00072157267],"about_ca_topic_score_codex":0.000003288756,"about_ca_topic_score_gemma":0.0000013261289,"teacher_disagreement_score":0.9070585,"about_ca_system_score_codex":0.00009852614,"about_ca_system_score_gemma":0.0006417203,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2160397234","doi":"10.1007/s002280000129","title":"Psychomotor effects of zaleplon and thioridazine coadministration","year":2000,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Thioridazine; Digit symbol substitution test; Hypnotic; Pharmacodynamics; Crossover study; Pharmacology; Pharmacokinetics; Drug interaction; Medicine; Anesthesia; Placebo","score_opus":0.03578507938339617,"score_gpt":0.40598628622607014,"score_spread":0.370201206842674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160397234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856225,0.00039841796,0.000111777226,0.0018230143,0.0011221197,0.00017620967,5.2815506e-7,0.000010299505,0.010735113],"genre_scores_gemma":[0.99112254,0.002645481,0.00078771985,0.0025200658,0.0017556291,3.693981e-7,0.0000010577018,0.000014939929,0.0011522104],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978869,0.0007423854,0.0009866094,0.00011680491,0.00015283948,0.00011448228],"domain_scores_gemma":[0.99867105,0.0005319154,0.00042403085,0.00008686617,0.00009104881,0.0001950594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019152026,0.000089739835,0.00043420462,0.00007045745,0.00002101147,0.0000051836428,0.00010225977,0.000032214644,0.00055411516],"category_scores_gemma":[0.00028921769,0.00006923516,0.00014396013,0.00007030126,0.00014335815,0.000059191698,0.000017079303,0.00035905535,0.000045030632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016326103,0.0031988905,0.14954473,0.0008521722,0.001276711,0.005576174,0.00036658693,0.000012762329,0.052292872,0.00008381154,0.21263924,0.55783],"study_design_scores_gemma":[0.011527717,0.0062629916,0.82355726,0.0001324092,0.00057784666,0.000060459945,0.000008055563,0.00009702657,0.0018040508,0.00003336246,0.15585688,0.00008194478],"about_ca_topic_score_codex":1.7896458e-7,"about_ca_topic_score_gemma":6.619053e-8,"teacher_disagreement_score":0.67401254,"about_ca_system_score_codex":0.000004849531,"about_ca_system_score_gemma":0.000038258986,"threshold_uncertainty_score":0.6067172},"labels":[],"label_agreement":null},{"id":"W2263265174","doi":"10.1007/s00228-015-2003-z","title":"Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria","year":2016,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University Belfast; Queen's University; Health Service Executive; Centre for Public Health, Queen's University Belfast; Health Research Board","keywords":"Polypharmacy; Medicine; Logistic regression; Cross-sectional study; Population; Database; Reimbursement; Pediatrics; Demography; Health care; Environmental health; Family medicine; Internal medicine","score_opus":0.3922349422752849,"score_gpt":0.5507346883670624,"score_spread":0.15849974609177753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263265174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328876,0.000040805073,0.001984103,0.0014903946,0.0022453053,0.0007186925,0.00001220973,0.00001409924,0.00020562959],"genre_scores_gemma":[0.99573964,0.000026709044,0.0016488776,0.00068240624,0.0017945798,0.000004130338,0.0000020603447,0.000035101893,0.00006652365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527466,0.0021945734,0.0016972674,0.0002829745,0.00026481558,0.00028572878],"domain_scores_gemma":[0.99774104,0.0007555687,0.0009482188,0.00017417873,0.00015667509,0.00022430789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047438713,0.00017084472,0.0004823053,0.0001182603,0.00014618333,0.000050122602,0.00026825178,0.00002540469,0.0004814627],"category_scores_gemma":[0.00044923264,0.0000859353,0.00016877706,0.00008207136,0.00025331942,0.0004648169,0.00017437694,0.00082835025,0.000022352106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004929736,0.0009591096,0.98152906,0.000022526368,0.00029264428,0.00066589063,0.00018231687,0.00028323827,0.009519202,0.000012142083,0.00010437339,0.0014997445],"study_design_scores_gemma":[0.01827143,0.0014838154,0.97593004,0.000116372175,0.00038545395,0.00038365918,0.00012777736,0.00218056,0.000118773234,0.000023374685,0.0008406249,0.00013812452],"about_ca_topic_score_codex":0.000011835578,"about_ca_topic_score_gemma":0.0000047601266,"teacher_disagreement_score":0.013341693,"about_ca_system_score_codex":0.00009690716,"about_ca_system_score_gemma":0.00022690443,"threshold_uncertainty_score":0.52716786},"labels":[],"label_agreement":null},{"id":"W2279815749","doi":"10.1007/s00228-002-0534-6","title":"Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case report","year":2002,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pharmacokinetics; Fluorouracil; Toxicity; Neutropenia; Pharmacology; Gastroenterology; Medicine; Dihydropyrimidine dehydrogenase; Internal medicine; Urinary system; Population; Chemotherapy; Thymidylate synthase","score_opus":0.07621597393733229,"score_gpt":0.3714326723831366,"score_spread":0.29521669844580434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279815749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909196,0.0032242076,0.000047299727,0.0011622248,0.0005309032,0.00040394923,0.00006636504,0.000018083732,0.0036273596],"genre_scores_gemma":[0.9956401,0.0022614459,0.0004007173,0.00050327607,0.0005282959,0.000003443361,0.00000907836,0.000038445298,0.0006151895],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9952,0.001232681,0.0024799206,0.0003207609,0.0004646743,0.00030201263],"domain_scores_gemma":[0.9948092,0.00084564835,0.0025582511,0.00017055511,0.0012543247,0.0003620339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002515291,0.00029362502,0.0013812606,0.00014887366,0.000090981914,0.00001059619,0.00013005707,0.000079000914,0.00048084318],"category_scores_gemma":[0.0012295314,0.00021388113,0.0002924232,0.00026912283,0.0002853568,0.0001860523,0.00010585051,0.0006560436,0.0000039490574],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029855132,0.011900393,0.11483157,0.0008439579,0.0145443035,0.5499642,0.005220126,0.00043166502,0.04139825,0.00002403987,0.043756675,0.18722971],"study_design_scores_gemma":[0.11837492,0.055966076,0.32964858,0.0017596586,0.017586788,0.3955292,0.00090699294,0.01120165,0.038515802,0.0000362411,0.028710684,0.0017633841],"about_ca_topic_score_codex":0.000008222981,"about_ca_topic_score_gemma":0.000007963211,"teacher_disagreement_score":0.21481702,"about_ca_system_score_codex":0.00007046479,"about_ca_system_score_gemma":0.00012677186,"threshold_uncertainty_score":0.87218195},"labels":[],"label_agreement":null},{"id":"W2345693147","doi":"10.1007/s00228-016-2065-6","title":"No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects","year":2016,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep Edouard Montpetit; Diabetes Canada; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Fondation du CHUM","keywords":"Rosuvastatin; Pantoprazole; Pharmacokinetics; Rosuvastatin Calcium; Pharmacology; Chemistry; Bioequivalence; Medicine","score_opus":0.04473967076725121,"score_gpt":0.3832373134828759,"score_spread":0.33849764271562466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345693147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887645,0.00028782015,0.00035092735,0.0045691025,0.0027181415,0.00027815942,0.0000049805135,0.00000577779,0.0030205403],"genre_scores_gemma":[0.9938513,0.001888202,0.0003491285,0.00285009,0.00076454453,9.971633e-7,3.9863684e-7,0.00002688939,0.0002684586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99615,0.0013223153,0.0018230509,0.00014775872,0.00031757008,0.00023931406],"domain_scores_gemma":[0.99571925,0.0025635962,0.0011034611,0.00014630854,0.00026919518,0.00019815945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036749234,0.00013645618,0.00075496966,0.00013165719,0.000017489006,0.0000013937182,0.00026178014,0.000043747175,0.0002832199],"category_scores_gemma":[0.0006482681,0.00006646001,0.00028536818,0.00014775667,0.00027240536,0.0000327087,0.00002573409,0.00055098056,0.000033032247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035264924,0.003510192,0.018815167,0.0007365712,0.0005126063,0.0034811827,0.00031887737,0.000026485553,0.86812025,0.00032571141,0.016381389,0.052506655],"study_design_scores_gemma":[0.06285037,0.028794238,0.30958793,0.0024992907,0.0008127669,0.000111611276,0.00006856125,0.00005024719,0.5311071,0.00018512912,0.06363153,0.00030117],"about_ca_topic_score_codex":7.755929e-7,"about_ca_topic_score_gemma":7.163557e-7,"teacher_disagreement_score":0.3370131,"about_ca_system_score_codex":0.000016827358,"about_ca_system_score_gemma":0.0001736416,"threshold_uncertainty_score":0.31010592},"labels":[],"label_agreement":null},{"id":"W2507759746","doi":"10.1007/s00228-016-2118-x","title":"Performance of the high-dimensional propensity score in adjusting for unmeasured confounders","year":2016,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University; McGill University; Centre Hospitalier de l’Université de Montréal; Programs for Assessment of Technology in Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Propensity score matching; Confounding; Medicine; Statistics; Econometrics; Internal medicine; Psychology; Mathematics","score_opus":0.4570305638231168,"score_gpt":0.4816920596247215,"score_spread":0.024661495801604705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507759746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923963,0.000015882952,0.0045982054,0.0011841129,0.0011033592,0.0003253765,0.000003850644,0.000016719274,0.0003562174],"genre_scores_gemma":[0.9891948,0.00003853084,0.009793291,0.00047060277,0.00038378642,0.000002101218,1.2519747e-7,0.000024430774,0.00009234646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99657154,0.0011684169,0.0016627416,0.00014632812,0.0002363314,0.00021465248],"domain_scores_gemma":[0.99467236,0.0029981409,0.0015707924,0.00015754394,0.0005169816,0.00008419486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062090205,0.00012407698,0.00054824835,0.000063285814,0.00004649117,0.0000031792895,0.00045643287,0.000049870672,0.000063475556],"category_scores_gemma":[0.004288101,0.00006439395,0.00019077389,0.00009432574,0.00040409263,0.00014757704,0.00013875349,0.00044390207,0.0000036030779],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013389224,0.0024660036,0.24251348,0.00069586746,0.0007489439,0.0003195572,0.00039992953,0.0006842929,0.46881017,0.010714956,0.053939413,0.20531818],"study_design_scores_gemma":[0.037520174,0.010370982,0.6516096,0.004207346,0.0008362848,0.0004095596,0.000068903704,0.0012797937,0.21879508,0.06762523,0.006202213,0.0010748559],"about_ca_topic_score_codex":5.151466e-7,"about_ca_topic_score_gemma":0.0000019300273,"teacher_disagreement_score":0.4090961,"about_ca_system_score_codex":0.000045164452,"about_ca_system_score_gemma":0.00018252582,"threshold_uncertainty_score":0.51335675},"labels":[],"label_agreement":null},{"id":"W2512647917","doi":"10.1007/s00228-016-2120-3","title":"High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate","year":2016,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Abiraterone acetate; Prostate cancer; Drug; Abiraterone; Medicine; Pharmacology; Castration; Cancer; Oncology; Prostate; Drug-drug interaction; Internal medicine; Androgen deprivation therapy; Hormone; Androgen receptor","score_opus":0.03840507762027174,"score_gpt":0.3893474036379929,"score_spread":0.3509423260177212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512647917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564755,0.00015811747,0.000021269481,0.0031495595,0.0004119505,0.00043783552,0.000056725792,0.000007950356,0.00010905819],"genre_scores_gemma":[0.99611104,0.0009513601,0.00021878173,0.00011927012,0.0002675379,0.0000070512356,0.0000048598476,0.000029285975,0.0022908074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972982,0.00080644654,0.0010863123,0.0002222725,0.00032919497,0.00025758764],"domain_scores_gemma":[0.9980102,0.00018800554,0.00078477897,0.00011641065,0.0006742956,0.00022631958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007900234,0.00015744191,0.00050958234,0.00016221122,0.00003580594,0.000007728837,0.00013810708,0.000013248418,0.00047253512],"category_scores_gemma":[0.000042891596,0.00007544907,0.00008649195,0.00016494532,0.00035863658,0.00021283144,0.00003298111,0.00039914725,0.0000111253075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085452005,0.0020249188,0.8659463,0.00018089179,0.0008634898,0.0017945152,0.0002554323,0.00017978234,0.025781816,0.000001501961,0.0028074281,0.014711951],"study_design_scores_gemma":[0.0364895,0.0037013942,0.950167,0.00071685563,0.00042979047,0.000025023732,0.000024320821,0.000006199836,0.007827141,0.000002981661,0.00051082793,0.00009895883],"about_ca_topic_score_codex":0.000027556174,"about_ca_topic_score_gemma":0.00002797288,"teacher_disagreement_score":0.08422074,"about_ca_system_score_codex":0.000093462986,"about_ca_system_score_gemma":0.00033655504,"threshold_uncertainty_score":0.5173928},"labels":[],"label_agreement":null},{"id":"W2526264022","doi":"10.1007/s00228-016-2139-5","title":"Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence","year":2016,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier Universitaire de Sherbrooke; Université de Montréal; AstraZeneca (Canada); Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Medical prescription; Asthma; Inhaled corticosteroids; Pharmacy; Pediatrics; Medication adherence; Physical therapy; Internal medicine; Family medicine; Pharmacology","score_opus":0.18042731009110685,"score_gpt":0.4469897721362984,"score_spread":0.2665624620451916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526264022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901529,0.000049957463,0.0062534492,0.0007656272,0.0009672433,0.00025486696,0.0000033357112,0.000013000334,0.0015396264],"genre_scores_gemma":[0.9858175,0.000031250547,0.0033129444,0.010384454,0.00033731232,0.0000020122213,0.000002528727,0.000022590864,0.00008941535],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957538,0.0018574297,0.0014831166,0.00031608823,0.00035134266,0.00023819905],"domain_scores_gemma":[0.99747175,0.0005428363,0.00073876034,0.00017931017,0.00047727182,0.0005900841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026938946,0.00016875005,0.0005852936,0.00019597077,0.000038967486,0.000026729831,0.00023960798,0.000062434534,0.00085315364],"category_scores_gemma":[0.0012893109,0.000110785244,0.00008375427,0.00021079481,0.00017784353,0.0003240153,0.000051750074,0.0007394826,0.000098333505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003743646,0.0014706819,0.10557827,0.0000478787,0.000046224497,0.0010357574,0.00006543432,0.000021890532,0.031683393,0.0000014697885,0.0027900154,0.8535153],"study_design_scores_gemma":[0.016576873,0.013196509,0.9616833,0.0019752367,0.000073265874,0.00012812755,0.000058870675,0.0009019663,0.0008319136,0.0000081202825,0.004359797,0.00020603833],"about_ca_topic_score_codex":0.0000015511799,"about_ca_topic_score_gemma":8.433185e-7,"teacher_disagreement_score":0.856105,"about_ca_system_score_codex":0.00007534982,"about_ca_system_score_gemma":0.0006292759,"threshold_uncertainty_score":0.9341434},"labels":[],"label_agreement":null},{"id":"W2557564208","doi":"10.1007/s00228-016-2162-6","title":"Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies","year":2016,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ZonMw; Stichting Stoffels-Hornstra","keywords":"Medicine; Anticholinergic; Medical prescription; Sedative; Psychiatry; Quality of life (healthcare); Drug; MEDLINE; Internal medicine; Pharmacology","score_opus":0.6758278482273231,"score_gpt":0.6514718916572956,"score_spread":0.024355956570027537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557564208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009210242,0.98193985,0.000105186366,0.0071885507,0.00047500106,0.00079016975,0.000025261565,0.000004220917,0.000261487],"genre_scores_gemma":[0.012152381,0.9855621,0.0006124682,0.0011835629,0.0003192259,0.0000029153143,0.0000021099215,0.000025279354,0.00013997448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9768226,0.017440978,0.0046931067,0.00031310445,0.00055222766,0.0001779547],"domain_scores_gemma":[0.9596799,0.029471004,0.009218775,0.0002698588,0.0011534417,0.0002070415],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028761512,0.00033410173,0.005734408,0.00011243166,0.000035820118,0.0000039213996,0.0003423208,0.000077556455,0.00007048968],"category_scores_gemma":[0.010705819,0.00013429791,0.000701642,0.00020620202,0.0015455522,0.000102815255,0.00023696205,0.0012116393,0.0000026999583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004456872,0.0009568847,0.010740757,0.20542976,0.011115143,0.00016925624,0.00066036853,0.0000012020225,0.00007613359,0.00015705636,0.0075010853,0.7587355],"study_design_scores_gemma":[0.007567677,0.0019530848,0.010510741,0.07726754,0.015655894,0.00022981083,0.000240652,0.0000051960737,0.000030776628,0.00004380353,0.8861792,0.00031558855],"about_ca_topic_score_codex":0.0000022999382,"about_ca_topic_score_gemma":3.2816732e-7,"teacher_disagreement_score":0.87867814,"about_ca_system_score_codex":0.000020895382,"about_ca_system_score_gemma":0.00032226238,"threshold_uncertainty_score":0.99762744},"labels":[],"label_agreement":null},{"id":"W2602181241","doi":"10.1007/s00228-017-2238-y","title":"Tapering or abrupt cessation of proton pump inhibitors?","year":2017,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority","funders":"","keywords":"Tapering; Medicine; Pharmacology; Anesthesia; Computer science","score_opus":0.13175758268948035,"score_gpt":0.45812112500881264,"score_spread":0.3263635423193323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602181241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7242165,0.00041054864,0.00013422193,0.2383929,0.017770581,0.0021448077,0.000047774698,0.00005168509,0.016830957],"genre_scores_gemma":[0.8175493,0.0005364677,0.00086352904,0.13331825,0.042562217,0.000008396043,0.000041758547,0.00014703735,0.0049730414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947904,0.0014039564,0.002611991,0.0003121946,0.0005415302,0.00033998207],"domain_scores_gemma":[0.9941112,0.00051869516,0.004284862,0.00033012146,0.00049555185,0.00025957555],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002426886,0.00032191887,0.001548831,0.00022859349,0.000072149196,0.000022060716,0.0004721384,0.00030669253,0.0008230092],"category_scores_gemma":[0.0010863052,0.00021005733,0.00071421225,0.000056745863,0.00032311777,0.00013482367,0.00012962967,0.003431542,0.00010478053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022733014,0.0006801721,0.019310167,0.00073323166,0.0017648446,0.12122337,0.000060126364,0.000003054596,0.0006329297,2.1230426e-7,0.83151495,0.02180367],"study_design_scores_gemma":[0.015707841,0.00959319,0.043100018,0.00076943677,0.0022881932,0.0017447381,0.0000041465914,0.0000093598765,0.0035149322,0.000012473326,0.9230942,0.00016147444],"about_ca_topic_score_codex":9.204262e-7,"about_ca_topic_score_gemma":6.5867184e-8,"teacher_disagreement_score":0.11947863,"about_ca_system_score_codex":0.00005366757,"about_ca_system_score_gemma":0.00042343503,"threshold_uncertainty_score":0.9988676},"labels":[],"label_agreement":null},{"id":"W2606897780","doi":"10.1007/s00228-017-2253-z","title":"Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada","year":2017,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Zopiclone; Sedative; Zolpidem; Medicine; Benzodiazepine; Medical prescription; Odds ratio; Sedative/hypnotic; Logistic regression; Odds; Population; Demography; Psychiatry; Insomnia; Internal medicine; Pharmacology; Environmental health","score_opus":0.08511017066100389,"score_gpt":0.3782066828787777,"score_spread":0.2930965122177738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606897780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703544,0.0001993989,0.000013881835,0.00022985408,0.002116424,0.000268019,0.000038520848,0.000002406956,0.000096032185],"genre_scores_gemma":[0.99934363,0.000076347846,0.00001953415,0.00027490658,0.00019324626,0.0000017486698,0.0000057549405,0.000015316755,0.00006948552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656546,0.0013902804,0.0014452687,0.00021066944,0.00022877564,0.0001595165],"domain_scores_gemma":[0.996895,0.00081052736,0.0017573421,0.0001602693,0.00025759652,0.00011926172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010986879,0.00008212565,0.00045571025,0.00004961035,0.00008121937,0.000023283459,0.00035290953,0.00005945078,0.00062069047],"category_scores_gemma":[0.00042249908,0.00010234482,0.00008736137,0.00005662067,0.00015589624,0.00011755306,0.000044846034,0.0004894262,6.4107996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032458734,0.0015469303,0.98768985,0.000022687022,0.0004713504,0.00043101652,0.00052398385,0.00020688197,0.00000394183,3.5229675e-7,0.0028437527,0.005934681],"study_design_scores_gemma":[0.014673044,0.0014384924,0.9822127,0.00017703122,0.00016140143,0.000014844324,0.0009220285,0.00018118529,8.748769e-7,0.0000014234311,0.00013464966,0.000082307146],"about_ca_topic_score_codex":0.2665489,"about_ca_topic_score_gemma":0.60258734,"teacher_disagreement_score":0.3360384,"about_ca_system_score_codex":0.00004007179,"about_ca_system_score_gemma":0.00030052813,"threshold_uncertainty_score":0.7383352},"labels":[],"label_agreement":null},{"id":"W2731559721","doi":"10.1007/s00228-017-2278-3","title":"Adverse cardiac events associated with incident opioid drug use among older adults with COPD","year":2017,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; COPD; Hazard ratio; Internal medicine; Adverse effect; Heart failure; Opioid; Retrospective cohort study; Emergency department; Propensity score matching; Emergency medicine; Confidence interval","score_opus":0.03832160820411382,"score_gpt":0.3784239220613039,"score_spread":0.34010231385719003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731559721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446,0.00020691984,0.00001990382,0.00097213854,0.0016887203,0.0007120846,0.000033600787,0.000026188856,0.0018804311],"genre_scores_gemma":[0.99495536,0.00033963018,0.00017589846,0.0006749805,0.0017243817,0.0000051462534,0.000015667523,0.00009383961,0.0020151031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942862,0.0023971752,0.0013348234,0.00045946232,0.00094942545,0.0005729281],"domain_scores_gemma":[0.994247,0.0007912104,0.0020771981,0.000542014,0.0011463556,0.0011962241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034140702,0.0003092072,0.0010894473,0.00015223214,0.00027717667,0.000042990345,0.0006778617,0.00008093375,0.0005779932],"category_scores_gemma":[0.0019275761,0.00021391214,0.0004494701,0.00011155653,0.0010008315,0.0005625371,0.00031267328,0.0018410252,0.00009187993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009222614,0.0012048633,0.9520773,0.00008381609,0.0016667363,0.013243999,0.00023943733,0.000030169655,0.00006377972,0.0000014637927,0.017148085,0.005017678],"study_design_scores_gemma":[0.023102626,0.0012784108,0.9692678,0.00091396674,0.000990269,0.00012462308,0.00016184345,0.00007722499,0.000077930716,0.000002845869,0.0037813482,0.00022115363],"about_ca_topic_score_codex":0.000026896963,"about_ca_topic_score_gemma":0.000014399599,"teacher_disagreement_score":0.017190399,"about_ca_system_score_codex":0.00023926678,"about_ca_system_score_gemma":0.0007572614,"threshold_uncertainty_score":0.8723084},"labels":[],"label_agreement":null},{"id":"W2734786126","doi":"10.1007/s00228-017-2293-4","title":"Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Randomized controlled trial; Pharmacist; Clinical pharmacy; Intervention (counseling); Absolute risk reduction; Post-hoc analysis; Pharmaceutical care; Emergency medicine; Internal medicine; Pediatrics; Pharmacy; Confidence interval; Family medicine; Psychiatry","score_opus":0.14143874780745205,"score_gpt":0.4690525569994617,"score_spread":0.32761380919200966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734786126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777879,0.00015514712,0.00031810868,0.007818246,0.008849821,0.0032013392,0.0000011236368,0.000011121393,0.0018571896],"genre_scores_gemma":[0.99510956,0.0010039692,0.0010151627,0.0011541817,0.0014892009,0.000024905466,0.0000056232248,0.000025921236,0.00017147313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9847451,0.009674605,0.004549764,0.00025734823,0.00048697498,0.00028624866],"domain_scores_gemma":[0.9910898,0.0030669076,0.0049445378,0.0002581438,0.0003151305,0.000325444],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021350328,0.00019858696,0.0024119748,0.0003470999,0.00008250037,0.00006110238,0.00035766856,0.000108994434,0.0002987215],"category_scores_gemma":[0.030716738,0.00013518281,0.0006427931,0.00009758097,0.0003806971,0.0006988474,0.000086704735,0.00158932,0.000031695938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9790019,0.0021391285,0.0047841864,0.000036242865,0.00051142566,0.0007113168,0.00016146775,0.000039758383,0.0007137868,0.00001684879,0.0006856246,0.011198359],"study_design_scores_gemma":[0.9689489,0.0026348983,0.022412915,0.00017347602,0.00094190583,0.00006873114,0.000026180265,0.0021177898,0.000037506805,0.000108258544,0.0024118698,0.00011755407],"about_ca_topic_score_codex":0.00001443415,"about_ca_topic_score_gemma":0.000003330694,"teacher_disagreement_score":0.017628727,"about_ca_system_score_codex":0.0000565132,"about_ca_system_score_gemma":0.0002863367,"threshold_uncertainty_score":0.9774479},"labels":[],"label_agreement":null},{"id":"W2762696253","doi":"10.1007/s00228-017-2343-y","title":"Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France: a study based on the French National Health Insurance Information System","year":2017,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Population; Defined daily dose; Quarter (Canadian coin); Dementia; Drug; Health care; Emergency medicine; Family medicine; Pediatrics; Environmental health; Psychiatry; Internal medicine","score_opus":0.03900200504012839,"score_gpt":0.42467356713204135,"score_spread":0.38567156209191295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762696253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97744066,0.00012835169,0.0000095320365,0.01998777,0.0017023695,0.0005949826,0.00002358749,0.0000060378525,0.000106709536],"genre_scores_gemma":[0.998258,0.00017197646,0.00005626454,0.0010276882,0.00043882756,0.000005719125,0.000001073145,0.000010935738,0.000029506973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99498826,0.002937842,0.0014024561,0.000120413955,0.00029631928,0.00025468765],"domain_scores_gemma":[0.9967084,0.00093104143,0.0018032978,0.00016806097,0.00021561341,0.00017357807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005734894,0.00010653476,0.00043213484,0.0001275137,0.0006539975,0.000029905359,0.00018883395,0.000038473278,0.00003693319],"category_scores_gemma":[0.00038558335,0.00006125527,0.00006119947,0.00006969709,0.00014740018,0.000241677,0.000050748928,0.0008848409,0.000008079648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008949659,0.0001886021,0.96311784,0.00017566513,0.000026881198,0.000006562695,0.017937925,0.000025745281,4.7363002e-7,0.0000058066053,0.01576223,0.0018572962],"study_design_scores_gemma":[0.005599422,0.00079281157,0.9872446,0.0008334261,0.000010358525,0.0000023224532,0.0040736794,0.00014424932,2.1331738e-7,0.0000075157777,0.0012430137,0.00004839513],"about_ca_topic_score_codex":0.000111715075,"about_ca_topic_score_gemma":0.00007140338,"teacher_disagreement_score":0.024126746,"about_ca_system_score_codex":0.00010266512,"about_ca_system_score_gemma":0.00038971796,"threshold_uncertainty_score":0.5030086},"labels":[],"label_agreement":null},{"id":"W2767975651","doi":"10.1007/s00228-019-02670-9","title":"Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement","year":2019,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute for Health and Care Research","keywords":"Toxic epidermal necrolysis; Causality (physics); Adverse drug reaction; Reliability (semiconductor); Medicine; Statistic; Drug reaction; Drug; Cohen's kappa; Validity; Dermatology; Psychiatry; Clinical psychology; Statistics; Psychometrics; Mathematics","score_opus":0.08289148585455476,"score_gpt":0.4276342015359399,"score_spread":0.34474271568138515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767975651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318815,0.000051721872,0.00059075357,0.006197492,0.0061041294,0.0019950839,0.000035808076,0.000039438484,0.0017974222],"genre_scores_gemma":[0.9918181,0.00017784703,0.0025831866,0.0025024407,0.0018263139,0.000030141939,0.000022401737,0.00007618137,0.0009634424],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952353,0.0010120113,0.0023668874,0.0005299451,0.00035593272,0.000499926],"domain_scores_gemma":[0.9941862,0.0026121812,0.0017387932,0.00032304696,0.0005395167,0.0006002269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00730797,0.00030792993,0.0013040012,0.00022528705,0.00013022502,0.000031287644,0.00021373508,0.000101337355,0.00005061708],"category_scores_gemma":[0.0008836936,0.00026580182,0.00074696244,0.00013162958,0.00007520544,0.0005585284,0.00009986067,0.0010748004,0.000043928583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033821056,0.0033347479,0.004215127,0.0006497646,0.0035972453,0.0010101955,0.00024229307,0.00017093886,0.6780432,0.00008538476,0.013728216,0.29154083],"study_design_scores_gemma":[0.05884148,0.0064314115,0.58987993,0.00042430614,0.00512219,0.0019316537,0.0013604583,0.0016452179,0.011175272,0.000106393076,0.32229626,0.00078540086],"about_ca_topic_score_codex":0.000006252737,"about_ca_topic_score_gemma":0.000002747964,"teacher_disagreement_score":0.6668679,"about_ca_system_score_codex":0.00025323805,"about_ca_system_score_gemma":0.0004580094,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W2805720231","doi":"10.1007/s00228-018-2496-3","title":"Tamoxifen and the risk of Parkinsonism: a case/non-case study","year":2018,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tamoxifen; Medicine; Parkinsonism; Oncology; Internal medicine; Pharmacology; Breast cancer; Disease; Cancer","score_opus":0.20605437582554453,"score_gpt":0.5328072979525367,"score_spread":0.32675292212699214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805720231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850571,0.00041491204,0.00017868154,0.0010558976,0.0065019284,0.00057352893,0.000034631368,0.000022022536,0.0061612558],"genre_scores_gemma":[0.9895035,0.0017459018,0.00015870828,0.0036081597,0.0047690542,0.0000065166537,5.294682e-7,0.000038122882,0.00016947628],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.98454607,0.012211837,0.0022946869,0.0003295209,0.00020565193,0.00041225457],"domain_scores_gemma":[0.991417,0.005109888,0.0022343772,0.00024122054,0.0005067773,0.0004907407],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017489564,0.000289242,0.000979778,0.00016944789,0.0005565225,0.000020136904,0.00050401886,0.00012359192,0.0008288624],"category_scores_gemma":[0.0008104846,0.0001893644,0.00044820065,0.00028106925,0.002513693,0.00020073885,0.0002602335,0.0026575725,0.00010303096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03169904,0.0107482085,0.15721983,0.000107838474,0.014220589,0.40502337,0.022077622,0.00080461137,0.0110317655,0.000097225886,0.16588227,0.18108761],"study_design_scores_gemma":[0.12222979,0.0096065905,0.014673338,0.0000522362,0.013426378,0.19157998,0.009128515,0.007505482,0.007596977,0.00039663212,0.6229212,0.00088286895],"about_ca_topic_score_codex":0.000037256865,"about_ca_topic_score_gemma":0.000010721905,"teacher_disagreement_score":0.45703894,"about_ca_system_score_codex":0.000018652943,"about_ca_system_score_gemma":0.00016619256,"threshold_uncertainty_score":0.9996433},"labels":[],"label_agreement":null},{"id":"W2890556124","doi":"10.1007/s00228-018-2554-x","title":"Tamoxifen administration and the risk of Parkinsonism","year":2018,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tamoxifen; Parkinsonism; Medicine; Administration (probate law); Antiestrogen; Pharmacology; Internal medicine; Political science; Breast cancer; Disease; Cancer","score_opus":0.05564036763805693,"score_gpt":0.38572127340458895,"score_spread":0.33008090576653204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890556124","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41200036,0.003297297,0.0003807172,0.5661286,0.008676331,0.0009188094,0.00014848281,0.000024874147,0.008424511],"genre_scores_gemma":[0.5845031,0.0070592384,0.001048764,0.37884548,0.027466344,0.0000035012622,0.000028069215,0.0000827916,0.0009626997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271435,0.004510104,0.0018893209,0.00027293028,0.00038841128,0.00022487382],"domain_scores_gemma":[0.9947016,0.00138815,0.0030907434,0.00023627265,0.00035603694,0.00022716084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004666624,0.00025776812,0.0012487178,0.00010937027,0.00007470422,0.00001571325,0.00027601476,0.00021684493,0.00037856126],"category_scores_gemma":[0.00075776136,0.00014526767,0.00067784794,0.00006468676,0.00088455627,0.000044503282,0.00008687108,0.0022192488,0.000053360603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059045795,0.00033572226,0.0016121255,0.00008082574,0.0026148716,0.0069466466,0.000058697995,3.0393593e-7,0.00003483369,0.0000062395466,0.9725345,0.0098707015],"study_design_scores_gemma":[0.016895207,0.0037413964,0.019995974,0.000111494934,0.005342804,0.0006535132,0.0000059057666,0.000026430725,0.0001660828,0.00027282044,0.95267874,0.00010963021],"about_ca_topic_score_codex":0.0000016017007,"about_ca_topic_score_gemma":2.2549749e-7,"teacher_disagreement_score":0.18728313,"about_ca_system_score_codex":0.000017629729,"about_ca_system_score_gemma":0.00032089755,"threshold_uncertainty_score":0.9641655},"labels":[],"label_agreement":null},{"id":"W2896414613","doi":"10.1007/s00228-018-2564-8","title":"Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000–2016","year":2018,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Clopidogrel; Lansoprazole; Medicine; Esomeprazole; Concomitant; Acute coronary syndrome; Omeprazole; Rabeprazole; Proton-pump inhibitor; Pantoprazole; CYP2C19; Internal medicine; Drug; Pharmacology; Aspirin; Myocardial infarction","score_opus":0.049308081505132925,"score_gpt":0.38468215333036476,"score_spread":0.3353740718252318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896414613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937799,0.0016469676,0.000022006949,0.00059449684,0.0012888475,0.00030249672,0.000004707497,0.000013097922,0.002347468],"genre_scores_gemma":[0.99131465,0.0034251742,0.00008827343,0.0011651897,0.0035855754,0.0000040561927,0.0000034457642,0.000029342576,0.00038427362],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967094,0.0013865043,0.0012307633,0.00023006488,0.00020017094,0.00024306965],"domain_scores_gemma":[0.99869734,0.00016831656,0.00046342466,0.00013559543,0.00016029012,0.0003750107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016994847,0.00017721912,0.0007693,0.00020617158,0.00004743066,0.000011026166,0.000108596905,0.000068676265,0.00036072874],"category_scores_gemma":[0.00011478027,0.00012069052,0.00041073773,0.00015175898,0.00054249814,0.00010476045,0.000045957513,0.0003801596,0.000037638572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010205005,0.001782465,0.42559487,0.00003092335,0.0014058503,0.0041519515,0.0004226628,0.0000033408494,0.0011462463,0.000002885842,0.00732311,0.54793066],"study_design_scores_gemma":[0.03210294,0.013887617,0.7857264,0.00022047713,0.00065673765,0.00032491796,0.000052720607,0.000034123794,0.0030224533,0.000008470183,0.16379145,0.00017165147],"about_ca_topic_score_codex":0.0000030935917,"about_ca_topic_score_gemma":0.0000013982783,"teacher_disagreement_score":0.54775906,"about_ca_system_score_codex":0.000057956036,"about_ca_system_score_gemma":0.00016144256,"threshold_uncertainty_score":0.49216166},"labels":[],"label_agreement":null},{"id":"W2912599786","doi":"10.1007/s00228-018-02615-8","title":"Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?","year":2019,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); Canadian Armed Forces; Université de Montréal; Montreal Heart Institute","funders":"Réseau Québécois de Recherche sur les Médicaments","keywords":"Spironolactone; Medicine; Hazard ratio; Cohort; Internal medicine; Diabetes mellitus; Proportional hazards model; Cohort study; Heart failure; Confidence interval; Endocrinology","score_opus":0.018085596692888173,"score_gpt":0.31797928266067527,"score_spread":0.2998936859677871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912599786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558985,0.00011404402,0.000013676881,0.003778239,0.0001346531,0.00027205376,0.000006714688,0.0000017658384,0.00008900574],"genre_scores_gemma":[0.9986599,0.0001063962,0.00017424706,0.0007375985,0.00021148747,1.7922387e-7,0.0000023262862,0.00001220134,0.000095670155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974468,0.0010964893,0.00094938726,0.000101489815,0.00029708692,0.00010875854],"domain_scores_gemma":[0.99774593,0.00070390484,0.0010884884,0.0000772996,0.00027428297,0.00011008708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028361636,0.000079981066,0.00069101655,0.00007461874,0.000013924801,0.0000033258434,0.00007062618,0.00005176545,0.00021067024],"category_scores_gemma":[0.00034667295,0.000043519365,0.00015125905,0.00006988129,0.000113426366,0.000051723535,0.00003258405,0.0004568015,0.0000082475835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018009284,0.00017041853,0.99231726,0.000011273328,0.00044708065,0.00000352984,0.00008708066,0.000011520932,0.00034474072,4.5319706e-7,0.0036258213,0.0011798718],"study_design_scores_gemma":[0.020427432,0.0011863186,0.9751826,0.000070215254,0.0006659336,0.0000032555338,0.000020498348,0.00011864807,0.00023467436,0.0000105026875,0.0020397608,0.000040169],"about_ca_topic_score_codex":0.000007215287,"about_ca_topic_score_gemma":0.0000012011385,"teacher_disagreement_score":0.018626504,"about_ca_system_score_codex":0.00001534045,"about_ca_system_score_gemma":0.000081361686,"threshold_uncertainty_score":0.23066914},"labels":[],"label_agreement":null},{"id":"W2913514525","doi":"10.1007/s00228-019-02632-1","title":"Sex-by-formulation interaction in bioequivalence trials with transdermal patches","year":2019,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Transdermal; Medicine; Pharmacokinetics; Rivastigmine; Pharmacology; Transdermal patch; Internal medicine","score_opus":0.60535816344768,"score_gpt":0.6141343016009941,"score_spread":0.008776138153314128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913514525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054990663,0.9745198,0.0002897811,0.00033383718,0.014932042,0.0013704346,0.00019024021,0.000032722695,0.0028320919],"genre_scores_gemma":[0.01093989,0.98212945,0.00017753005,0.0016343251,0.0044384627,0.000017380062,0.0000601565,0.00014889412,0.0004539096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9601115,0.030404165,0.00761822,0.00068903243,0.00043699343,0.0007401132],"domain_scores_gemma":[0.98465455,0.007696959,0.006479675,0.0002662882,0.00027847177,0.0006240531],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.027242754,0.0008288938,0.006234952,0.0006580682,0.00009693927,0.000044593467,0.0011863337,0.000657702,0.001701821],"category_scores_gemma":[0.00064655126,0.00059020496,0.0017025827,0.00048287192,0.00031012224,0.0003332471,0.00014352247,0.006060686,0.00034373195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001932073,0.0009772966,0.00017088206,0.00198146,0.0017416748,0.0007857286,0.00016964135,0.00032056752,0.0004035384,0.000008138,0.015199699,0.9763093],"study_design_scores_gemma":[0.008574903,0.0009961791,0.000056806566,0.0011481588,0.006832458,0.0003624267,0.00002847534,0.00015810182,0.00034043394,0.000010759212,0.9809098,0.0005814861],"about_ca_topic_score_codex":0.000001908394,"about_ca_topic_score_gemma":9.434968e-7,"teacher_disagreement_score":0.9757278,"about_ca_system_score_codex":0.00011281594,"about_ca_system_score_gemma":0.00078255346,"threshold_uncertainty_score":0.99965495},"labels":[],"label_agreement":null},{"id":"W2924012744","doi":"10.1007/s00228-019-02660-x","title":"A pharmacist-physician intervention model using a computerized alert system to reduce high-risk medication use in primary care","year":2019,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Pharmacist; Intervention (counseling); Clinical pharmacy; Beers Criteria; Emergency medicine; Adverse effect; Pharmacy; Family medicine; Medical emergency; Polypharmacy; Intensive care medicine; Internal medicine; Nursing","score_opus":0.2226676650606155,"score_gpt":0.48176410289638044,"score_spread":0.25909643783576497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924012744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878367,0.00015185804,0.0053828023,0.0006756435,0.004418953,0.0006897961,0.000013659581,0.000027400665,0.00080315105],"genre_scores_gemma":[0.98557794,0.00016316531,0.006700306,0.0063711638,0.0010631648,0.0000018615066,0.000016224003,0.000042095333,0.00006406681],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941663,0.0026952578,0.0021397418,0.00031884364,0.00039793062,0.00028193518],"domain_scores_gemma":[0.9968528,0.000720489,0.0014568458,0.00018945438,0.00030789003,0.00047249408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030787927,0.00019846475,0.00091493677,0.00024901112,0.000039568524,0.000024555522,0.00027874619,0.000062704086,0.00005251318],"category_scores_gemma":[0.00020588076,0.00016562159,0.00038953914,0.00019249358,0.000065035114,0.00038408051,0.00015350306,0.0011891868,0.00016044226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089633495,0.008563233,0.38774055,0.004361087,0.0030246526,0.0048931926,0.0022860242,0.08459416,0.13800897,0.00005707178,0.013748142,0.26308942],"study_design_scores_gemma":[0.096340045,0.006371971,0.2897251,0.0030545718,0.0032178308,0.000536687,0.0004146837,0.56554985,0.0021168322,0.000013685461,0.031912643,0.000746112],"about_ca_topic_score_codex":0.000007419887,"about_ca_topic_score_gemma":5.171316e-7,"teacher_disagreement_score":0.4809557,"about_ca_system_score_codex":0.00025076335,"about_ca_system_score_gemma":0.00018001524,"threshold_uncertainty_score":0.67538524},"labels":[],"label_agreement":null},{"id":"W3015628601","doi":"10.1007/s00228-020-02877-1","title":"Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis","year":2020,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University; University of Ottawa","funders":"Cancer Research UK","keywords":"Pharmacovigilance; Medicine; Rivaroxaban; Dabigatran; Intensive care medicine; Pharmacology; Warfarin; Drug; Atrial fibrillation; Internal medicine","score_opus":0.16843476630251286,"score_gpt":0.4597060204725366,"score_spread":0.29127125417002375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015628601","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017651381,0.0016246757,0.0005580091,0.9690889,0.0049257,0.000439485,0.00003456482,0.00006986208,0.005607396],"genre_scores_gemma":[0.23292874,0.0048741926,0.0007820593,0.71436435,0.045192663,3.3129163e-7,0.00006886629,0.00008622157,0.0017025529],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381804,0.0026186213,0.0022642813,0.00045941584,0.0004890339,0.00035061626],"domain_scores_gemma":[0.99630016,0.0012025625,0.0018068696,0.0001701022,0.0001639466,0.00035637658],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00199251,0.0003692099,0.0027380243,0.00046087432,0.000069186055,0.000042441457,0.00032405075,0.00016664935,0.0007630137],"category_scores_gemma":[0.0005338428,0.00028745376,0.0013950921,0.0004912242,0.0002766546,0.00011466792,0.00019245007,0.0025097872,0.00009859596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011076144,0.00002866462,0.10165532,0.00013883272,0.009130558,0.011556658,0.00003069647,0.000021061402,0.00006227527,5.8105786e-7,0.8684388,0.007828947],"study_design_scores_gemma":[0.0055118417,0.0008979756,0.069176875,0.000035337667,0.017033748,0.00005887095,0.000004718971,0.0003098846,0.000017763423,0.000009921078,0.90671533,0.00022771594],"about_ca_topic_score_codex":0.0000011372796,"about_ca_topic_score_gemma":3.0615536e-7,"teacher_disagreement_score":0.25472456,"about_ca_system_score_codex":0.000020149375,"about_ca_system_score_gemma":0.00010616122,"threshold_uncertainty_score":0.99995774},"labels":[],"label_agreement":null},{"id":"W3030013219","doi":"10.1007/s00228-020-02922-z","title":"External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients","year":2020,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Meropenem; Critically ill; Pharmacokinetics; Medicine; Population pharmacokinetics; Intensive care medicine; Population; Pharmacology; Antibiotics; Biology; Microbiology; Antibiotic resistance","score_opus":0.12695556673601807,"score_gpt":0.44775382409003717,"score_spread":0.3207982573540191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030013219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988885,0.00012566902,0.006465411,0.0023208617,0.0008121706,0.00067540037,0.000019509951,0.0000051613792,0.00069083594],"genre_scores_gemma":[0.99211174,0.00018545754,0.003474066,0.00335869,0.00081109273,0.0000011794667,0.00002056319,0.000030860425,0.0000063768216],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952321,0.0010705334,0.002733744,0.00021109915,0.0005692189,0.00018331737],"domain_scores_gemma":[0.9931489,0.0004002634,0.0013128957,0.000079885765,0.004779287,0.0002787243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00306501,0.00014479246,0.00076459214,0.000117690695,0.000016339982,0.0000054331317,0.00019306703,0.00005561373,0.00014453886],"category_scores_gemma":[0.0028862322,0.0001279703,0.0002886532,0.00013690001,0.000115541334,0.00011253763,0.000041604802,0.00038441937,0.0000026859066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0796932,0.01393623,0.14910188,0.0016246297,0.001354302,0.00046410653,0.0011581162,0.051437818,0.19490007,0.0005990301,0.012435429,0.4932952],"study_design_scores_gemma":[0.06626311,0.014506793,0.5415387,0.00041422155,0.0030684867,0.00003892,0.00007109501,0.35412604,0.01861772,0.00029432468,0.0007823791,0.0002782231],"about_ca_topic_score_codex":0.000001571299,"about_ca_topic_score_gemma":2.925629e-7,"teacher_disagreement_score":0.493017,"about_ca_system_score_codex":0.000023039524,"about_ca_system_score_gemma":0.00016148291,"threshold_uncertainty_score":0.5218477},"labels":[],"label_agreement":null},{"id":"W3042430577","doi":"10.1007/s00228-020-02958-1","title":"Patients’ experiences on adverse drug reactions reporting: a qualitative study","year":2020,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Confusion; Medicine; Usability; Drug reaction; Social media; Family medicine; Qualitative research; Adverse drug reaction; Content analysis; Pharmacovigilance; Drug; Psychology; Psychiatry","score_opus":0.440949099645519,"score_gpt":0.5933673748761954,"score_spread":0.15241827523067641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042430577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717997,0.00005463486,0.000041177333,0.0050267433,0.009127362,0.0005126599,0.000021161708,0.000083139006,0.013333467],"genre_scores_gemma":[0.97731054,0.00017745093,0.00008781076,0.018213956,0.0037553813,0.000017360175,0.0000061562237,0.000046338955,0.0003849954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9833746,0.010335301,0.004859398,0.0005155304,0.00044156975,0.00047361845],"domain_scores_gemma":[0.98961246,0.0026586344,0.0059712417,0.00016868171,0.000538631,0.0010503645],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009304058,0.00034661815,0.00096739957,0.00017212362,0.0003467523,0.000016872773,0.0006765259,0.00009540868,0.0024971112],"category_scores_gemma":[0.0041836253,0.00029145114,0.00061567826,0.00041094347,0.00043038637,0.0003721261,0.00014415443,0.003234062,0.0007048953],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014469867,0.019017117,0.04490116,0.00007094056,0.0031884024,0.0070750145,0.31250507,0.003892315,0.006585221,0.00007437369,0.5726629,0.015557634],"study_design_scores_gemma":[0.018333798,0.0056457664,0.01227997,0.000031388197,0.00088198116,0.00005377466,0.12737986,0.00032856857,0.0028280423,0.000024306306,0.83167326,0.0005392808],"about_ca_topic_score_codex":0.0000020705036,"about_ca_topic_score_gemma":4.3386527e-7,"teacher_disagreement_score":0.25901037,"about_ca_system_score_codex":0.000054595897,"about_ca_system_score_gemma":0.00022308025,"threshold_uncertainty_score":0.99995375},"labels":[],"label_agreement":null},{"id":"W3049022420","doi":"10.1007/s00228-020-02983-0","title":"Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age","year":2020,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Child bearing; Progestin; Medicine; Sexual dysfunction; Gynecology; Obstetrics; Population; Endocrinology; Internal medicine; Environmental health; Hormone","score_opus":0.07876983033497892,"score_gpt":0.37043016246941496,"score_spread":0.29166033213443604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049022420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920506,0.00015206952,0.0014575637,0.0025862583,0.0006666889,0.00019812472,0.000003634663,0.000017019052,0.002868066],"genre_scores_gemma":[0.9944238,0.000079658435,0.00047307697,0.0040247533,0.00090816524,0.000001656772,0.0000011249543,0.000021421813,0.000066362154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676305,0.0011043355,0.0015086617,0.00019215996,0.0002608924,0.00017087166],"domain_scores_gemma":[0.9973139,0.00072157965,0.0012832012,0.00007832325,0.00034466907,0.00025828666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022737293,0.0001332176,0.00084938563,0.000138175,0.000031071708,0.0000031486616,0.00008792505,0.000039750306,0.00031299636],"category_scores_gemma":[0.0015310451,0.000094105555,0.00010184303,0.0002668483,0.0003156209,0.000056709447,0.000033105585,0.0008228796,0.000012222553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11102552,0.0030422017,0.7821517,0.00041782955,0.0022755312,0.001916712,0.0028871703,0.0049441974,0.026195895,0.000014411545,0.011518971,0.053609878],"study_design_scores_gemma":[0.029402755,0.026844986,0.92018485,0.0001280685,0.0005591474,0.0000750626,0.0016122125,0.00037254769,0.0016742438,0.0000025690115,0.019015593,0.00012793952],"about_ca_topic_score_codex":0.000002238199,"about_ca_topic_score_gemma":6.7228666e-7,"teacher_disagreement_score":0.1380332,"about_ca_system_score_codex":0.000022425878,"about_ca_system_score_gemma":0.00012975775,"threshold_uncertainty_score":0.38375133},"labels":[],"label_agreement":null},{"id":"W3088312602","doi":"10.1007/s00228-020-02998-7","title":"Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults","year":2020,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Kingston General Hospital; University of Toronto","funders":"","keywords":"Tigecycline; Dosing; Minimum inhibitory concentration; Pharmacokinetics; Volume of distribution; Pharmacodynamics; Pharmacology; Medicine; Antibiotics; Elimination rate constant; Antibacterial agent; Microbiology; Biology","score_opus":0.10090262027842452,"score_gpt":0.4359197052647506,"score_spread":0.3350170849863261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088312602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879736,0.000096481155,0.0038613887,0.006272941,0.0007657838,0.0006892807,0.000012930426,0.000006902356,0.0003207387],"genre_scores_gemma":[0.9901994,0.00008114476,0.0030153478,0.0047423095,0.0019154281,8.6177164e-7,0.0000070948195,0.000031449606,0.000006963057],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967389,0.0007685694,0.0017901892,0.00020626847,0.0003043607,0.00019170635],"domain_scores_gemma":[0.9954854,0.000858132,0.0007173906,0.000076261036,0.0025515745,0.00031123526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027694316,0.00013506688,0.00059952924,0.00008416792,0.00002838299,0.000008302205,0.000113966904,0.000053142183,0.00012869335],"category_scores_gemma":[0.0024264685,0.000110501605,0.00018045277,0.00014123869,0.00017353818,0.00008711254,0.000026527629,0.0004269069,0.000004303043],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0834239,0.004464946,0.033632196,0.0006315721,0.0011841253,0.0006464669,0.0027147608,0.24386202,0.55823696,0.000013122824,0.016034383,0.055155534],"study_design_scores_gemma":[0.059409704,0.0062205573,0.1662156,0.00041763083,0.0013030802,0.000020013815,0.00013113585,0.7550426,0.0074127405,0.0000034358206,0.0036364435,0.00018705435],"about_ca_topic_score_codex":4.3321322e-7,"about_ca_topic_score_gemma":3.7552232e-7,"teacher_disagreement_score":0.5508242,"about_ca_system_score_codex":0.000026918246,"about_ca_system_score_gemma":0.00029093956,"threshold_uncertainty_score":0.45061246},"labels":[],"label_agreement":null},{"id":"W3091490551","doi":"10.1007/s00228-020-02994-x","title":"Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review","year":2020,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Université de Genève","keywords":"Anticholinergic; Medicine; Delirium; MEDLINE; Scale (ratio); Meta-analysis; Systematic review; Clinical psychology; Intensive care medicine; Internal medicine","score_opus":0.24090878133513854,"score_gpt":0.5610527865478637,"score_spread":0.3201440052127252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091490551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079745706,0.99213594,0.00003946526,0.002190467,0.0017058133,0.0020428165,0.00009211684,0.000018266053,0.0009776818],"genre_scores_gemma":[0.0023907167,0.9665074,0.000060034898,0.029220289,0.0016225936,0.00000484713,0.00002304235,0.0001192105,0.00005189093],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96282613,0.023680924,0.012141733,0.00053624075,0.00047420838,0.0003407801],"domain_scores_gemma":[0.9634899,0.01896382,0.010628479,0.00048539892,0.0055274596,0.00090493966],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017475251,0.0007987775,0.01823855,0.0002960653,0.000034533092,0.000012511531,0.0006369638,0.00025678668,0.00014484722],"category_scores_gemma":[0.094082266,0.00039853176,0.0071777375,0.00032543583,0.00078586396,0.000052400184,0.0002246507,0.0036832425,0.00013385598],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010801664,0.00074067246,0.00043573155,0.7631854,0.012940411,0.0023123985,0.000047074507,2.6589123e-7,0.0000019508336,0.000007763213,0.027127853,0.19212036],"study_design_scores_gemma":[0.0069112875,0.010053047,0.0022599518,0.7129844,0.02757044,0.001470285,0.00016300018,0.00000465816,4.0005125e-7,0.000008362046,0.23799409,0.0005801069],"about_ca_topic_score_codex":8.402509e-7,"about_ca_topic_score_gemma":1.03425116e-7,"teacher_disagreement_score":0.21086623,"about_ca_system_score_codex":0.00005765692,"about_ca_system_score_gemma":0.0007379278,"threshold_uncertainty_score":0.99984664},"labels":[],"label_agreement":null},{"id":"W3095778807","doi":"10.1007/s00228-020-03028-2","title":"Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists","year":2020,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Dexmedetomidine; Medicine; Premedication; Sedation; Anesthesia; Bradycardia; Anesthesiology; Adverse effect; Heart rate; Internal medicine","score_opus":0.40284677103248095,"score_gpt":0.4871362729308778,"score_spread":0.08428950189839685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095778807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034405,0.0018074394,0.000025863494,0.0061800135,0.0011428073,0.00018129151,0.000030798466,0.000010339081,0.0002774186],"genre_scores_gemma":[0.9624097,0.02860758,0.0015133152,0.006141505,0.0012839271,6.35478e-7,0.000010735978,0.000025789535,0.000006862222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99058944,0.005600443,0.0028931168,0.00030339087,0.00032861004,0.00028497184],"domain_scores_gemma":[0.99222344,0.0042759557,0.0021322349,0.00014285103,0.00069524406,0.00053028256],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007577065,0.00019861887,0.0012940606,0.00021054188,0.000024895524,0.0000070996143,0.00052989257,0.00010820107,0.00027086475],"category_scores_gemma":[0.012085278,0.00015037159,0.00024486464,0.0005032882,0.0004015212,0.00029824037,0.0002148739,0.0011638703,0.00001692115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014204533,0.0016883078,0.8449766,0.000048415357,0.0003938421,0.0012904011,0.00009548909,0.00017965665,0.002290213,0.0000072032403,0.006377635,0.12844768],"study_design_scores_gemma":[0.0057058344,0.010898422,0.9464717,0.000021074244,0.00036416668,0.00004556395,0.000026596139,0.0015734343,0.00043273566,0.0000064784695,0.03432099,0.00013302173],"about_ca_topic_score_codex":0.000027998794,"about_ca_topic_score_gemma":0.0000080149075,"teacher_disagreement_score":0.12831466,"about_ca_system_score_codex":0.000024910345,"about_ca_system_score_gemma":0.00021947411,"threshold_uncertainty_score":0.9962363},"labels":[],"label_agreement":null},{"id":"W3118622903","doi":"10.1007/s00228-020-03078-6","title":"Blinding, pragmatism, and the PRECIS-2 tool for designing and assessing randomized trials","year":2021,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine; Western University","funders":"","keywords":"Blinding; Randomized controlled trial; Medicine; Research design; Pragmatism; Endpoint Determination; Clinical trial; Medical physics; Surgery; Internal medicine; Philosophy; Epistemology; Sociology","score_opus":0.8050444084390438,"score_gpt":0.7576008687410295,"score_spread":0.04744353969801429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118622903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7578981,0.0009933484,0.13176781,0.09592025,0.007934916,0.0032061792,0.000016623146,0.000023215294,0.0022395852],"genre_scores_gemma":[0.85696477,0.0027805832,0.05039564,0.084012285,0.005140243,0.00006868308,0.0000014864311,0.000041938336,0.00059436995],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.89052075,0.10289834,0.005702258,0.00022429894,0.00025198582,0.00040234358],"domain_scores_gemma":[0.7767353,0.21803486,0.0042291177,0.00009950537,0.0006242325,0.00027697594],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22529072,0.000120366196,0.0016786248,0.000075441094,0.00068987,0.00005959113,0.00021026008,0.000061959545,0.00039159963],"category_scores_gemma":[0.16301446,0.000069963644,0.00026078144,0.00013718802,0.0005637154,0.00026320704,0.00015658404,0.0009820347,0.000011888681],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1747457,0.0002948147,0.015024929,0.0010654349,0.0018980114,0.00041284543,0.033226117,0.000048394293,0.005770547,0.0048638755,0.43540055,0.32724878],"study_design_scores_gemma":[0.78308445,0.0003851286,0.010351607,0.0003607484,0.001055234,0.00014509831,0.001969041,0.0012734145,0.00024160273,0.0024228648,0.19849704,0.00021374084],"about_ca_topic_score_codex":0.0000014048046,"about_ca_topic_score_gemma":8.44992e-7,"teacher_disagreement_score":0.6083388,"about_ca_system_score_codex":0.000022795919,"about_ca_system_score_gemma":0.0010845854,"threshold_uncertainty_score":0.8440358},"labels":[],"label_agreement":null},{"id":"W3118851976","doi":"10.1007/s00228-020-03057-x","title":"A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management","year":2021,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Warfarin; Medicine; Discontinuation; Anesthesia; Ambulatory; Drug interaction; Drug; Atrial fibrillation; Pharmacology; Surgery; Internal medicine","score_opus":0.22562102041112975,"score_gpt":0.4829743637971114,"score_spread":0.25735334338598165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118851976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81438065,0.000117591444,0.0003831215,0.114829436,0.009513262,0.0003730759,0.0000026420166,0.000022764765,0.060377467],"genre_scores_gemma":[0.9849173,0.00033786704,0.0023292778,0.0029564968,0.0030146313,3.230924e-7,9.388824e-7,0.000022866687,0.006420339],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578476,0.0019902755,0.0015572498,0.00018975169,0.00031828956,0.00015965357],"domain_scores_gemma":[0.99742985,0.00094299717,0.0009676757,0.0002321096,0.00026876805,0.00015863124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023696283,0.00013540976,0.0005476294,0.000090218586,0.00007356935,0.000016294605,0.00013823259,0.00003351794,0.00095156085],"category_scores_gemma":[0.00086647266,0.00008813327,0.0005645036,0.00020824777,0.00015689683,0.00013059496,0.00026031426,0.0007488617,0.000074280564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028124012,0.0017950205,0.07883761,0.0005123598,0.0073444666,0.32486856,0.0008664259,0.00089112937,0.0022746965,0.010218458,0.38481146,0.15945582],"study_design_scores_gemma":[0.013446154,0.0017534307,0.07335189,0.00020454507,0.0022693367,0.026426286,0.0010284578,0.00009691911,0.004291561,0.00031424814,0.8766024,0.00021476281],"about_ca_topic_score_codex":8.36006e-7,"about_ca_topic_score_gemma":0.0000016363235,"teacher_disagreement_score":0.49179095,"about_ca_system_score_codex":0.00003059192,"about_ca_system_score_gemma":0.00010229282,"threshold_uncertainty_score":0.99996173},"labels":[],"label_agreement":null},{"id":"W3121068848","doi":"10.1007/s00228-020-03082-w","title":"ACE inhibitor-related angioedema in a COVID-19 patient—a plausible contribution of the viral infection?","year":2021,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Angioedema; Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Viral infection; Virology; Viral disease; Immunology; Internal medicine; Virus; Disease; Infectious disease (medical specialty)","score_opus":0.05204126737279186,"score_gpt":0.38220650479590074,"score_spread":0.3301652374231089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121068848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62608165,0.002506513,0.000087216766,0.3597172,0.010171553,0.0006345604,0.000028107843,0.000030417776,0.0007427694],"genre_scores_gemma":[0.65977216,0.00067787495,0.000069705755,0.33159867,0.0071463934,0.0000028134891,0.000069116926,0.00006544892,0.00059783505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901447,0.0046785926,0.0037801098,0.00038640833,0.000593905,0.0004162288],"domain_scores_gemma":[0.9938575,0.0015771225,0.003329445,0.00025779475,0.00066456175,0.0003135724],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032893908,0.0003418364,0.0015349081,0.00033239077,0.00010136818,0.000021953208,0.00030207826,0.00054353225,0.001074114],"category_scores_gemma":[0.0030969838,0.000253289,0.001228685,0.0005284646,0.0004460006,0.00013943398,0.00020921681,0.0037763102,0.000028282522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010120583,0.0005526064,0.095148236,0.00015125284,0.0006955365,0.003966255,0.00022764743,0.00025180532,0.0007179972,0.000013196401,0.8953472,0.0019162492],"study_design_scores_gemma":[0.01332409,0.0017858823,0.101222135,0.00077823363,0.0010274191,0.001095629,0.000020093585,0.00009859281,0.000853333,0.00008616788,0.8794493,0.00025913506],"about_ca_topic_score_codex":0.000024221283,"about_ca_topic_score_gemma":0.000009309349,"teacher_disagreement_score":0.033690482,"about_ca_system_score_codex":0.00020977203,"about_ca_system_score_gemma":0.0013847644,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W3161195859","doi":"10.1007/s00228-021-03137-6","title":"Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age","year":2021,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"","keywords":"Medicine; Levonorgestrel; Gallbladder disease; Cholecystectomy; Gynecology; Population; Hormonal contraception; Medroxyprogesterone acetate; Polycystic ovarian disease; Obstetrics; Family planning; Internal medicine; Estrogen; Polycystic ovary","score_opus":0.0778974190953614,"score_gpt":0.37734899740626204,"score_spread":0.29945157831090063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161195859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970192,0.00059778016,0.000021876278,0.0016777056,0.0002251451,0.00012975044,0.000017308019,0.0000016213073,0.00030964907],"genre_scores_gemma":[0.9967263,0.002348017,0.00019365882,0.00022383712,0.00040815532,5.0966e-7,0.0000013542711,0.000009502782,0.00008867711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528414,0.002783062,0.0014398795,0.00014316983,0.00021803279,0.0001317177],"domain_scores_gemma":[0.99566865,0.0019510441,0.0016756094,0.000108953776,0.00051462045,0.000081102386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047786417,0.000077570105,0.00073124317,0.000076555225,0.000013674643,0.0000030550061,0.000092780894,0.000044871256,0.00008191655],"category_scores_gemma":[0.004565557,0.000052618132,0.00016646061,0.00016082187,0.00028366904,0.00006918797,0.000056506935,0.00064661633,6.6769445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025075444,0.0006742241,0.9575477,0.000054168548,0.0018511997,0.00020885149,0.0018953586,0.000038884013,0.016640874,0.0000021062417,0.0033356752,0.015243404],"study_design_scores_gemma":[0.0080261165,0.0013205359,0.9822616,0.000052004987,0.00057076773,0.000018489216,0.0004704851,0.0000058446726,0.0032144005,0.000040111277,0.003979561,0.000040095005],"about_ca_topic_score_codex":0.0000050431677,"about_ca_topic_score_gemma":0.000001363365,"teacher_disagreement_score":0.024713878,"about_ca_system_score_codex":0.00002236199,"about_ca_system_score_gemma":0.00012576555,"threshold_uncertainty_score":0.5465728},"labels":[],"label_agreement":null},{"id":"W3185760221","doi":"10.1007/s00228-021-03177-y","title":"Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis","year":2021,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Aspirin; Medicine; Pharmacodynamics; Internal medicine; Thromboxane B2; Pharmacology; Gastroenterology; Pharmacokinetics; Platelet","score_opus":0.022003987445535115,"score_gpt":0.3196779995525838,"score_spread":0.2976740121070487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185760221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759156,0.00081546564,0.00019852168,0.00012890116,0.0006641085,0.0002474652,0.0000047201734,0.000009303329,0.00033997156],"genre_scores_gemma":[0.99720776,0.00057997415,0.00040040127,0.0013044172,0.0004231103,0.0000012325811,0.000010596255,0.00004022522,0.000032281587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647325,0.0017508758,0.0009936416,0.00020772878,0.00036883695,0.00020568176],"domain_scores_gemma":[0.99824584,0.00038134324,0.0005792672,0.00015441462,0.00039039034,0.00024874372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009032693,0.00016745157,0.00097287894,0.00009289421,0.000023193266,0.0000047885337,0.0001574459,0.000038399885,0.00016084098],"category_scores_gemma":[0.00007455967,0.00011522381,0.0003504332,0.00021816032,0.00024347602,0.000082829894,0.000047962752,0.0005842801,0.0000093203425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018049499,0.0032653697,0.94730985,0.00018869364,0.0025643883,0.00555579,0.00007149984,0.00030431777,0.0029233133,0.0000011245771,0.00060724857,0.01915891],"study_design_scores_gemma":[0.052121148,0.0043963664,0.9382417,0.00045238956,0.00095643336,0.00015457436,0.000021031407,0.000024786284,0.00211255,0.0000012488903,0.0014014365,0.00011628841],"about_ca_topic_score_codex":6.389493e-7,"about_ca_topic_score_gemma":5.095949e-7,"teacher_disagreement_score":0.03407165,"about_ca_system_score_codex":0.000023835424,"about_ca_system_score_gemma":0.00023466542,"threshold_uncertainty_score":0.46986908},"labels":[],"label_agreement":null},{"id":"W3202945239","doi":"10.1007/s00228-021-03229-3","title":"Response to letter regarding the article “Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age”","year":2021,"lang":"en","type":"letter","venue":"European Journal of Clinical Pharmacology","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cholecystectomy; Family planning; Gynecology; Hormone; Obstetrics; Population; Research methodology; Endocrinology; Internal medicine; Environmental health","score_opus":0.10069867842230304,"score_gpt":0.3924671367556461,"score_spread":0.2917684583333431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202945239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67692417,0.0003597687,0.00003813179,0.32183328,0.00041426357,0.0003856066,0.000016476499,0.0000018785561,0.000026381656],"genre_scores_gemma":[0.8893343,0.00084639335,0.00020143331,0.10010225,0.00916066,0.0000063669504,0.0000023911014,0.00003285388,0.00031330457],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9814491,0.014944708,0.0024862872,0.00035914095,0.00046478372,0.00029597277],"domain_scores_gemma":[0.98812443,0.0069401264,0.0035940567,0.0003331133,0.00090206054,0.00010619716],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.020300785,0.00016473618,0.0012462946,0.00018002454,0.000043061973,0.000009963223,0.00019625788,0.00015947943,0.000036790847],"category_scores_gemma":[0.015162649,0.000099134755,0.00027552326,0.0002555536,0.00038237358,0.000095914766,0.0000939354,0.0029833044,0.0000020825935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04403555,0.00037939416,0.22025207,0.00022140863,0.0029393015,0.0010980038,0.005126946,0.00011331755,0.03903629,6.7129633e-7,0.6634603,0.02333677],"study_design_scores_gemma":[0.0048280987,0.0016911994,0.7605807,0.0001883247,0.000596643,0.000031803407,0.00013380508,0.000003359597,0.001200853,0.000011562676,0.23066545,0.000068218884],"about_ca_topic_score_codex":0.000008829728,"about_ca_topic_score_gemma":6.1655396e-7,"teacher_disagreement_score":0.5403286,"about_ca_system_score_codex":0.00011229843,"about_ca_system_score_gemma":0.00021595777,"threshold_uncertainty_score":0.9993169},"labels":[],"label_agreement":null},{"id":"W3211121827","doi":"10.1007/s00228-021-03244-4","title":"Trends and variation in benzodiazepine use in nursing homes in the USA","year":2021,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Drug Abuse; National Institute on Aging; National Institutes of Health","keywords":"Benzodiazepine; Medicine; Nursing homes; Minimum Data Set; Quarter (Canadian coin); Long-term care; Logistic regression; Demography; Emergency medicine; Psychiatry; Nursing; Internal medicine; Geography","score_opus":0.08290988621651407,"score_gpt":0.4513624424952605,"score_spread":0.3684525562787464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211121827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775311,0.0013136674,0.00004027498,0.0070741656,0.0025839782,0.000044491266,9.704453e-7,0.000002536655,0.01140882],"genre_scores_gemma":[0.99575627,0.0009823545,0.00012943732,0.0025771847,0.00038480465,6.643473e-7,0.0000012302913,0.0000120265595,0.00015600424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928786,0.0054638246,0.0011737203,0.00018060289,0.0000965543,0.000206673],"domain_scores_gemma":[0.998075,0.0014060551,0.00032051044,0.000090752095,0.000041646264,0.000066054905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035512545,0.0000905104,0.00032017165,0.00032935367,0.000019197034,0.000017799788,0.0001717399,0.00008316005,0.00081338995],"category_scores_gemma":[0.00039632115,0.000066639346,0.000089086694,0.0004788215,0.00012238156,0.000108401524,0.000022998489,0.0011214907,0.000024817675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001531787,0.004145645,0.60904914,0.0000056578574,0.00026739112,0.012145595,0.008994056,0.0005846664,0.00067273376,0.00060221134,0.016012372,0.34598875],"study_design_scores_gemma":[0.008614863,0.0002734229,0.9851065,0.00004672403,0.00006851311,0.00018585486,0.00032369414,0.000059607086,0.0000032904823,0.0001383301,0.0051099784,0.00006918917],"about_ca_topic_score_codex":0.000012014597,"about_ca_topic_score_gemma":0.00007204508,"teacher_disagreement_score":0.3760574,"about_ca_system_score_codex":0.000017225182,"about_ca_system_score_gemma":0.000037342517,"threshold_uncertainty_score":0.8906049},"labels":[],"label_agreement":null},{"id":"W333819909","doi":"10.1007/s00228-015-1860-9","title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries","year":2015,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":489,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sahlgrenska Akademin; Tartu Ülikool; Turun Yliopisto; Universitair Medisch Centrum Groningen; Université de Toulouse; Göteborgs Universitet; Karolinska Institutet; Lunds Universitet; Örebro Universitet; Stockholms Universitet; Vrije Universiteit Amsterdam","keywords":"European union; Delphi method; Medicine; German; Family medicine; Delphi; Older people; Clinical Practice; Gerontology; Geography; Business; Computer science","score_opus":0.16637360541060442,"score_gpt":0.47310897520885553,"score_spread":0.3067353697982511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W333819909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.854418,0.004404954,0.006337919,0.113557994,0.009421994,0.0011993952,0.00019148264,0.000051658568,0.010416612],"genre_scores_gemma":[0.9831547,0.0015658274,0.0009757451,0.011346197,0.0020694346,0.0000037117682,0.00004020824,0.000055516106,0.0007886521],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933974,0.0033046643,0.0022490167,0.00024159974,0.00050001097,0.00030726753],"domain_scores_gemma":[0.9914888,0.0047142333,0.0019148448,0.00023741784,0.0009489263,0.0006957751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007042041,0.00019646059,0.000741847,0.00006222521,0.00014587044,0.000034933477,0.0005039729,0.000057673067,0.00031675067],"category_scores_gemma":[0.003009125,0.00012548677,0.00037507326,0.00012622355,0.0005565756,0.00015092806,0.00015005343,0.000677836,0.000042397794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014647199,0.0019555935,0.017758546,0.00008797578,0.0027215842,0.00041920922,0.0027149823,0.000015779828,0.0045659686,0.00008875237,0.9401818,0.014842605],"study_design_scores_gemma":[0.015567933,0.0019207036,0.009575902,0.00008641758,0.0015471627,0.00010425117,0.0005947216,0.0005530926,0.000540963,0.000050198385,0.9693063,0.00015237779],"about_ca_topic_score_codex":0.00001349965,"about_ca_topic_score_gemma":0.000004364071,"teacher_disagreement_score":0.12873672,"about_ca_system_score_codex":0.000030365605,"about_ca_system_score_gemma":0.00039873965,"threshold_uncertainty_score":0.51172024},"labels":[],"label_agreement":null},{"id":"W4221096369","doi":"10.1007/s00228-021-03260-4","title":"Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database","year":2022,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Statistics Canada; Institut du Savoir Montfort; Canadian Physiotherapy Association; NOSM University; Ottawa Public Health; University of Ottawa","funders":"University of Ottawa","keywords":"Nested case-control study; Medicine; Moxifloxacin; Levofloxacin; Population; Ciprofloxacin; Quinolone; Cohort; Case-control study; Database; Internal medicine; Pediatrics; Antibiotics; Environmental health","score_opus":0.06502889867511136,"score_gpt":0.42526746659212133,"score_spread":0.36023856791701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221096369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347824,0.0030297928,0.00080397207,0.0004980595,0.0013574236,0.00073566136,0.00005122026,0.000012094989,0.000033542354],"genre_scores_gemma":[0.9953581,0.0023173476,0.00036541483,0.0010073977,0.00088478776,0.0000010904682,0.0000023921052,0.00003982079,0.00002364706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9893304,0.00709239,0.0024946388,0.0003112157,0.00035926947,0.00041205093],"domain_scores_gemma":[0.9960482,0.00064372603,0.0024718232,0.00020325044,0.00022655215,0.00040646124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01142781,0.00019614906,0.0011398768,0.00022193154,0.00022213257,0.000008650501,0.00021321581,0.000023196873,0.0002098198],"category_scores_gemma":[0.00025484522,0.00016685831,0.0002369504,0.00021055675,0.00015642255,0.000044647648,0.00023068342,0.0016912097,0.0000019237702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024879312,0.0076646875,0.87033296,0.0003422161,0.005137441,0.044529464,0.0013252748,0.0027227765,0.010175581,0.000012868053,0.0037462427,0.02913117],"study_design_scores_gemma":[0.12571196,0.09380178,0.57541496,0.00041185456,0.015172608,0.1475847,0.00408566,0.028553866,0.00022269181,0.000008976493,0.0083486205,0.0006822915],"about_ca_topic_score_codex":0.000055559278,"about_ca_topic_score_gemma":0.0000039772726,"teacher_disagreement_score":0.294918,"about_ca_system_score_codex":0.000109816836,"about_ca_system_score_gemma":0.000562416,"threshold_uncertainty_score":0.7347559},"labels":[],"label_agreement":null},{"id":"W4233366311","doi":"10.1007/s00228-019-02710-4","title":"Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement","year":2019,"lang":"en","type":"erratum","venue":"European Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Toxic epidermal necrolysis; Drug; Adverse drug reaction; Causality (physics); Dermatology; Drug reaction; Medicine; Pharmacology; Intensive care medicine","score_opus":0.08059287545656225,"score_gpt":0.4293442888033986,"score_spread":0.34875141334683635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233366311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5130068,0.00028968652,0.0025441803,0.014375878,0.44502884,0.008862862,0.00032240996,0.0001524836,0.015416828],"genre_scores_gemma":[0.83907557,0.0017944212,0.003647443,0.00910347,0.031361394,0.00022828112,0.0005688161,0.00053125503,0.113689385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918493,0.0017533106,0.003943348,0.0010289216,0.00065428764,0.00077079976],"domain_scores_gemma":[0.98938733,0.0039206315,0.0039051832,0.0005479724,0.0012181329,0.0010207734],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009244266,0.000686518,0.0027430183,0.0006080419,0.00023307423,0.00006831787,0.00038238626,0.00035165975,0.000041261137],"category_scores_gemma":[0.0032428252,0.00062839716,0.0014639031,0.00024916616,0.00009175822,0.00054494286,0.0001935144,0.0038810375,0.00006111359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016219913,0.0012717389,0.000111157766,0.00048191837,0.0023556573,0.0004963358,0.00009276453,0.000079678764,0.02394442,0.0000035929947,0.8331123,0.13642846],"study_design_scores_gemma":[0.014875755,0.0043577403,0.06270834,0.0009692109,0.005568129,0.0011376737,0.00044983756,0.000720805,0.0006844696,0.000010732515,0.90787435,0.0006429365],"about_ca_topic_score_codex":0.00002201615,"about_ca_topic_score_gemma":0.000018502165,"teacher_disagreement_score":0.41366744,"about_ca_system_score_codex":0.0008368343,"about_ca_system_score_gemma":0.0017125135,"threshold_uncertainty_score":0.99961674},"labels":[],"label_agreement":null},{"id":"W4236318971","doi":"10.1007/s00228-011-1090-8","title":"Comparative adherence to oxybutynin or tolterodine among older patients","year":2011,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Tolterodine; Oxybutynin; Discontinuation; Medicine; Tolerability; Persistence (discontinuity); Retrospective cohort study; Cohort; Internal medicine; Adverse effect; Overactive bladder","score_opus":0.34816122574491726,"score_gpt":0.507473786028481,"score_spread":0.15931256028356378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236318971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755322,0.00005263228,0.00021091742,0.000356571,0.0014029429,0.00036983096,0.0000056404037,0.0000129636755,0.02205632],"genre_scores_gemma":[0.99370426,0.0001129852,0.0012120398,0.0021286893,0.00095030543,0.0000021023832,0.0000024984863,0.000023548226,0.0018635977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610394,0.0016598526,0.0013753634,0.00022439782,0.00031161093,0.00032486152],"domain_scores_gemma":[0.9976042,0.00040555696,0.00042619836,0.00013011876,0.0006215193,0.0008124276],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023314082,0.00015236069,0.00071517663,0.00014996843,0.0000486094,0.000009140858,0.00031848287,0.000039262144,0.005528633],"category_scores_gemma":[0.00037487436,0.000099158286,0.0001977721,0.00018833809,0.00023466538,0.00012608757,0.00015683322,0.00092127314,0.00046387006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033836856,0.005688217,0.55350155,0.00007944684,0.0009306804,0.008252761,0.0047992975,0.0000063213965,0.001379202,0.000004127607,0.35203746,0.03948409],"study_design_scores_gemma":[0.008965462,0.029671226,0.94056517,0.0000957227,0.00016142918,0.000119541124,0.00009530453,0.000020056452,0.0023253495,0.0000060652715,0.017849768,0.00012491412],"about_ca_topic_score_codex":0.0000028935137,"about_ca_topic_score_gemma":0.000001410829,"teacher_disagreement_score":0.38706362,"about_ca_system_score_codex":0.000019238567,"about_ca_system_score_gemma":0.00016181654,"threshold_uncertainty_score":0.99538046},"labels":[],"label_agreement":null},{"id":"W4288060488","doi":"10.1007/s00228-022-03368-1","title":"Attitudes and beliefs of older adults and caregivers towards deprescribing in French-speaking countries: a multicenter cross-sectional study","year":2022,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski; Institute of Aging; Quebec Network for Research on Aging; Université Laval","funders":"","keywords":"Deprescribing; Medicine; Cross-sectional study; Logistic regression; Multicenter study; Multivariate analysis; Gerontology; Polypharmacy; Randomized controlled trial; Internal medicine","score_opus":0.1319646972161337,"score_gpt":0.47342935049367674,"score_spread":0.34146465327754305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288060488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963972,0.0008586389,0.000016544636,0.00045354682,0.0014286316,0.00035629765,0.00001014093,0.0000057324073,0.00047325648],"genre_scores_gemma":[0.9978289,0.0003145689,0.0001386014,0.0013241881,0.0003446444,0.0000020178497,0.0000012366538,0.00001579274,0.000030042002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963735,0.0014349376,0.001383597,0.00023772028,0.0003850044,0.00018524668],"domain_scores_gemma":[0.99773854,0.0010912841,0.00070412026,0.00007276791,0.00018396844,0.00020931922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036680026,0.0001225609,0.0005089532,0.00015434627,0.00009861714,0.000017196136,0.00014188973,0.000025600788,0.0005758837],"category_scores_gemma":[0.0005426461,0.000102597114,0.00011541746,0.000096074225,0.0002332474,0.00017540585,0.0002989847,0.0010764375,0.0000016113797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004298553,0.0012898364,0.9870348,0.000111418834,0.00027859665,0.0010579432,0.0028713741,0.00008449339,0.000090297166,0.0000014616679,0.00018126494,0.0026999405],"study_design_scores_gemma":[0.02159893,0.0025142266,0.97054935,0.00007055552,0.00015913925,0.00018427064,0.0007085222,0.00033847624,0.00001989926,0.0000010934059,0.0037728688,0.0000826908],"about_ca_topic_score_codex":0.000039605067,"about_ca_topic_score_gemma":0.000006506139,"teacher_disagreement_score":0.017300377,"about_ca_system_score_codex":0.00004119772,"about_ca_system_score_gemma":0.00008809954,"threshold_uncertainty_score":0.6305523},"labels":[],"label_agreement":null},{"id":"W4293093355","doi":"10.1007/s00228-022-03374-3","title":"Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies","year":2022,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Università di Catania; McGill University","keywords":"Medicine; Ketamine; Population; Prospective cohort study; Emergency department; Randomized controlled trial; Clinical trial; Dosing; Adverse effect; Asthma; Systematic review; Intensive care medicine; Internal medicine; Anesthesia; MEDLINE","score_opus":0.164892249030505,"score_gpt":0.4555735384581788,"score_spread":0.2906812894276738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293093355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016846756,0.9952276,0.0000016512713,0.00002851487,0.0006231552,0.0022317758,0.000046580935,0.0000055437044,0.00015049873],"genre_scores_gemma":[0.0004218841,0.9984053,0.00009844857,0.0005413713,0.00028237212,0.000023310842,0.000016243608,0.000061112725,0.00014998858],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98544335,0.0077489982,0.0057645873,0.00027265752,0.00060046604,0.000169967],"domain_scores_gemma":[0.9879155,0.0029749775,0.007665686,0.0003017787,0.0009518596,0.00019019624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038125082,0.0003354001,0.0067010783,0.00033684867,0.000028846576,0.0000027578935,0.0002977381,0.00006401868,0.0003750235],"category_scores_gemma":[0.0062578814,0.00019306393,0.0009868164,0.00043838605,0.00032167762,0.00011526178,0.000157602,0.0012378696,0.000007759243],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074626174,0.0022647954,0.0021679425,0.92556566,0.002963579,0.00074387103,0.00004539777,0.000002469698,1.0745313e-7,0.00000130232,0.0040954035,0.06140322],"study_design_scores_gemma":[0.0031737008,0.006662164,0.0049105817,0.5748483,0.009436937,0.000090368645,0.00004167809,1.977518e-7,1.3475021e-7,4.4307484e-7,0.4006711,0.00016443842],"about_ca_topic_score_codex":1.6838422e-7,"about_ca_topic_score_gemma":1.1663951e-7,"teacher_disagreement_score":0.3965757,"about_ca_system_score_codex":0.0001404202,"about_ca_system_score_gemma":0.00078636035,"threshold_uncertainty_score":0.7872918},"labels":[],"label_agreement":null},{"id":"W4309271384","doi":"10.1007/s00228-022-03418-8","title":"Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service—a cross-sectional study of patients in a Canadian Health Region","year":2022,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Pfizer Canada; Bayer Canada","keywords":"Medicine; Warfarin; Cross-sectional study; Atrial fibrillation; Thrombosis; Logistic regression; Anticoagulant; Internal medicine; Apixaban; Rivaroxaban; Emergency medicine","score_opus":0.3919679520637401,"score_gpt":0.5230460538148225,"score_spread":0.13107810175108242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309271384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941398,0.000024205096,0.0000013769508,0.0013934239,0.0031083468,0.00085579255,0.000005652517,0.000009398394,0.0004620066],"genre_scores_gemma":[0.9974615,0.00013984491,0.0000879005,0.001728061,0.0005207238,0.0000015214598,0.000008429521,0.000018304672,0.00003371545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99440163,0.002477627,0.002197415,0.00023264541,0.00040962308,0.00028105022],"domain_scores_gemma":[0.99802065,0.00031686938,0.0010016824,0.00011737769,0.00021590474,0.00032752458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042240154,0.00012125203,0.00083640486,0.00049822876,0.00007721764,0.000009915119,0.0002084467,0.00002532003,0.00039736644],"category_scores_gemma":[0.00034345218,0.000109693196,0.00014438543,0.00066681387,0.000025057132,0.00006686576,0.00010623804,0.00046569147,0.000007125413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010612238,0.00074304105,0.9834911,0.00001151022,0.00038127284,0.00040181237,0.0007290781,0.00056412234,0.00001283125,0.0000013235572,0.0010752028,0.001976451],"study_design_scores_gemma":[0.031880002,0.009967226,0.9495822,0.000010604179,0.00005700097,0.0000059164286,0.00011570811,0.000070729824,0.0000029007808,0.0000017940192,0.008228171,0.00007769872],"about_ca_topic_score_codex":0.011112221,"about_ca_topic_score_gemma":0.01598685,"teacher_disagreement_score":0.03390887,"about_ca_system_score_codex":0.00027227952,"about_ca_system_score_gemma":0.000479797,"threshold_uncertainty_score":0.99547285},"labels":[],"label_agreement":null},{"id":"W4313545666","doi":"10.1007/s00228-022-03440-w","title":"Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase","year":2023,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pharmacovigilance; Medicine; Odds ratio; Adverse effect; Confidence interval; Internal medicine; Concomitant","score_opus":0.07830385741918297,"score_gpt":0.4469132733492375,"score_spread":0.3686094159300546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313545666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932995,0.0011924792,0.000016708085,0.0042647123,0.00044264013,0.0002944742,0.000016818205,0.00001149925,0.00046119015],"genre_scores_gemma":[0.9848893,0.013077209,0.00018238607,0.0014574305,0.00016754489,0.000004626613,0.000003506775,0.000015543934,0.00020239923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995309,0.0025076817,0.001618795,0.00018038275,0.00015196967,0.00023219909],"domain_scores_gemma":[0.9965338,0.0019139532,0.0010089834,0.00014199647,0.00010606533,0.0002952143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043583564,0.0001383557,0.0010865305,0.00025548972,0.00004582303,0.0000047880317,0.00010489018,0.00003254966,0.00006126965],"category_scores_gemma":[0.00043108437,0.00007598559,0.00040968173,0.0006864786,0.00032772435,0.000042678457,0.00004663423,0.00043580672,0.000033602828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014588507,0.0011130668,0.9228002,0.000043509273,0.0042416523,0.0020139404,0.00042041347,0.00022559833,0.0005621655,0.000003443571,0.0020673072,0.051920235],"study_design_scores_gemma":[0.057502918,0.0032437874,0.9240235,0.000048177764,0.0070662117,0.00009854581,0.000054891465,0.0012822042,0.00037510338,0.000018605413,0.0062155006,0.00007056134],"about_ca_topic_score_codex":0.000040437488,"about_ca_topic_score_gemma":0.000014830115,"teacher_disagreement_score":0.051849674,"about_ca_system_score_codex":0.000030344108,"about_ca_system_score_gemma":0.00012850524,"threshold_uncertainty_score":0.30986023},"labels":[],"label_agreement":null},{"id":"W4318067206","doi":"10.1007/s00228-023-03454-y","title":"The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review","year":2023,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; Canada Research Chairs; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Cannabidiol; Cannabis; Cognition; Medicine; Tetrahydrocannabinol; Pharmacology; Cannabinoid; Clinical trial; Internal medicine; Psychiatry","score_opus":0.11622488925082894,"score_gpt":0.5028555411142079,"score_spread":0.38663065186337897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318067206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004818385,0.98542756,0.0000023439118,0.0046566837,0.0034285942,0.0043120133,0.000034661938,0.000034042576,0.0020558974],"genre_scores_gemma":[0.00005069366,0.98949414,0.0000044270632,0.0011715551,0.0033140203,0.00011095274,0.000016742235,0.00018829177,0.0056491625],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9719082,0.018156469,0.00756625,0.00047993855,0.0012678957,0.00062124414],"domain_scores_gemma":[0.9885834,0.003690121,0.005474618,0.0006981041,0.00082679547,0.00072697975],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.028270256,0.000649463,0.008922985,0.0004007936,0.00014587471,0.00003421353,0.0011998576,0.00023022709,0.00021552858],"category_scores_gemma":[0.013342035,0.00031576143,0.0043443805,0.0008492392,0.00067363406,0.00004759467,0.00023547946,0.0038861658,0.00073273043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047953904,0.00013438093,8.771923e-7,0.5289267,0.002220798,0.0022583855,0.000004008704,2.1712655e-7,0.0000024026454,0.0000039750926,0.38372493,0.08224381],"study_design_scores_gemma":[0.0019333158,0.008177233,0.000010982204,0.3552136,0.014685947,0.0012535241,0.000003516448,8.414049e-7,0.000009463412,0.0000014181242,0.6185459,0.00016425758],"about_ca_topic_score_codex":4.2215933e-7,"about_ca_topic_score_gemma":2.986599e-7,"teacher_disagreement_score":0.23482096,"about_ca_system_score_codex":0.000117016825,"about_ca_system_score_gemma":0.0013113667,"threshold_uncertainty_score":0.9999294},"labels":[],"label_agreement":null},{"id":"W4405621629","doi":"10.1007/s00228-024-03786-3","title":"A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress","year":2024,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Fondation Institut de Cardiologie de Montréal","keywords":"Pharmacogenomics; Medicine; Dosing; Drug; Cohort; Pharmacogenetics; Pharmacology; Regimen; Cohort study; Adverse effect; Population; Internal medicine; Genotype; Environmental health; Biology","score_opus":0.2332271823783899,"score_gpt":0.5520659957347568,"score_spread":0.3188388133563669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405621629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859471,0.0037765687,0.000002587774,0.006846634,0.0019656196,0.0012267419,0.0000044996086,0.000004697004,0.00022556235],"genre_scores_gemma":[0.9976861,0.0008092271,0.00009010264,0.0006021278,0.00076661934,0.000006894292,7.1270046e-7,0.000015643463,0.000022585722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9822275,0.01570561,0.0012146102,0.00026652758,0.00036771665,0.00021804946],"domain_scores_gemma":[0.99437094,0.0049233115,0.00025442336,0.00016609443,0.00015299463,0.00013221963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023083616,0.00012159942,0.00063383416,0.00014233711,0.00007076079,0.000014599248,0.00023697643,0.000045728135,0.000009071646],"category_scores_gemma":[0.0007296181,0.00006394249,0.00011525688,0.00023955824,0.0008387162,0.000049334132,0.00011205616,0.0015372128,9.776686e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033079956,0.000991804,0.9082147,0.00029890848,0.00064629683,0.0013883908,0.0130309835,0.00002711984,0.00077942654,0.000024001323,0.006757311,0.0645331],"study_design_scores_gemma":[0.010594238,0.020312985,0.95176697,0.0002327617,0.00065001415,0.0006126277,0.0034986162,0.00020136096,0.0019749622,0.000035491696,0.010028417,0.00009158524],"about_ca_topic_score_codex":0.000026964957,"about_ca_topic_score_gemma":0.000008364168,"teacher_disagreement_score":0.06444151,"about_ca_system_score_codex":0.000022557462,"about_ca_system_score_gemma":0.00019477113,"threshold_uncertainty_score":0.80003667},"labels":[],"label_agreement":null},{"id":"W4408679963","doi":"10.1007/s00228-025-03817-7","title":"Influence of cigarette smoking on drugs’ metabolism and effects: a systematic review","year":2025,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacokinetics; Jadad scale; Pharmacodynamics; Pharmacology; Observational study; Drug; Meta-analysis; Internal medicine","score_opus":0.14036840201208808,"score_gpt":0.5251490608771655,"score_spread":0.3847806588650774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408679963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014397127,0.9861194,0.000011937273,0.0002974067,0.0074635088,0.002381941,0.00009787411,0.00003010859,0.0021581366],"genre_scores_gemma":[0.0008980474,0.9789481,0.00005628052,0.01798867,0.0017085521,0.00004890577,0.000008377822,0.00010472836,0.00023831375],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9603912,0.029553285,0.008124574,0.0006957568,0.0005831707,0.0006520136],"domain_scores_gemma":[0.97510105,0.014738159,0.00822875,0.00050470344,0.0006506452,0.00077667757],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.021074831,0.0009788574,0.010137129,0.0007208139,0.00014956301,0.000022710277,0.0018295834,0.00055558933,0.0001660003],"category_scores_gemma":[0.0048032966,0.000718465,0.0021659762,0.00068545836,0.00066301215,0.00012349505,0.00055672514,0.005638361,0.00005147799],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019692081,0.00049637206,0.0000041202734,0.70622337,0.0056040008,0.00074716046,0.00007285392,0.000054292763,0.000019922627,0.00009313049,0.01240553,0.27408233],"study_design_scores_gemma":[0.0026625993,0.00033817737,0.000022659093,0.25739187,0.049041014,0.00016758018,0.0000034756367,0.00000671682,0.000064020176,0.000025082112,0.6898562,0.0004206544],"about_ca_topic_score_codex":4.8612344e-7,"about_ca_topic_score_gemma":4.249315e-8,"teacher_disagreement_score":0.67745066,"about_ca_system_score_codex":0.000049045528,"about_ca_system_score_gemma":0.0007300733,"threshold_uncertainty_score":0.9995266},"labels":[],"label_agreement":null},{"id":"W4409471102","doi":"10.1007/s00228-025-03826-6","title":"Letter to the editor: Relevant errors in a systematic review and network meta-analysis evaluating the efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia","year":2025,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Teva Pharmaceutical Industries","keywords":"Tardive dyskinesia; Meta-analysis; Dyskinesia; Psychological intervention; Medicine; Systematic review; MEDLINE; Pharmacology; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Biology","score_opus":0.32428193215356516,"score_gpt":0.545004204868117,"score_spread":0.2207222727145518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409471102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092688657,0.98254645,0.000018979537,0.010787672,0.0006038255,0.0050646747,0.00002483602,0.0000021561711,0.000024548433],"genre_scores_gemma":[0.0039008078,0.99257475,0.00013686484,0.001627567,0.0015002985,0.00018797103,0.000007689058,0.00001531597,0.000048721304],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9666178,0.027385006,0.0049039386,0.00033020758,0.0004902287,0.0002727902],"domain_scores_gemma":[0.9810997,0.015902689,0.0022710261,0.00037261643,0.00019335786,0.0001605772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015691975,0.00037251526,0.0076932814,0.0002846215,0.000066320405,0.000013183038,0.00053093076,0.000072009985,0.00012604862],"category_scores_gemma":[0.0021572977,0.00012028541,0.0036448818,0.0008140577,0.00025324072,0.00001949092,0.00017874766,0.0010629682,0.0000032003045],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008529941,0.007702243,0.00028159,0.322998,0.50706255,0.0017494917,0.0006953344,0.0002248531,0.0000013311505,0.0000318967,0.036442775,0.11428003],"study_design_scores_gemma":[0.005277324,0.0064744917,0.00257181,0.041909385,0.91767895,0.00010888267,0.00002704682,0.000027007976,2.2712547e-7,0.000008065822,0.02579714,0.000119653916],"about_ca_topic_score_codex":0.0000027393694,"about_ca_topic_score_gemma":0.000015235335,"teacher_disagreement_score":0.41061643,"about_ca_system_score_codex":0.00008342745,"about_ca_system_score_gemma":0.00019334047,"threshold_uncertainty_score":0.54385567},"labels":[],"label_agreement":null},{"id":"W4411363608","doi":"10.1007/s00228-025-03862-2","title":"Trends in adverse drug reaction reporting in eight selected countries after the implementation of new pharmacovigilance regulation in 2012: a joinpoint regression analysis","year":2025,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"College ter Beoordeling van Geneesmiddelen","keywords":"Pharmacovigilance; Drug; Drug reaction; Pharmacology; Adverse drug reaction; Medicine; Adverse effect","score_opus":0.10941987005096443,"score_gpt":0.5280481886088624,"score_spread":0.41862831855789795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411363608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98963135,0.0007147235,0.00010334456,0.005100486,0.002571306,0.0003107557,0.000017330822,0.000016339856,0.0015343523],"genre_scores_gemma":[0.9944994,0.0017562462,0.00008584063,0.0021495426,0.0005489487,0.000013138168,0.000025681837,0.000019033128,0.00090217136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98929405,0.004369135,0.005231208,0.00038778933,0.00026916596,0.00044864492],"domain_scores_gemma":[0.99382955,0.0010918843,0.0044371067,0.00018254355,0.0002921262,0.0001668031],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010263833,0.00027201918,0.00099898,0.0018317763,0.0000847592,0.000010888249,0.00036322785,0.000139437,0.001380662],"category_scores_gemma":[0.00038287748,0.00021483035,0.0004376557,0.0032114107,0.00020194988,0.0005627184,0.00009325914,0.0021579235,0.00001209757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008851865,0.0008414615,0.8624148,0.00005652659,0.0010337874,0.000896258,0.001837851,0.010528653,0.039142523,0.000025370164,0.038114622,0.036256272],"study_design_scores_gemma":[0.0098630935,0.00009497114,0.9118569,0.00011373506,0.0010484622,0.0000289547,0.00043225448,0.0018000206,0.011704531,0.000063320076,0.062809244,0.00018452335],"about_ca_topic_score_codex":0.00009006912,"about_ca_topic_score_gemma":0.0004706721,"teacher_disagreement_score":0.049442083,"about_ca_system_score_codex":0.0002264981,"about_ca_system_score_gemma":0.00046940224,"threshold_uncertainty_score":0.9995322},"labels":[],"label_agreement":null},{"id":"W4412486364","doi":"10.1007/s00228-025-03883-x","title":"Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies","year":2025,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Ottawa; McGill University","funders":"Charité – Universitätsmedizin Berlin; Deutsche Forschungsgemeinschaft","keywords":"Concomitant; Medicine; Observational study; Stroke (engine); Intensive care medicine; MEDLINE; Internal medicine; Pharmacology","score_opus":0.3887247070336716,"score_gpt":0.5415644067133302,"score_spread":0.15283969967965855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412486364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028045038,0.9943201,0.000026625105,0.00017895874,0.0008312429,0.0017130151,0.00003792863,0.000004173477,0.00008343538],"genre_scores_gemma":[0.0027972981,0.9963694,0.0002865396,0.00017515666,0.00027307452,0.0000011809143,0.000006724345,0.000019493345,0.00007112652],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9872389,0.006993122,0.005166088,0.00020332505,0.0002870562,0.0001114969],"domain_scores_gemma":[0.97848475,0.015305969,0.005282895,0.00015679329,0.000679332,0.00009023265],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009672489,0.00025874667,0.009175765,0.00023678095,0.000022624907,0.0000038486573,0.00012887747,0.000070004266,0.000016130982],"category_scores_gemma":[0.00869971,0.00016303084,0.00087302976,0.00025272302,0.00035665682,0.00008007966,0.0001933213,0.0003206137,8.129845e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060234877,0.000037327307,0.00261482,0.9667388,0.00572676,0.00010368304,0.000018865203,9.811599e-7,0.0000057659495,0.00003750759,0.00053587364,0.02357722],"study_design_scores_gemma":[0.0035830091,0.000814306,0.013721678,0.9235913,0.03117272,0.00010221064,0.00001445892,0.0000058897062,0.0000058126625,0.000005370629,0.026842408,0.00014083576],"about_ca_topic_score_codex":3.9943663e-7,"about_ca_topic_score_gemma":4.3736403e-8,"teacher_disagreement_score":0.04314755,"about_ca_system_score_codex":0.00002111948,"about_ca_system_score_gemma":0.00025167974,"threshold_uncertainty_score":0.9996504},"labels":[],"label_agreement":null},{"id":"W4412532807","doi":"10.1007/s00228-025-03880-0","title":"The effects of trazodone exposure during pregnancy on fetal outcomes: a systematic review","year":2025,"lang":"en","type":"review","venue":"European Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Trazodone; Medicine; Pregnancy; Fetus; Obstetrics; Pharmacology; Antidepressant; Internal medicine; Biology","score_opus":0.06633688570507604,"score_gpt":0.4618646273763413,"score_spread":0.39552774167126525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412532807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021072924,0.9878131,0.0000025004538,0.0004164956,0.00728028,0.0034880303,0.000009749069,0.000016040005,0.0007630462],"genre_scores_gemma":[0.00030117633,0.9950654,0.000022807648,0.0011173221,0.0005959045,0.000047559482,0.00000269429,0.000058424786,0.0027887407],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9837262,0.008309182,0.006763841,0.00029928886,0.0005262926,0.00037521933],"domain_scores_gemma":[0.9848164,0.008801452,0.0053179874,0.00050195446,0.00021040473,0.00035183516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040225512,0.00048178594,0.006956114,0.00017450875,0.000111042864,0.000009929688,0.00074075407,0.00015650902,0.000035003315],"category_scores_gemma":[0.004294616,0.00024145946,0.0023792018,0.00019840417,0.00015998454,0.000039964914,0.00014325225,0.0022412662,0.00007076241],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029332386,0.00043415817,0.000021798432,0.9520846,0.0015206302,0.003306669,0.000014571878,5.2012002e-8,3.8803685e-7,0.0000061021906,0.0005127886,0.04180491],"study_design_scores_gemma":[0.0026709621,0.0029622102,0.0002461117,0.9512974,0.012589172,0.00091697724,0.0000016439334,7.7557e-8,0.000010352396,0.0000016353139,0.029158818,0.00014461913],"about_ca_topic_score_codex":1.812761e-7,"about_ca_topic_score_gemma":6.647527e-8,"teacher_disagreement_score":0.04166029,"about_ca_system_score_codex":0.000065757864,"about_ca_system_score_gemma":0.00043829984,"threshold_uncertainty_score":0.98464316},"labels":[],"label_agreement":null},{"id":"W571725045","doi":"10.1007/s00228-015-1881-4","title":"Trends in inpatient antiparkinson drug use in the USA, 2001–2012","year":2015,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of Ottawa","funders":"Canadian Institutes of Health Research; National Institute of Neurological Disorders and Stroke; Fulbright Canada","keywords":"Medicine; Polypharmacy; Pergolide; Levodopa; Population; Drug; Pharmacology; Parkinson's disease; Dopamine agonist; Disease; Internal medicine; Dopamine; Dopaminergic","score_opus":0.19754883722920422,"score_gpt":0.44073620332668356,"score_spread":0.24318736609747935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571725045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907194,0.00038465246,0.000019520625,0.0023559642,0.0018956411,0.00013358594,0.000005041461,0.000004874788,0.0044813305],"genre_scores_gemma":[0.99240744,0.00032165818,0.0004099445,0.0054091616,0.0008338643,0.0000018731699,0.0000046919245,0.000021759297,0.00058959646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947904,0.00297363,0.0013435627,0.0002053928,0.00036481625,0.00032219695],"domain_scores_gemma":[0.9982919,0.0004060206,0.00053097954,0.00016619841,0.00012405482,0.00048082083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005375234,0.00015985894,0.00057096564,0.0003531612,0.000021645601,0.000016089642,0.0002616373,0.00004242871,0.0004205963],"category_scores_gemma":[0.00038626665,0.0000992429,0.00023579694,0.00032637798,0.00009391671,0.0001975521,0.000058798738,0.00081371726,0.00012735793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004050996,0.0045191315,0.75180155,0.000007382448,0.00016679983,0.016589021,0.00049663906,0.00006767289,0.000111289,0.000015085936,0.18212831,0.0400461],"study_design_scores_gemma":[0.012829497,0.0013227292,0.7324603,0.000038847647,0.00015605618,0.00016863017,0.000054704527,0.00007593513,0.000039043574,0.000019697834,0.25276196,0.00007255492],"about_ca_topic_score_codex":0.000024673094,"about_ca_topic_score_gemma":0.00006183999,"teacher_disagreement_score":0.070633665,"about_ca_system_score_codex":0.000065411514,"about_ca_system_score_gemma":0.00015496544,"threshold_uncertainty_score":0.46052346},"labels":[],"label_agreement":null},{"id":"W883499483","doi":"10.1007/s00228-015-1889-9","title":"Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons","year":2015,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Interchangeability; Bioequivalence; Equivalence (formal languages); Point estimation; Sample size determination; Statistics; Econometrics; Medicine; Statistical power; Sample (material); Mathematics; Computer science; Pharmacology; Pharmacokinetics; Chromatography","score_opus":0.3642071753732102,"score_gpt":0.45116830184339196,"score_spread":0.08696112647018178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W883499483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931662,0.0034192952,0.00010447494,0.0010965075,0.0008918209,0.00017760853,0.0001504155,0.000009223614,0.0009844498],"genre_scores_gemma":[0.99664164,0.0012361136,0.0007468973,0.0010899993,0.00024483548,0.0000010906973,0.0000012718161,0.00002676856,0.000011376897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99517035,0.00057242054,0.0035288043,0.00034035443,0.00009591971,0.0002921308],"domain_scores_gemma":[0.9939953,0.0018574498,0.0032642898,0.00020338655,0.00027345374,0.0004060842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008415866,0.00022152833,0.0015484745,0.0002915657,0.00004639495,0.000024403867,0.00063116313,0.0000614737,0.00002580352],"category_scores_gemma":[0.0031360448,0.00020934813,0.00016609096,0.00025190786,0.0006256157,0.00029921616,0.0003113297,0.0006233934,0.000026191134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008017011,0.0019183474,0.9431192,0.00012766187,0.001713386,0.00010615315,0.0038297696,0.007077661,0.00078567123,0.00065606873,0.037545845,0.0023185315],"study_design_scores_gemma":[0.023760373,0.02546935,0.8856111,0.00036917554,0.001071417,0.000066614506,0.0033184255,0.0032154096,0.0147396065,0.0041381842,0.036693815,0.0015464979],"about_ca_topic_score_codex":0.000010222588,"about_ca_topic_score_gemma":6.909377e-7,"teacher_disagreement_score":0.05750807,"about_ca_system_score_codex":0.000042809243,"about_ca_system_score_gemma":0.00008005933,"threshold_uncertainty_score":0.8536969},"labels":[],"label_agreement":null}]}